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The requirement for the dual expression of PTPα and Src for mouse embryonic 
development and integrin signaling was investigated using genetically modified mutant 
mice or cells with a deficiency in both PTPα and Src. PTPα/Src homozygous double 
mutant mice were generated by intercrossing PTPα+/-Src+/- or PTPα-/-Src+/- mice. 
Mouse fibroblasts were isolated from embryos of appropriate genotypes, and 
spontaneously immortalized. 
 
The combined ablation of PTPα and Src does not result in embryonic lethality, but 
appears to increase the rate of postnatal mortality between birth and three weeks of age. 
PTPα/Src double mutant mice exhibit toothlessness and growth retardation manifested 
in reduced overall body weight and reduced weight of many major organs, similar to 
defects in single mutant Src-null mice. These findings suggest that the dual expression 
of PTPα and Src is not essential for mouse embryonic development and that the 
observed defects are mainly attributable to the ablation of Src. Despite the absence of 
additional unique defects in PTPα/Src double mutant mice, the enhanced incidence of 
postnatal mortality suggests that the residual activity of Fyn, Yes and/or other SFKs in 
PTPα-/-Src-/-mice can be insufficient for normal maturation to the adulthood.  
 
Mouse embryonic fibroblasts with a combined absence of PTPα and Src display 
reduced adhesion to and spreading on fibronectin (FN), accompanied by altered 
cytoskeletal organization, that is distinct from or more severe than the defects in single 




comparable to that in wild type cells, even though this is reduced in PTPα-/- cells and 
delayed in Src-/- cells. Typically, downregulation of Erk is observed upon cell 
detachment from the substratum, however, in the double mutant cells, Erk remains 
fully activated when the cells are placed in suspension. These observed defects in cells 
dually deficient in PTPα and Src suggest that PTPα-mediated SFK activation is 
essential for integrin signaling, and plays a negative feedback role in orchestrating 
integrin signaling. 
 
To determine how PTPα is regulated upon integrin stimulation and how a signal 
emanating from integrin is transduced to PTPα, thus linking the actions of PTPα to 
SFKs, the phosphorylation status of PTPα was investigated. PTPα is phosphorylated at 
Tyr789 upon integrin stimulation, and SFKs (either Src or Fyn/Yes) are required for 
full integrin-induced PTPα phosphorylation. Further investigations show that integrin-
stimulated phosphorylation of PTPα depends on PTPα catalytic activity, the formation 
of SFK-FAK complex, and on an intact cytoskeleton. Unlike mitosis, PTPα 
phosphorylation is not required for integrin-induced Src and Fyn activation. However, 
it is essential for downstream events that promote cytoskeletal reorganization, focal 
adhesion formation, and cell migration. These findings identify and distinguish two 
roles of PTPα in integrin signaling, an early role as an SFK activator which is not 
phosphorylation dependent, and a later role in cytoskeletal organization that requires 
its phosphorylation. 
 
These studies demonstrate that PTPα and Src are two interconnected molecules with 
reciprocal interactions in the complex network of integrin signaling. PTPα functions in 
integrin signaling both as an SFK activator and an SFK effector.  









1. 1 Protein phosphorylation 
Phosphorylation of proteins on serine/threonine or tyrosine residues is a rapid, 
reversible post-translational modification that functions as a specific “switching” 
mechanism to form or disrupt regulatory connections between proteins. Reversible 
protein phosphorylation is crucial for the regulation of numerous cellular events, 
including cell growth and tissue differentiation, inter-cellular communication, as well 
as immune responses. Protein phosphorylation is a highly regulated process by which 
information can be shuttled from the cell surface to the nucleus. The balance of protein 
phosphorylation is under the control of kinases and phosphatases. 
 
Compared to protein phosphorylation in general, phosphorylation on tyrosine residues 
is extensively utilized only in multicellular eukaryotes. Tyrosine phosphorylation plays 
key roles in many biological processes including proliferation, differentiation, 
migration, and survival, and is also important in coordinating processes among 
neighbouring cells in embryogenesis and organ development, as well as tissue 
homeostasis (Hunter 1995). Abnormalities in tyrosine phosphorylation can lead to 
numerous inherited or acquired human diseases. Transmembrane and intracellular 
protein tyrosine kinases (PTKs) are activated by extracellular signals and generate 
phosphotyrosyl proteins, either by auto- or substrate phosphorylation. The first PTK to 
be identified was v-Src (a Rous sarcoma virus protein) which can transform cells 
through initiating tyrosine phosphorylation-based signaling events (Brugge et al., 1977; 
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Eckhart et al., 1979; Hunter et al., 1980; Sefton et al., 1980). Based on the current 
genome sequence information, it is estimated that there are more than 100 PTKs 
encoded by the human genome (Alonso et al., 2004). It is generally agreed that 
tyrosine phosphorylation is regulated by the equal and balanced actions of PTKs and 
protein tyrosine phosphatases (PTPs), but the first PTP was purified and characterized 
in 1988 (Tonks et al., 1988), ten years following the first identification of PTKs 
(Brugge et al., 1977; Eckhart et al., 1979; Hunter et al., 1980; Sefton et al., 1980). 
Subsequently, a large number of PTPs were identified through cDNA cloning using 
polymerase chain reaction (PCR) and low-stringency hybridization techniques. Recent 
findings have led to the understanding that PTPs play specific and active, even 
dominant, roles in setting the levels of tyrosine phosphorylation in cells and in the 
regulation of physiological processes (Fischer et al., 1991; Walton et al., 1993; Tonks 
et al., 1996; Mustelin et al., 2003). PTP1B was the first PTP to be identified (Tonks et 
al., 1988). A surprising finding was that PTP1B did not show any significant overall 
sequence similarity to the serine/threonine protein phosphatases (PPs), indicating that 
it evolved separately. After nearly twenty years of investigation of PTPs, it is now 
clear that they comprise a large superfamily of related enzymes (Fig. 1.1). There are 
107 genes in the human genome that encode members of four PTP families (Alonso et 
al., 2004). Moreover, PTPs are highly specific, not only for particular phosphorylated 
proteins but also for non-protein (i.e. phospholipid) substrates. 
 
1.2 Protein tyrosine phosphatase (PTP) superfamily 
Protein phosphatases can be generally divided into two main groups, PPs and PTPs, 
based on their substrate specificity. PPs, such as PP1 and PP2A, specifically hydrolyze 
serine/threonine phosphoesters (P-Ser/Thr) and comprise a large family of metallo-
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protein enzymes whose functions within the cells are extremely diverse and highly 
regulated. Catalysis by PPs has been proposed to proceed by a direct attack of an 
activated water molecule on the phosphorus center of the substrate, without phosphoryl 
transfer to the enzyme (Egloff et al., 1995). PPs play in a variety of key roles in 
biological processes including embryonic development, cell proliferation, and death. 
Unlike PPs, PTPs dephosphorylate phosphotyrosine (P-Tyr) and possess different 
characteristics of protein structure and catalytic mechanism. PTPs do not share any 
sequence similarity with PPs, and they do not require metal ions for catalysis (Dixon 
1995; Denu et al., 1996). 
 
PTPs are characterized by a conserved active sequence motif within the catalytic 
domain of ∼240 amino acid residues (PTP domain). The catalytic domain of each PTP 
displays 30-40% identity among individual enzymes. Outside the conserved catalytic 
domain, the amino acid sequences of PTPs vary greatly. The first PTP crystal structure, 
that of PTP1B (Barford et al., 1994; Jia et al., 1995), provided insights into what 
structural elements constituted the minimum PTP catalytic domain and suggested 
which region defined substrate specificity. Subsequent crystal structures of other PTPs 
have confirmed and refined these general characteristics. All PTPs possess at least one 
catalytic domain, and each PTP is composed of at least one conserved domain 
characterized by a signature motif CX5R containing cysteine and arginine residues 
known to be essential for PTP catalytic activity (Guan et al., 1991). 
 
Based on overall structure and subcellular localization, PTPs are divided into two 
groups, receptor-like (RPTPs) and intracellular PTPs (Fig. 1.1). The ligands for RPTPs 
are largely unknown. RPTPs consist of an extracellular domain, one transmembrane 
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spanning region, and two tandem intracellular PTP domains. The exception is a small 
















































































Figure 1.1. Schematic diagram of structures of selected members of the PTP 
superfamily. The inset box shows some of the various structural motifs that can be 
found in the PTPs (FN-III: Fibronectin type-III; MAM: Meprin/A5/PTPμ domain; Ig: 
Immunoglobulin-like domain; CAH: Carbonic anhydrase-like; C(X5)R: PTP signature 
motif; SH2: Src homology 2 domain; PEST: Pro-Glu-Ser-Thr motif; CH2A/B: 
sequence homology found in Cdc25; CAAX: prenylation motif). 
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Intracellular PTPs possess a single catalytic domain with flanking regions often 
containing novel protein-protein interaction or targeting domains that direct the 
enzymes to specific intracellular locations. DSPs (dual specific PTPs) are an additional 
family of intracellular PTPs that can dephosphorylate both P-Ser/Thr and P-Tyr. PTEN 
is classified as a DSP, and in addition to its protein tyrosine phosphatase activity, it 
plays a major role in cells as a lipid phosphatase. Another member of the intracellular 
PTPs is LMW-PTP (low molecular weight PTP), an 18 KDa enzyme that is widely 
expressed in many cells. It has been shown that LMW-PTP can dephosphorylate the 
PDGF receptor or p190RhoGAP in PDGF signaling (Chiarugi et al., 2000). The PRLs 
are 3 closely related intracellular PTPs with a unique (among PTPs) C-terminal 
prenylation motif (CAAX motif), and the expression of PRL-3 is upregulated in colon 
cancer metastases (Zeng et al., 2000; Saha et al., 2001). 
 
1.3 Catalytic mechanism of protein tyrosine phosphatases 
Crystal structures of the catalytic domains of PTP1B (Barford et al., 1994; Jia et al., 
1995), Yop51 PTP (Stuckey et al., 1994; Fauman et al., 1996), VHR (Yuvaniyama et 
al., 1996) and LMW-PTPs (Su et al., 1994), in conjunction with the kinetic data from 
in vitro assays, have provided bases for understanding the specificity of 
phosphotyrosine recognition and the mechanism of catalysis. Enzymological and 
mutational studies have elucidated that all PTPs share a common two-step catalytic 
mechanism. The first step is the formation of a covalent thiophosphate intermediate 
through transfer of the phosphate group on the substrate to the essential cysteine 
residue in the PTP active site. This is a rate-limiting step in most PTP-mediated 
catalyses. The second step is the hydrolysis of the phosphate group from the 
intermediate and recovery of the enzyme (Guan et al., 1991; Zhang et al., 1995). 
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The PTP signature motif C(X5)R within each PTP domain forms a continuous 
phosphate-binding loop located at the base of the catalytic cleft, with the invariant 
cysteine residue (C) at the bottom of the active cleft (Neel et al., 1997). Only the side 
chain of a P-Tyr residue in a target substrate is of sufficient length to reach the 
catalytic cysteine residues at the bottom of the cleft; while P-Ser and P-Thr are too 
short to be dephosphorylated (Dixon 1995). A WPD loop located ~30 amino acids N-
terminal to the active site is important for PTP-mediated catalytic hydrolysis. The 
aspartic acid residue (Asp) within the WPD loop serves as a general acid for the 
formation of a phospho-enzyme intermediate (Barford et al., 1994; Zhang et al., 1994; 
Jia et al., 1995). Upon substrate binding, the phosphorylated tyrosine residue of the 
substrate fits into the catalytic cleft and the WPD loop moves closer to the 
phosphotyrosine residue. The phenyl ring of the phosphotyrosine residue is protonated 
by the Asp of the WPD loop, facilitating a nucleophilic attack by the essential cysteine 
residue on the phosphoester bond and resulting in the formation of a thiophosphate 
intermediate (Guan et al., 1991; Cho et al., 1992; Wo et al., 1992). The intermediate 
then undergoes hydrolysis by a water molecule which is hydrogen bonded to the WPD 
Asp, releasing the phosphate moiety and allowing the recovery of the active enzyme 
(Lohse et al., 1997; Zhang 1998). The mutation of Asp to Ala in the WPD loop 
dramatically reduces PTP catalytic activity, converting the enzyme into a substrate-
trapping mutant (Denu et al., 1996; Wu et al., 1996; Flint et al., 1997; Lohse et al., 
1997). 
 
1.4 Receptor-like PTPs and their features 
Generally, RPTPs consist of an intracellular segment containing one or two PTP 
domains, a single transmembrane domain and a variable extracellular segment. 
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Interestingly, the second PTP domain of most RPTPs displays little or no catalytic 
activity, suggesting that the second PTP domain may have another role (Streuli et al., 
1990; Cho et al., 1992). The diversity of extracellular segments of RPTPs presumably 
reflects an equivalent diversity in the ligands to which they may respond, although the 
ligands for the RPTPs have generally not been identified. RPTPs can be subdivided 
into five types based on common features found in the extracellular domains (Fig. 1.1). 
Type I RPTPs are represented by the hematopoietic cell restricted CD45 family, which 
has multiple isoforms that vary in size of the extracellular domain, and arise from the 
differential splicing of exons 4, 5, and 6 (Thomas et al., 1987). CD45 was first 
identified as a major surface protein on nucleated hematopoietic cells, and is critical 
for classical antigen receptor signaling by modulating SFK activity (Ostergaard et al., 
1989; Thomas 1989; Guttinger et al., 1992; Cahir McFarland et al., 1993). Type II 
RPTPs are LAR (leukocyte common antigen related protein)-like PTPs, including 
LAR, PTPδ, and PTPσ. The extracellular segments of this type of PTP consist of three 
immunoglobulin-like (Ig-like) repeats and four to eight type-III fibronectin (FN-III) 
repeats depending on the alternative splicing. They are expressed as pro-proteins and 
undergo a proteolytic process to generate functional LAR-PTPs (Streuli et al., 1988; 
Streuli et al., 1992). With the exception of LAR that is widely expressed, most other 
LAR-like PTPs are preferentially expressed in neurons, and are implicated in neuronal 
development (Tian et al., 1991; Thompson et al., 2003). Type III RPTPs are 
characterized by eight fibronectin type-III like repeats within their extracellular 
domains, such as PTPβ. PTPα and PTPε are type IV PTPs, and the members of this 
small group generally have a short, heavily glycosylated extracellular domain. PTPα 
has been shown to play roles in cell proliferation, transformation, and neuronal 
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differentiation (Pallen 2003). Type V molecules include PTPξ and PTPγ, which have 
an N-terminal carbonic anhydrase-like domain (CAH-like). 
 
1.5 Receptor-like protein tyrosine phosphatase alpha (PTPα) 
1.5.1 Overview of PTPα 
PTPα, isolated by many groups using PCR-based PTP identification and cloning, is a 
widely expressed transmembrane molecule that is particularly highly expressed in 
brain (Kaplan et al., 1990; Krueger et al., 1990; Matthews et al., 1990; Sap et al., 1990). 
It is a ∼130 kDa membrane-spanning PTP that has a very short and heavily 
glycosylated extracellular domain that is connected to two classic intracellular catalytic 
domains (termed D1 and D2) (Fig. 1.2). The ligand for PTPα has not been identified. 
Three alternatively spliced variants of PTPα have been reported.  The smallest isoform 
lacking any insertions is a ubiquitously expressed 123 amino acid form of PTPα, 
with/on which most studies have been conducted.  A second isoform is expressed in 
brain, skeletal muscle and certain differentiated cell types that contains a 9 amino acid 
insertion in the juxtamembrane extracellular domain arising from the alternative 
splicing of a 27 base pair mini-exon (Kaplan et al., 1990; Krueger et al., 1990). These 
two isoforms have similar catalytic activities in vitro, including towards the SFKs Fyn 
and Src. However, when expressed in cultured cells, the larger isoform is twice as 
effective in promoting the transforming activity of Src (Kapp et al., 2007). A third 
splice variant of PTPα contains a 36 amino acid insertion within the first catalytic 
domain (Matthews et al., 1990), however no studies have examined the expression of 
this isoform or the effects of this insertion on PTPα function. Another unusual 
characteristic of PTPα is that the membrane distal domain (PTPα-D2) of PTPα has 
detectable catalytic activity, although this is much lower than that of the membrane 
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proximal domain (PTPα-D1) (Wang et al., 1991; Lim et al., 1997). Most first or 
membrane proximal domains (D1) of RPTPs such as CD45 or LAR are catalytically 
active, whereas the second or membrane distal domains (D2) have either no detectable 
or extremely low in vitro activity, usually less than 0.1% of that of D1 (Streuli et al., 
1990; Cho et al., 1992). The D2 domain of PTPα displays about 10% of D1 activity 
towards the low molecular weight substrate para-nitrophenyl phosphate (pNPP) (Lim 
et al., 1997; Wu et al., 1997). The relatively high activity of PTPα-D2 towards pNPP is 
due to two factors, the higher intrinsic activity of PTPα-D2 compared to that of the D2 
domains of other RPTPs, and/or the lower activity of PTPα-D1 compared to that of D1 
of other RPTPs (Lim et al., 1997; Wu et al., 1997). PTPα-D2 has catalytic activity 
towards pNPP, but it does not display the same relative level of activity towards 
phosphotyrosyl peptide substrates. Sequence alignment of these two domains has 
revealed that the different catalytic activity and substrate recognition result from only 
two amino acid differences between D1 and D2, and this has been confirmed by the 
point mutation of each residue in PTPα-D2 to its variant counterpart in PTPα-D1 (Val 
536 to Tyr or Glu 671 to Asp). The mutation of these two residues within PTPα-D2 
positively affects the catalytic efficiency of D2 towards both pNPP and phosphotyrosyl 
peptide (Lim et al., 1998; Buist et al., 1999). The differences in PTPα-D2 catalytic 
activity and substrate specificity from PTPα-D1 indicate disparate functions of these 
two domains. The evolutionary conservation and intrinsically low activity of the PTP-
D2 domain infer a non-enzymatic role of this domain in PTP functions, perhaps 
through effecting protein-protein interactions that could regulate specific PTP targeting 
and substrate localization. 
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1.5.2 Biological properties of PTPα 
1.5.2.1 Substrates of PTPα 
Overexpression of PTPα in rat embryo fibroblasts or in P19 embryonic carcinoma 
cells increases Src/Fyn activity, and induces cell transformation and neuronal 
differentiation, respectively (Zheng et al., 1992; den Hertog et al., 1993). Conversely, 
the ablation of PTPα in mice results in decreased Src/Fyn activity, accompanied by 
increased phosphorylation at the Src/Fyn C-terminal tyrosine residue (Ponniah et al., 
1999; Su et al., 1999). The latter finding indicates that Src and Fyn are physiological 
substrates of PTPα. The insulin receptor (IR) was implicated as another potential 
substrate in experiments overexpressing PTPα in baby hamster kidney cells stably 
overexpressing insulin receptors (BHK-IR). In this system, PTPα down-regulated 
insulin signaling by dephosphorylating the insulin receptor (Moller et al., 1995). A 
constitutive interaction of the IR with PTPα and PTPε was detected in 293 cells using 
a bioluminescence resonance energy transfer (BRET) method, and it was reported that 
insulin stimulation does not further recruit PTPα or PTPε to the IR (Lacasa et al., 
2005). However, insulin signaling transduction is normal in PTPα-deficient mice, 
suggesting that PTPα does not play an essential role in insulin signaling (Le et al., 
2004). In addition, an adaptor protein p130Cas has been identified as a substrate of 
PTPα in NIH3T3 cells using a substrate trapping strategy (Buist et al., 2000). 
 
1.5.2.2 Biological functions of PTPα 
The role of PTPα-mediated Src/Fyn activation has been widely investigated in mouse 
and cell systems. PTPα has been shown to play a role in cellular differentiation of the 
skeletal muscle. Myoblasts with antisense RNA-mediated diminished PTPα expression 
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fail to undergo fusion, and do not form myotubes in differentiation media, a process 
that occurs via an Src-mediated signaling pathway (Lu et al., 2002). PTPα-mediated 
Src/Fyn activation is essential for integrin signaling, as fibroblasts derived from PTPα-
null mice possess reduced Src/Fyn activity and are defective in integrin-mediated cell 
spreading and migration (Ponniah et al., 1999; Su et al., 1999; Zeng et al., 2003). The 
role of PTPα in integrin signaling is fully discussed in section 1.7.2.1. As an activator 
of SFKs, PTPα is involved in mitosis by activating Src via a displacement mechanism 
(Zheng et al., 2001). PTPα is tyrosine phosphorylated at its C-terminal tyrosine residue 
789, and associates with the SH2 domain of Grb2 (an adaptor protein). Mitotic stimuli 
can induce a conformational change of PTPα and disrupt the interaction of phospho-
Tyr789 with Grb2. The exposed phospho-Tyr789 of PTPα binds to the Src SH2 
domain and brings the phospho-Tyr527 of Src closer to the PTPα catalytic domain to 
be dephosphorylated, thus activating Src (Zheng et al., 2001; Zheng et al., 2002). 
 
Correlating with its high expression in brain, PTPα plays an essential role in the 
central nervous system (CNS). Histological analysis reveals a less compacted CA1 
hippocampal region obtained from PTPα-/- mouse brain than in wild type animals. This 
hippocampal abnormality in PTPα-/- mice results from the reduced migration of 
neurons in the pyramidal cell layers in the CA1 region during embryonic development, 
suggesting a role of PTPα in hippocampal development (Petrone et al., 2003). PTPα 
plays a role not only in hippocampal development, but also in hippocampal function. 
PTPα interacts with N-methyl-D-aspartate receptors (NMDARs) and is involved in the 
induction of synaptic long-term potentiation (LTP) in CA1 hippocampal neurons, 
which is related to learning and memory (Lei et al., 2002; Petrone et al., 2003). 
Phosphorylation of NMDARs upon stimulation increases their activity and is 
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important for their proper functions. NMDARs are phosphorylated by Src and/or Fyn 
and PTPα-mediated Src and Fyn activation is important (Tezuka et al., 1999; Cheung 
et al., 2001; Le et al., 2006). Consistent with the defects observed in hippocampus in 
the absence of PTPα, mouse behavioral studies indicate that PTPα-null mice have 
defects in Morris Maze learning, decreased locomotor activity, and decreased anxiety 
(Skelton et al., 2003). In addition, a recent finding shows that PTPα is essential for 
neural adhesion molecule (NCAM)-mediated Fyn activation and neurite elongation. 
NCAM-induced neurite outgrowth is blocked in PTPα-deficient neurons, or in neurons 
transfected with catalytically inactive form of PTPα (Bodrikov et al., 2005). 
 
More investigations have identified that PTPα is also an important molecule involved 
in a variety of other biological processes, including the regulation of potassium 
channel activity or its involvement in T cell signaling. Although CD45 is the most 
highly expressed phosphatase in hematopoietic cells, the expression of PTPα is also 
detectable in thymocytes and splenocytes. Like CD45, PTPα is required for CD3-
induced T-cell proliferation, but unlike CD45 it is not required for T-cell development 
(Kishihara et al., 1993; Maksumova et al., 2005). PTPα is a component of the SFK 
regulatory network in thymocytes and is required for suppression of Fyn activity in the 
unstimulated cells. The regulatory functions of PTPα in T cells cannot be compensated 
for by CD45 (Maksumova et al., 2005). The regulatory role of PTPα in a voltage-gated 
potassium channel (Kv1.2 channel) was demonstrated in a cell culture system. 
Tyrosine phosphorylation of Kv1.2 channel inhibits its activity. m1 binding to its 
receptor mAChR (muscarinic acetylcholine receptor) induces tyrosine phosphorylation 
and suppression of Kv1.2 channel (Huang et al., 1993). PTPα associates with the 
Kv1.2 channel upon stimulation of 293 cells stably expressing mAChR and the Kv1.2 
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channel, and can affect Kv1.2 activity in m1-mAChR signaling by dephosphorylating 
the Kv1.2 channel (Tsai et al., 1999). Tyrosine phosphorylation of PTPα is important 
for its regulation of Kv1.2, although this does not change PTPα catalytic activity (Tsai 
et al., 1999). 
 
Taken together, these findings suggest that PTPα plays many critical roles in 
regulating various cellular events. Nevertheless, most or all of its functions are effected 
through dephosphorylation and activation of Src and/or Fyn. 
 
1.5.3 Combinatorial regulation of PTPα catalytic activity and specificity 
Although the ligands for RPTPs have not been identified, PTP catalytic activity and 
specificity are as tightly regulated as those of PTKs, showing high specificity for 
particular phosphorylated proteins and even non-protein (i.e. phospholipid) substrates. 
Overall, PTPα catalytic activity and specificity are regulated in a combinatorial 




Crystallization of PTPα-D1 revealed a symmetrical dimer formed by the interaction of 
a helix-turn-helix “wedge” at the N-terminal region of D1 of one monomer with entry 
to the D1 catalytic motif of the other monomer (Bilwes et al., 1996). The insertion of 
the wedge in PTPα is predicted to interfere with substrate binding and inhibit its 
activity. Evidence of PTPα dimerization has been obtained using fluorescence 
resonance energy transfer (FRET) between cyan and yellow derivatives of the green 
fluorescent protein fused to PTPα (Tertoolen et al., 2001). A negative effect of PTPα 
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homodimerization has been demonstrated in vivo. Stable disulphide-bonded full-length 
PTPα homodimers are formed by ectopic expression in PTPα-/- cells of different 
mutants with single cysteine (Cys) residue replacement at different positions in the 
juxtamembrane region of PTPα. Expression of a Pro137Cys mutant cannot rescue the 
ability of PTPα to activate Src while expression of wild type PTPα or Phe135Cys and 
Thr141Cys mutants can, suggesting that homodimerization of PTPα at Cys137 
probably inhibits PTPα catalytic activity towards phospho-Tyr527 of Src (Jiang et al., 
1999). The transmembrane region of PTPα seems to be essential for intermolecular 
associations, but not the helix-turn-helix wedge in PTPα-D1 domain, as dimer 
formation is not prevented by the mutation or deletion of the entire cytoplasmic region 
(Jiang et al., 2000). Further investigations have revealed that H2O2-induced oxidation 
resulted in a conformational change of PTPα mediated by oxidation of cysteine residue 
of PTPα-D2 domain, and thus stabilizing the inactive dimer (van der Wijk et al., 2003). 
Compared to the PTPα-D1 domain, the PTPα-D2 domain does not possess an 
inhibitory wedge motif and the N-terminal region of D2 is more flexible (Sonnenburg 
et al., 2003). The flexibility of PTPα-D2 is likely to be important for dynamic 
alterations in intra- and intermolecular interactions that are critical for PTPα function. 
 
1.5.3.2 Phosphorylation 
PTPα is constitutively tyrosine phosphorylated at a residue very near its C-terminus, 
Tyr789 (Fig. 1.2) (den Hertog et al., 1994; Su et al., 1994). Normally, ~20% of cellular 
PTPα is phosphorylated at Tyr789, but the phosphorylation level can be increased by 
the transient overexpression of Src, suggesting that Src may be the kinase responsible 
for phosphorylating Tyr789 in vivo (den Hertog et al., 1994). Phosphorylated Tyr789 
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creates a binding site on PTPα for Grb2 via its SH2 domain (den Hertog et al., 1994; 
Su et al., 1996), or for Src/Fyn via the SH2 domain (Zheng et al., 2002), and 
potentially for other unidentified proteins. The intrinsic catalytic activity of PTPα is 
not affected by the phosphorylation status of PTPα at 789, as PTPα mutated at this site 
displays a level of catalytic activity comparable to that of wild type PTPα (Su et al., 
1996; Zheng et al., 2000). The importance of PTPα phosphorylation at Tyr789 has 
been demonstrated in cell culture systems. Overexpression in PC12 cells of PTPα 
mutated at Tyr789 significantly enhances FGF-induced neurite outgrowth while 
expression of wild type PTPα inhibits neurite outgrowth, although the mechanism is 
unclear. In addition, phosphorylation of PTPα at Tyr789 may mediate its localization 
to focal adhesions, as the PTPαY789F mutant cannot be detected at focal adhesion 
sites when it is expressed in NIH3T3 cells (Lammers et al., 2000). Phosphorylation of 
PTPα at Tyr789 is important for the regulation of PTPα specificity rather than activity, 
and is required for Src activation during mitosis (Zheng et al., 2001; Zheng et al., 
2002). Phosphorylated PTPα possesses higher catalytic activity towards phospho-
Tyr527 than towards phospho-Tyr416 in Src. However, its dephosphorylation of more 
general PTP substrates such as Raytide and myelin basic protein exhibits no different 
effects (Zheng et al., 2000). 
 
In fibroblasts, serine phosphorylation of PTPα is detectable at two major sites, Ser180 
and Ser202 in the intracellular juxtamembrane domain (Fig. 1.2). Phosphorylation of 
these two serine residues of PTPα increases its catalytic activity ∼1.5-2 fold. Protein 
kinase C (PKC) is responsible for PTPα serine phosphorylation, although it is not clear 
which PKC isoform phosphorylates PTPα (Tracy et al., 1995; Zheng et al., 2001; 
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Zheng et al., 2002). PTPα is found to associate with PKCδ in a signaling complex that 
mediates the anti-tumor activity of TT-332 (a somatostatin analogue), and lies 
downstream of phosphoinositide-3 kinase (PI3-K) and PKCδ in the signaling pathway 
(Stetak et al., 2001). Phosphorylation of PTPα at Ser180 and Ser204 reduces the 
affinity of Grb2 SH2 binding to phospho-Tyr789 of PTPα without reducing the 
affinity of Src SH2 binding, resulting in less Grb2 and more Src binding to PTPα 
during mitosis (Zheng et al., 2002). How PTPα serine phosphorylation influences 
phospho-Tyr789 binding affinity is unclear. One possibility is that serine 
phosphorylation of PTPα can induce a conformation change that favors its binding 
affinity to the SH2 domain of Src rather than to that of Grb2. 
 
1.5.3.3 Protein-protein interactions 
Besides the association of tyrosine phosphorylated PTPα with the SH2 domains of 
Grb2 or Src, several other proteins that interact with PTPα have been identified and 
proposed to modulate its functions (Fig. 1.2). The extracellular region of PTPα 
associates in cis with the glycosylphosphatidylinositol-linked cell surface molecule 
contactin, possibly forming a receptor complex in which PTPα transduces a signal to 
activate Fyn (Zeng et al., 1999). Through cDNA expression library screening, the 
Ca2+-binding protein calmodulin (CaM) has been discovered to interact with a region 
in the N-terminus of the PTPα-D2 domain, blocking the interaction of even a small 
molecule like pNPP with the catalytic cleft (Liang et al., 2000). PTPα-D2 can 
indirectly associate with NMDARs through the PDZ2 domain of the scaffolding 
protein postsynaptic density 95 (PSD-95) (Lei et al., 2002). PSD-95 is an important 
adaptor protein that mediates the association of Src/Fyn with the NMDARs through its 
PDZ domains (Tezuka et al., 1999; Cheung et al., 2001). Another molecule NCAM 
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associates with PTPα in brain, required for NCAM-mediated Fyn activation (Bodrikov 
et al., 2005). Furthermore, PTPα interacts with the integrin subunit α5 upon cross-





































Figure 1.2. PTPα catalytic activity and specificity are regulated by 
phosphorylation and protein-protein interaction (adapted from (Pallen 2003). The 
phosphorylation of two serine residues (S180/204) at the intracellular juxtamembrane 
domain of PTPα can increase catalytic activity 1.5-2 fold. Phosphorylated Tyr789 near 
the C-terminus can interact with the SH2 domain of Grb2 or SFKs. Several proteins 
can interact with the D2 domain of PTPα, including camodulin (CaM) and 
postsynaptic density protein (PSD-95). Contactin is a cell surface molecule expressed 
in brain, interacting with the extracellular region of PTPα. PTPα can interact with 
integrin subunit αv upon integrin engagement. PTPα associates with neural adhesion 
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1.5.3.4 Proteolysis 
Full length PTPα can be cleaved by calpain at a site in the intracellular juxtamembrane 
region to generate a 66kDa (p66) form of PTPα. However, the truncated PTPα retains 
its membrane localization, possibly through dimerization with uncleaved PTPα. In 
primary cortical neurons, only a small portion of PTPα was found to be cleaved by 
calpain (Gil-Henn et al., 2001). PTPα preferentially localizes to focal adhesions when 
PTPαC433S is overexpressed in NIH3T3 cells. A truncated form of PTPα (p75) is 
detected upon treatment of these cells with pervanadate, but it no longer localizes at 
focal adhesion sites (Lammers et al., 2000). The different localization of intact and 
truncated forms of PTPα indicates proteolysis is involved in regulating PTPα although 
the mechanism is still unclear. 
 
1.5.3.5 Oxidation 
Oxidation by reactive oxygen species (ROS) at the active cysteine residue within the 
PTP signature motif is a mechanism involved in regulating PTPα catalytic activity. It 
has been shown that oxidative stress induces a rapid, reversible, and cysteine-
dependent conformational change in PTPα-D2, leading to the stabilization of PTPα 
dimers, and thus to inhibition of PTPα (Blanchetot et al., 2002). A recent study 
demonstrated that phosphorylation of PTPα at tyrosine 789 can be suppressed by the 
treatment of cells with H2O2 (Hao et al., 2006), indicating the importance of oxidation 
in the regulation of PTPα function.    
 
1.6 PTPs involved in regulating Src family kinases (SFKs) 
Src was initially identified as a transforming protein (v-Src) of an oncogenic retrovirus 
(Rous sarcoma virus) (Bishop 1983). A ubiquitously expressed and highly conserved 
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cellular homologue of v-Src (termed c-Src) was subsequently discovered and proven to 
possess protein tyrosine kinase activity (Bishop 1983). Following the discovery of c-
Src, several proteins containing structures similar to c-Src have been identified and 
termed Src family kinases (SFKs) (Cance et al., 1994; Lee et al., 1994; Oberg-Welsh et 
al., 1995; Thuveson et al., 1995). c-Src has been shown to be involved in cell 
proliferation (Brown et al., 1996). Subsequent studies of these related proteins showed 
that SFKs regulate many cellular events including cytoskeletal organization, 
differentiation, survival, adhesion and migration. SFKs have nine mammalian family 
members that share redundant and specific functions. Src, Fyn, and Yes are widely 
expressed in most tissues, and Src is especially highly expressed in neurons and blood 
platelets. Hck, Blk, Fgr, Lck , Lyn, and Yrk are mainly expressed in hematopoietic 
cells. Among these members, Lck and Lyn have also been detected in neurons (Sudol 
et al., 1993; Brown et al., 1996). 
 
1.6.1 Structure and regulation of SFKs 
SFKs are 52~62 kDa proteins that are composed of six distinct functional regions. 
They contain: (1) a SH4 (SH: Src homology) domain, (2) a unique region, (3) a SH3 





















Figure 1.3. Structural organization of SFK proteins. SFKs contain six distinct 
functional regions. (1) a SH4 domain for the membrane anchorage; (2) an unique 
domain; (3) an SH3 domain that mediates the protein-protein interactions by binding 
amino acid sequences rich in proline residues; (4) an SH2 domain that binds to short 
contiguous amino acid sequences containing phosphotyrosine; (5) a kinase domain 
(SH1) containing one autophosphorylatable tyrosine residue (Y416 in Src); (6) a short 
negative regulatory tail with a tyrosine residue (Y527 in Src) that is phosphorylated by 
the cytoplasmic tyrosine kinase Csk (C-terminal Src kinase). 
 
SFKs are constitutively associated with the plasma membrane through the SH4 domain. 
The SH4 domain is typically a 15 amino acid sequence that contains a signal for 
modification by myristylation at the glycine residue (Resh 1993). The unique domain, 
specific for each SFK member, is likely responsible for the specific interaction of 
SFKs with particular receptors and protein targets (Thomas et al., 1997). The SH3 
domain is a motif found in many proteins, including SFKs, that recognizes and binds 
to proline-rich regions of other proteins. In the absence of such intermolecular 
associations, the SH3 domain of SFKs forms an intramolecular association with its 
own linker region between the kinase domain and the SH2 domain, and this is 
important in negatively regulating catalytic activity (Pawson 1995). The SH2 domain 
recognizes a short amino acid sequence carrying phosphotyrosine. Three to five amino 
acid residues following the phosphorylated tyrosine residue of the targeted substrate 
determine the specificity of the SH2 domain of SFKs (Songyang et al., 1993). The SH2 
domain of each SFK is a second regulatory region, controlling the range of proteins 
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interacting with SFKs and modulating their catalytic activity. In the low activity state, 
this region is tightly bound to a specific phosphotyrosine residue at the C-terminus of 
each SFK via an intramolecular interaction. The kinase domain (SH1 domain) is 
responsible for catalytic activity, and plays a crucial role in specific substrate 
recognition (Hughes 1996). There is an autophosphorylatable tyrosine residue located 
within the kinase domain (Tyr416 in Src), and phosphorylation of this residue is 
important for full SFK activation (Smart et al., 1981; Cartwright et al., 1986). The C-
terminal region of SFKs plays a significant role in the negative regulation of SFK 
activity. There is a conserved tyrosine residue near the C-terminus of each SFK 
(Tyr527 in Src), and its phosphorylation mediates the intramolecular association with 
the SH2 domain, as described above, to negatively regulate SFK activity. Accordingly, 
elimination of this tyrosine residue (by naturally occurring or manipulated mutation or 
deletion) from the SFKs increases activity (Schwartzberg 1998). 
 
SFKs are tightly regulated in their responses to different stimuli. The crystal structure 
of human Src has shown that SFKs present a closed conformation in the resting 
condition (Fig. 1.4A) (Pawson 1997; Sicheri et al., 1997; Xu et al., 1997). Both the 
SH2 and SH3 domains of Src are located at the opposite side of the catalytic cleft. The 
SH2 domain interacts with the phosphorylated tyrosine residue at the C-terminus of 
Src, which is phosphorylated by a cytoplasmic kinase called Csk (C-terminal Src 
kinase) (Nada et al., 1991). Meanwhile, the SH3 domain interacts with the linker 
region between the SH2 domain and the kinase domain. These intramolecular 
interactions maintain the SFKs in the repressed state, and stabilize the inactive 
conformation of SFKs as illustrated in Figure 1.4A. SFK catalytic activity can be 
modulated by perturbing one or more of these intramolecular interactions. This can 
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occur in three ways. Displacement of either of the SH2- or SH3-mediated interaction 
by high affinity ligands for the SH2 or SH3 domain can disrupt the intramolecular 
interactions within SFKs and lead to their activation. Dephosphorylation of the 
negative regulatory C-terminal tail of SFKs by PTPs is another way to disturb the 
intramolecular interactions and activate SFKs (Fig. 1.4B), and this is observed upon 
the ectopic expression of phosphatases in cells (Mustelin et al., 1992; Zheng et al., 
1992). SFKs are activated following the disturbance of intramolecular constraints upon 
the kinase, and a tyrosine residue within the kinase domain (Tyr416 in Src) is 
autophosphorylated and stabilizes the kinase in a highly active conformation (Fig. 
1.4B). Besides these three classical ways to activate SFKs, it has been shown that G 
proteins like Gαs and Gαi but not Gαq can directly stimulate SFK activity, although 
the mechanism is still unclear (Ma et al., 2000). G protein-mediated Src activation 
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Figure 1.4. Mechanisms involved in the activation of SFKs. (A) The conformation 
of inactivated SFKs. A phosphorylated tyrosine residue near the C-terminus of SFKs 
(Tyr527 in Src) interacts with the SH2 domain and blocks the accessibility of the 
kinase domain to substrate. Three events, as listed in circle, can disrupt intramolecular 
interactions to activate SFKs. (B) The conformation of fully activated SFKs, in which 
the intramolecular interactions are disrupted and a tyrosine residue within the kinase 
domain (Tyr416 in Src) is phosphorylated. 
 
 
1.6.2 Regulation of SFK activity by PTPs 
1.6.2.1 PTPα 
Overexpression of PTPα in rat embryonic fibroblasts induces cell transformation, 
accompanied by an increase in Src activity and reduced phosphorylation of the 
tyrosine residue near the Src C-terminus (Zheng et al., 1992). The same effects on Src 
were observed when PTPα was overexpressed in embryonal carcinoma P19 cells, 
although in these cells PTPα promoted neuronal differentiation (den Hertog et al., 
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1993). Different biological outcomes are obtained when PTPα is overexpressed in 
different cell types, but both processes are accompanied by Src activation, suggesting 
that these cellular effects are PTPα-dependent or related. The requirement of PTPα for 
Src/Fyn dephosphorylation and activation has been confirmed in a knockout mouse 
system. Kinase activity of Src/Fyn in PTPα-/- mouse brain and fibroblasts is 
significantly reduced, and this correlates with enhanced phosphorylation of the C-
terminal Tyr527 of Src (Ponniah et al., 1999; Su et al., 1999). The latter experimental 
system confirms that PTPα is a physiological positive regulator of the SFKs Src and 
Fyn. In another approach to characterize potential substrates of PTPα in a specific cell 
line, anti-sense PTPα was introduced into 3T3-L1 adipocytes to diminish PTPα 
expression. The down-regulation of PTPα expression by 85% in 3T3-L1 cells resulted 
in 80% reduced Src activity compared to that of the control cells, indicating that PTPα 
plays a role in the regulation of Src kinase activity in 3T3-L1 cells (Arnott et al., 1999). 
 
PTPα is a positive physiological regulator of Src and Fyn, but the ablation of PTPα 
does not completely abolish the activity of Src/Fyn, suggesting that PTPα may not be 
the sole PTP regulating SFK activity. Indeed, several other PTPs that can regulate SFK 




CD45 was first identified as a major surface protein of nucleated hematopoietic cells, 
comprising close to 10% of B and T cell membrane proteins (Thomas 1989). Studies 
of CD45-deficient mice indicate that CD45 plays a positive regulatory role in early 
thymocyte development, the selection of CD4+CD8+ T cells, and B cell maturation 
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(Byth et al., 1996). CD45 is essential for T cell receptor (TCR) and B cell receptor 
(BCR) mediated signaling (Pingel et al., 1989; Koretzky et al., 1990; Kishihara et al., 
1993; Ogimoto et al., 1995; Pao et al., 1997). SFKs play critical roles in TCR or BCR 
signal transduction, and CD45-mediated regulation of SFK activity in response to 
stimuli is important for T or B cell signaling events (Guttinger et al., 1992; Katagiri et 
al., 1995). Different SFK members are expressed in T or B cells. T cells primarily 
express Lck and Fyn-T (a hematopoietic isoform of Fyn); while B cells mainly express 
Lyn, Blk, and Fyn (Lowell et al., 1996). 
 
Evidence has been obtained from the studies on CD45-deficient cell lines that CD45 is 
the phosphatase responsible for activating Lck and Fyn in T cells, or Lyn in B cells, by 
dephosphorylating the phosphorylated tyrosine residues at the SFK C-terminus. 
Phosphorylation of these inhibitory tyrosine residues (Tyr505 in Lck, Tyr528 in Fyn, 
and Tyr508 in Lyn) was increased in the absence of CD45, accompanied by decreased 
SFK activity and reduced induction of tyrosine phosphorylation upon TCR or BCR 
engagement (Mustelin et al., 1992; Cahir McFarland et al., 1993; Hurley et al., 1993; 
Pao et al., 1997). However, CD45 has also been shown to dephosphorylate 
phosphotyrosine residues within the kinase domain (Tyr394 in Lck, Tyr416 in Fyn, 
and Tyr397 in Lyn) to inactivate SFKs (Yanagi et al., 1996; Katagiri et al., 1999). The 
ability of CD45 to dephosphorylate both inhibitory and activating phosphotyrosine 
residues within SFKs likely results from its different compartmentalization within cells 
during different stages in signaling. SFKs are dephosphorylated at their C-terminus by 
CD45. This results in autophosphorylation within the kinase domain. However, CD45 
prevents kinase activation by also dephosphorylating this site, maintaining the SFK in 
a “dually dephosphorylated” state. In this state, the kinase is neither fully repressed nor 
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fully activated, and is considered to be in a “primed” state ready for rapid activation. 
Sphingolipid and cholesterol-rich plasma membrane microdomains termed lipid rafts 
are an important platform for cell signaling in T or B cells. Some signaling proteins, 
including activated SFKs, translocate to lipid rafts immediately upon TCR or BCR 
ligation, while CD45 is excluded from lipid rafts in the early time period of signaling 
(Cheng et al., 1999). The pre-activated or primed SFKs are activated in lipid rafts, in 
the absence of CD45, by phosphorylation at the tyrosine residue within the kinase 
domain, and thus are fully activated. The activated SFKs phosphorylate downstream 
signaling proteins to transduce downstream signaling events. After that, CD45 appears 
to enter the lipid rafts and dephosphorylate the activating phosphotyrosine residues 
within the SFKs to terminate signaling (Shrivastava et al., 2004). 
 
1.6.2.3 PTP1B 
PTP1B was the first mammalian PTP to be identified and purified (Tonks et al., 1988). 
It is widely expressed and localized predominantly to endoplasmic reticulum (ER) 
through a cleavable proline-rich C-terminal segment (Charbonneau et al., 1989; 
Frangioni et al., 1992). Evidence that PTP1B is one of PTPs responsible for 
dephosphorylating phospho-Tyr527 of Src came from studies on breast cancer cell 
lines. Increased Src activity is detected in several human breast cell lines such as 
MDA-MB-435S, BT-483 and SK-BR-3 (Egan et al., 1999; Bjorge et al., 2000). In the 
MDA-MB-435S cell line, PTP1B was identified to be the phosphatase responsible for 
dephosphorylating and activating Src (Bjorge et al., 2000). Furthermore, other studies 
showed that overexpression of catalytically inactive PTP1B in cells led to increased 
tyrosine phosphorylation of Src and decreased Src activity (Arregui et al., 1998). 
PTP1B-mediated Src activation is involved in integrin signaling, and this is further 
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described in section 1.7.2.3. In addition, PTP1B is an important phosphatase in other 
signaling pathways. Mice deficient in PTP1B are resistant to diabetes and diet-induced 
obesity (Elchebly et al., 1999; Klaman et al., 2000). Further investigations on PTP1B-/- 
mice demonstrate that the insulin receptor (IR), insulin receptor substrate-1 (IRS-1), 
and leptin-activated Jak2 are substrates of PTP1B (Goldstein et al., 2000; Salmeen et 
al., 2000). Increased and sustained tyrosine phosphorylation of receptor tyrosine 
kinases (RTKs) such as the EGFR and PDGFR is detected in PTP1B-/- fibroblasts upon 
stimulation, suggesting a regulatory role of PTP1B in receptor-mediated signaling (Haj 
et al., 2003). 
 
1.6.2.4 SHP1 and SHP2 
SHPs, including SHP1 and SHP2, are intracellular PTPs. SHPs, sharing a ∼60% 
sequence identity with one another, contain two SH2 domains termed the N-terminal 
SH2 domain (N-SH2) and the C-terminal SH2 domain (C-SH2) (Pei et al., 1994). 
Basal SHP activity is low, as the catalytic domain is obstructed by the ‘backside’ of the 
N-SH2 domain (the surface opposite the P-Tyr-binding pocket) (Hof et al., 1998). This 
conformation blocks the catalytic cleft and interferes with substrate binding. The SH2 
domains of SHPs can bind many activated growth factor receptors such as the EGFR 
or adaptor proteins like IRS-1, and these associations can disrupt the intramolecular 
interactions of SHPs and lead to their activation (Feng et al., 1993; Kuhne et al., 1993; 
Pluskey et al., 1995). The role of SHPs in activating Src has been demonstrated in 
several cell lines. Src isolated from human platelets and Jurkat T cells is preferentially 
dephosphorylated by SHP1 at its C-terminal phosphotyrosine residue. Overexpression 
of a catalytically inactive form of SHP1 in human HEY ovarian adenocarcinoma cells 
reduced Src activity 1.5-2 fold compared to the cells expressing wild type SHP1, 
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suggesting an effect of SHP1 in modulating Src kinase activity (Somani et al., 1997). 
SHP2-/- fibroblasts display reduced Src activity, accompanied by increased tyrosine 
phosphorylation of Src Tyr527 in these cells. It has been shown that SHP2 activate 
SFKs by controlling Csk access to SFKs through regulating phosphorylation of the 
Csk regulator Cbp (Zhang et al., 2004). SHP2 has been shown to be involved in the 
regulation of early events in integrin signaling by activating Src (Oh et al., 1999). 
 
1.7 Integrin signaling 
Integrins are a major family of cell surface receptors that mediate the attachment of 
cells to the extracellular matrix (ECM). Some integrins can also bind to ligands such as 
fibrinogen or ICAM (intercellular adhesion molecule) on adjacent cells. These 
integrin-mediated adhesive interactions are involved in the regulation of many 
biological activities, including embryonic development, metastasis, programmed cell 
death, hemostasis, as well as leukocyte homing and activation (Juliano et al., 1993; 
Shattil et al., 1994). 18 α- and 8 β- integrin genes encode polypeptides that can be 
combined to form 24 types of α, β heterodimeric integrin receptors in mammalian cells 
(Hynes 2002). All α and β subunits are transmembrane proteins with large 
extracellular and short cytoplasmic domains without intrinsic kinase activity, and they 
are non-covalently associated. Although the cytoplasmic domains of integrins are 
devoid of intrinsic enzymatic activity, these regions are still important for the 
regulation of the ligand binding activity of the extracellular domain of the integrins 
(so-called “inside-out signaling”), and for mediating interactions with the cytoskeleton 
and transducing downstream signaling events (“outside-in signaling”). The importance 
of integrins has been elucidated by using a truncation or mutation strategy (Hibbs et al., 
1991; LaFlamme et al., 1994; Wennerberg et al., 1998). Both integrin clustering and 
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ligand occupancy are critical for the activation of intracellular integrin-mediated 
responses (Miyamoto et al., 1995). 
 
As shown in Fig.1.5, in the resting condition, integrins distribute separately across the 
plasma membrane. Engagement of integrins by specific ligands can induce aggregation 
of integrin receptors called integrin clustering, thus inducing signaling cascades that 
recruit many structural and signaling proteins to form functionally distinct adhesion 
complexes. The regions where integrins contact the extracellular matrix, mediating 
strong adhesion of cells to the ligands, are called focal adhesions (Burridge et al., 1996; 
Craig et al., 1996). There are more than 50 molecules reported to be involved in 
integrin signaling that are transiently or stably recruited to focal adhesions. These 
molecules include cytoskeletal proteins, proteases, protein kinases and phosphatases, 
small GTPases, and signaling proteins such as paxillin (Burridge et al., 1988). A 
critical and earliest event upon integrin stimulation is the tyrosine phosphorylation of 
many signaling and cytoskeletal proteins (Hynes 1992; Arroyo et al., 1994). Tyrosine 
kinases such as focal adhesion kinase (FAK) and SFKs are involved in integrin 
signaling. They are activated and localized to focal contacts upon integrin stimulation. 
FAK plays a central role in integrin signaling. Many of the signals resulting from 
integrin ligation are centered around FAK and its interaction with SFKs (Schaller et al., 
1994; Schlaepfer et al., 1997). In addition to the participation of PTKs in integrin 
signaling, several PTPs are also implicated as positive or negative regulators in 























Figure 1.5. Schematic representation of integrin signal transduction and 
downstream events emanating from integrin stimulation. (A) Unstimulated 
integrins are separately distributed across the plasma membrane. (B) Integrin 
engagement with extracellular matrix components induces integrin clustering. (C) 
Integrin activation by ligand binding (termed integrin occupancy) leads to a series of 
tyrosine phosphorylation events and the formation of focal adhesion complexes. 
Integrin signaling regulates many processes including cell migration, gene expression 
and cell survival. Numerous molecules are involved in integrin signaling, including 
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1.7.1 Kinases in integrin signaling 
1.7.1.1 Focal adhesion kinase (FAK) 
FAK is a non-receptor intracellular protein tyrosine kinase without SH2 or SH3 protein 
interaction domains (Fig. 1.6). FAK homologues that share over 90% amino acid 
sequence identity have been identified in human, mice and chickens (Hanks et al., 
1992; Schaller et al., 1992; Whitney et al., 1993). FAK and a second non-receptor PTK 
called proline-rich tyrosine kinase 2 (Pyk2) (Lev et al., 1995), cell adhesion kinase 
β (CAKβ) (Sasaki et al., 1995), or calcium-dependent tyrosine kinase (CADTK) (Yu et 
al., 1996), define a new subfamily of non-receptor PTKs. FAK is expressed in most 
tissues and in different cell types, while the expression pattern of Pyk2, sharing ∼45% 
overall amino sequence identity with FAK, appears to be more restricted than that of 
FAK. Pyk2 is highly expressed in brain and in hematopoietic cells. 
 
FAK comprises a central kinase domain flanked by large N- and C-terminal non-
catalytic domains (Fig. 1.6). The N-terminal domain is important for FAK interaction 
with the cytoplasmic domains of β integrins in vitro, although it is difficult to detect 
the association upon integrin stimulation in vivo, implying that this interaction may be 
transient or weak (Schaller et al., 1995). There are many protein-protein interaction 
sites within the C-terminal region of FAK, including one proline-1 (Pro-1) domain, 
one proline-2 (Pro-2) domain, and a focal adhesion targeting (FAT) domain. The 
proline-1 domain is the binding motif for the SH3 domain of p130Cas. The FAT domain, 
of ~100 amino acids, is likely responsible for directing FAK to the newly formed or 
existing adhesion complexes (Martin et al., 2002). Paxillin has been shown to associate 
with the C-terminus of FAK (Hildebrand et al., 1995). Several tyrosine residues that 
are important for FAK function have been identified, and are described further below. 
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A fragment of the C-terminus of FAK called FRNK (FAK-related non-kinase), or that 
of Pyk2 called PRNK (Pyk2-related non-kinase) (Fig. 1.6) are expressed in certain 
cells, and each fragment has an inhibitory effect on either FAK or Pyk2, respectively 
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Figure 1.6. Organization of the domains of focal adhesion kinase (FAK). FAK is a 
non-receptor tyrosine kinase, comprising a central kinase domain with large N- and C-
terminal non-catalytic domains. The N-terminal domain directs interaction with 
integrins and growth factor receptors. The C-terminal domain contains multiple 
protein-protein interaction regions such as with the cytoskeletal protein paxillin. There 
are two proline-rich domains that bind to the SH3 domains of other proteins such as 
p130Cas. The FAT domain at the C-terminus is the region required for focal adhesion 
targeting. FRNK is a truncated form of the C-terminus of FAK and may function as a 
negative regulator of FAK kinase activity. Several tyrosine residues within FAK are 
important for FAK functions. Tyr397 is an autophosphorylated residue that interacts 
with the SH2 domain of Src or with the p85 subunit of PI3-K. Tyrosine residues 
(Tyr576/577) are located within the kinase domain and their phosphorylation fully 
activates FAK. Phosphorylated Tyr925 near the C-terminus is a binding site for the 
SH2 domain of Grb2. 
 
 
Evidence that FAK is a downstream transducer of integrin-induced signaling came 
from the detection of increased tyrosine phosphorylation of FAK when cells were 
stimulated with anti-integrin antibodies or by plating on fibronectin (Guan et al., 1991; 
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Tyrosine phosphorylation of FAK in response to integrin stimulation leads to the 
formation of phosphotyrosine docking sites for several classes of signaling molecules. 
Six tyrosine residues within FAK have been shown to be phosphorylated in integrin 
signaling (Calalb et al., 1995; Schlaepfer et al., 1996). Two residues within the FAK 
N-terminal domain (Tyr397/Tyr407), two within the kinase domain activation loop 
(Tyr576/Tyr577), and two within the C-terminal region (Tyr861 and Tyr925) are 
phosphorylated in vivo. FAK Tyr397 is an autophosphorylated residue that is 
important for the correct and efficient function of FAK (Chan et al., 1994; Schaller et 
al., 1994; Calalb et al., 1995), whereas tyrosine residues 407, 576, 577, 861, and 925 
are reported to be phosphorylated by Src (Schlaepfer et al., 1994; Schlaepfer et al., 
1996; Schaller et al., 1999). Integrin ligation can induce autophosphorylation of FAK 
at Tyr397, creating a binding site for the SH2 domain of Src or other SFKs such as Fyn 
to form the SFK-FAK complex (Cobb et al., 1994; Schaller et al., 1994; Cary et al., 
1996). Recruitment of SFKs results in phosphorylation of Tyr576 and Tyr577 in the 
activation loop of FAK and fully activates FAK. The SFK-FAK complex can mediate 
the downstream signaling events such as the phosphorylation of certain FAK-
associated proteins such as p130Cas and paxillin, and the recruitment of other signaling 
molecules like Crk or Nck to bind to the phosphorylated p130Cas (Schaller et al., 1999). 
Phosphorylated Tyr925 creates a binding site for the SH2 domain of Grb2, an 
interaction that is believed to be important for integrin-mediated cell proliferation by 
mediating the activation of Ras/MAPK pathway (Schlaepfer et al., 1996; Schaller et al., 
1999). FAK is implicated in a number of biological processes that ultimately control 
the rate of cell spreading and migration, and generate an anti-apoptotic signal in 
response to cell adhesion (Ilic et al., 1995; Cary et al., 1996; Frisch et al., 1996). FAK-
deficient fibroblasts, exhibiting an increased number of focal adhesions on FN, spread 
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slowly when plated on FN and migrate poorly in response to chemotactic and 
haptotactic stimuli (Ilic et al., 1996; Owen et al., 1999; Sieg et al., 2000). However, 
overexpression of FAK in Chinese hamster ovary (CHO) cells has been shown to 
cause enhanced cell migration (Cary et al., 1996; Cary et al., 1998). Experiments 
involving the depletion (gene ablation) or overexpression of FAK indicate the 
importance of FAK in multiple integrin-mediated signaling events, which are 
determined by phosphorylation and activation of FAK. 
 
1.7.1.2 SFKs in integrin signaling 
The first identification of involvement of SFKs in integrin signaling was obtained from 
studies on v-Src transformed cells. These cells displayed reduced adhesion and an 
altered cell morphology, accompanied by hyperphosphorylation of many proteins 
related to integrin signaling such as paxillin or FAK (Guan et al., 1991; Burridge et al., 
1992). The mechanism underlying the morphological change of v-Src transformed 
cells was demonstrated in Swiss 3T3 cells overexpressing a temperature-sensitive 
mutant form of v-Src. v-Src translocates to focal adhesions when cells are shifted to a 
temperature permissive condition, and disrupts the cytoskeletal organization via its 
inhibition of RhoA (Fincham et al., 1996; Fincham et al., 1999). In fibroblasts, Src is 
transiently activated upon integrin stimulation, and translocates to newly formed focal 
adhesion structures during cell spreading onto FN coated surfaces (Kaplan et al., 1995). 
Many signaling and cytoskeletal proteins implicated in integrin-mediated signaling, 
including p130Cas, paxillin, tensin, and cortactin, are substrates of Src (Turner et al., 
1993; Thomas et al., 1995). Single knockout of Src, Fyn or Yes does not completely 
abolish tyrosine phosphorylation of proteins downstream of integrin signaling, but FN-
induced tyrosine phosphorylation of these proteins including FAK is nearly eliminated 
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in the cells lacking all Src, Fyn and Yes (SYF cells), suggesting the importance of 
SFKs in integrin signaling (Bockholt et al., 1995; Klinghoffer et al., 1999). Many 
investigations have shown that SFKs regulate integrin-mediated cell adhesion and 
spreading, focal adhesion remodeling and turnover as well as migration, but each SFK 
member possesses a specific function in integrin signaling (Kaplan et al., 1994; Kaplan 
et al., 1995; Fincham et al., 1998; Klinghoffer et al., 1999; Volberg et al., 2001). 
 
The specific and redundant roles of SFKs in integrin-mediated signaling events are 
under intensive investigation by many groups, especially the functions of Src, Fyn and 
Yes. Fibroblasts isolated from Src knockout mice (Src-/-) display reduced cell adhesion 
and spreading when plated on FN, and the defects can be rescued by re-expression of 
Src in these cells (Kaplan et al., 1995). The defects of Src-/- cells in integrin signaling 
imply that some functions of Src cannot be compensated for either by Fyn, Yes or 
other SFKs. The difference between Src and Fyn functions in cytoskeletal organization 
has been demonstrated in a Src/Csk or Fyn/Csk double knockout system. Csk is a 
negative regulator of SFKs that acts by phosphorylating their C-terminal tyrosine 
residue, as SFKs in cells isolated from Csk-/- mice exhibit decreased phosphorylation at 
the C-terminus and increased activity (Nada et al., 1993). It has been shown in cells 
derived from Src/Csk or Fyn/Csk double knockout mice that Src is mainly responsible 
for phosphorylation of cortactin and tensin, while phosphorylation of FAK and paxillin 
is dependent on both Src and Fyn (Thomas et al., 1995). The physical force generated 
between the ECM and the cytoskeleton upon integrin engagement is critical for cell 
migration on matrix, and recent studies have shown that Src, Fyn and Yes have 
different functions for the force-dependent signal transduction cascade initiated upon 
integrin stimulation (von Wichert et al., 2003; Kostic et al., 2006). Matrix rigidity 
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response, an early event of cells adhering to the substrate, is important for focal 
adhesion formation during the early phase of cell spreading on extracellular matrix. 
SYF cells exhibit defective FN rigidity response, and only re-expressed Fyn in SYF 
cells can restore this defect; while Src or Yes re-expression in SYF cells cannot 
(Kostic et al., 2006). PTPα-mediated Fyn activation has been shown to regulate the 
strength of cell response to matrix by the recruitment of Fyn to the leading edge of 
cells during the early phase of cell spreading (von Wichert et al., 2003; Kostic et al., 
2006). 
 
1.7.2 PTPs in integrin signaling 
The detachment of fibroblasts from the substratum induces a rapid dephosphorylation 
of signaling proteins including FAK, leading to focal adhesion disassembly, a process 
important for cell migration. The dynamics of cytoskeleton organization involved in 
cell migration require a set of tightly regulated and coordinated events. As described, 
many important kinases such as FAK and SFKs are involved in both the assembly and 
turnover of focal adhesions. In addition, recent studies have shown that a remarkable 
number of PTPs are involved in integrin signaling, including the dynamics of actin 
cytoskeleton organization or the processes of focal adhesion turnover (Angers-Loustau 




As a positive regulator of Src/Fyn, PTPα is an important molecule involved in integrin 
signaling. The role of PTPα in mediating the interaction of cells with the substratum 
was first demonstrated in A431 epidermal carcinoma cells (with high levels of EGF 
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receptor on the surface). A431 cells overexpressing PTPα exhibit an increased cell-
substratum adhesion upon EGF stimulation, while the parental A431 cells display 
EGF-induced cell rounding and lifting (Harder et al., 1998). In these A431 cells 
overexpressing PTPα, an increased activation of Src was detected, coupled with an 
increased association of Src with FAK. In another cell culture system, PTPα is 
translocated to focal adhesion sites when nerve growth cones are plated on laminin 
(Helmke et al., 1998). The localization of PTPα in focal adhesions appears to be 
dependent on its phosphorylation at Tyr789 (Lammers et al., 2000). The role of PTPα 
in integrin signaling has been further demonstrated in a PTPα knockout cell system. 
Fibroblasts derived from PTPα-deficient mice show delayed cell spreading on FN (Su 
et al., 1999), a phenotype strikingly similar to that of Src-/- fibroblasts (Kaplan et al., 
1995). In addition, these PTPα-/- cells exhibit reduced tyrosine phosphorylation of 
FAK and p130Cas, as well as reduced Erk activation following integrin stimulation (Su 
et al., 1999). The phenotypic similarity between PTPα-/- and Src-/- cells suggests that 
PTPα is involved in promoting integrin signaling through activation of SFKs, 
especially Src and Fyn. A requirement of PTPα-mediated Src/Fyn activation in 
integrin signaling is further supported by studies involving the use of the selective 
SFKs inhibitor PP2. Treatment of wild type cells with PP2 inhibits integrin-induced 
cell spreading and delays actin stress fiber assembly, similar to the defects observed in 
PTPα-/- cells, but no inhibitory effects can be observed when these cells are treated 
with PP3, an inactive analogue of PP2 (Zeng et al., 2003). PTPα is required for early 
integrin-proximal events, and FN-induced FAK Tyr397 phosphorylation is reduced in 
PTPα-/- cells. Reduced FAK Tyr397 phosphorylation can be rescued by the 
reintroduction of wild type PTPα into PTPα-/- cells, but catalytically inactive PTPα 
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cannot rescue this defect (Zeng et al., 2003). As described, FAK Tyr397 is essential for 
optimal integrin-stimulated cell spreading and migration (Sieg et al., 1999). Reduced 
FAK Tyr397 phosphorylation in PTPα-/- cells results in the reduced association of 
Src/Fyn and FAK, and this may be the explanation for the defective integrin-mediated 
cell spreading and migration (Zeng et al., 2003). Cell migration on the ECM is a 
dynamic process involving focal adhesion formation at the leading edge and 
disassembly at the rear of the migratory cells. The physical force generated at the focal 
adhesion site is critical in the regulation of the rate of cell migration on the ECM 
(Sheetz et al., 1998; Geiger et al., 2001). PTPα is not essential for cell adhesion on FN, 
but is an important transducer of mechanical forces during the early phase in cell 
spreading, as the strength of the integrin-cytoskeleton bond is dramatically reduced in 
the absence of PTPα (von Wichert et al., 2003). PTPα associates with integrin subunit 
αv after integrin is engaged, and the strengthening process likely depends on integrin 
αv, PTPα and the PTPα-mediated activation of Fyn (von Wichert et al., 2003). 
 
1.7.2.2 SHP2 
Homozygous SHP2 mutant mice die around day 8.5-10.5 of gestation and have similar 
abnormalities to FAK- and FN-deficient embryos (Watt et al., 1994; Ilic et al., 1995; 
Yu et al., 1998). The role of SHP2 in integrin signaling was demonstrated in SHP2 
knockout fibroblasts, as these SHP2-/- cells displayed delayed cell spreading on FN, 
reduced cell migration towards FN, and enhanced focal adhesion formation. FAK 
dephosphorylation was reduced upon cell detachment from the substratum, and its 
dynamic interaction with the Src SH2 domain was significantly impaired in the 
absence of SHP2, suggesting a role of SHP2 in the deactivation of FAK (Yu et al., 
1998). A fraction of SHP2 moves to focal contacts upon integrin engagement and 
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forms a complex with a tyrosine phosphorylated transmembrane protein called SHPS-1 
(SHP substrate 1) or SIRPα, and this activates SHP2 (Fujioka et al., 1996; Tsuda et al., 
1998). SHP2 transduces positive signals to induce downstream events such as MAPK 
activation and cell shape changes upon integrin stimulation (Oh et al., 1999). Increased 
actin stress fibers and enhanced focal adhesion contacts were observed in CHO 
(Chinese hamster ovary) cells or Rat-1 fibroblasts overexpressing a catalytically 
inactive mutant form of SHP2, indicating that SHP2 plays a role in cytoskeletal 
organization probably through inhibition of RhoA activity (Inagaki et al., 2000; 
Schoenwaelder et al., 2000). SHP2 has been shown to partition in lipid rafts after 
integrin engagement, and the lipid raft targeting of SHP2 accelerates integrin-induced 
cell spreading. Consequently, the localization of SHP2 to lipid rafts upon integrin 
stimulation leads to FAK phosphorylation at Tyr397 and Erk activation, while 
catalytically inactive SHP2 or cytoplasmic localized SHP2 does not have these effects 
(Lacalle et al., 2002). Taken together, these observations have shown that SHP2 is 
involved in integrin signaling via several pathways. 
 
1.7.2.3 PTP1B 
Increasing evidence indicates that PTP1B is an important phosphatase involved in 
integrin signaling. PTP1B has been shown to be involved in integrin signaling via its 
proline-dependent interaction with p130Cas, as overexpression of wild type PTP1B in 
rat 3Y1 cells interfered with integrin-induced cell spreading and cytoskeleton 
organization, but a proline to alanine mutant form of PTP1B (PA-PTP1B) was unable 
to exert the similar effects (Liu et al., 1996; Liu et al., 1998). It has been shown that the 
catalytic activity of PTP1B is also required for efficient integrin signaling. 
Overexpression of catalytically inactive mutant PTP1B in mouse L cells blocked 
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integrin-mediated cell adhesion and spreading, and resulted in an almost complete 
absence of focal adhesions and stress fibers. Furthermore, reduced phosphorylation of 
FAK was detected in these cells, accompanied by increased tyrosine phosphorylation 
of Src (Arregui et al., 1998). Consistent with this, reduced cell spreading, reduced 
p130Cas phosphorylation, and delayed Erk activation were observed upon integrin 
stimulation in PTP1B-deficient cells, compared to their wild-type counterparts (Cheng 
et al., 2001). Taken together, these findings indicate that PTP1B plays a positive role 
in integrin signaling. 
 
PTP1B localizes to the ER via a cleavable proline-rich C-terminal segment (Frangioni 
et al., 1992). A recent study showed that ER-bound PTP1B was targeted to newly 
formed cell-matrix adhesions (Hernandez et al., 2006). A substrate-trapping mutant 
form of PTP1B (PTP1B D181A), that can bind to substrate but cannot dephosphorylate 
it, was overexpressed in PTP1B-/- fibroblasts, and was detected at the distal tips of 
adhesion sites of the cells, the formation of which is dependent on an extension of the 
ER to the cell margin. These findings suggest that PTP1B is likely required for the 
maturation of focal adhesions (Hernandez et al., 2006). Besides the role of PTP1B in 
focal adhesion formation in integrin signaling, PTP1B is recently reported to be 
involved in the disassembly of the FAK-Src complex during cell migration. PTP1B is 
involved in focal adhesion disassembly by dephosphorylating α-actinin and FAK 
(Zhang et al., 2006). α-actinin is an important protein for cell-matrix contact formation, 
interacting with many focal adhesion proteins (Mangeat et al., 1984). Phosphorylated 
α-actinin is proposed to disrupt the Src-FAK association and expose phosphorylated 
FAK Tyr397 to be dephosphorylated by PTP1B. Following disruption of the Src-FAK 
complex, the phosphorylated α-actinin is then dephosphorylated by PTP1B (Zhang et 
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al., 2006). The disassembly of focal adhesions at the rear of the cells is important for 
efficient cell migration, and PTP1B and α-actinin provide a feedback loop for Src-
FAK complex formation and cell migration. 
 
1.7.2.4 PTP-PEST 
PTP-PEST is a cytoplasmic PTP, containing a sequence rich in proline (P), glutamic 
acid (E), serine (S) and threonine (T) residues (Yang et al., 1993; Cote et al., 1998). 
p130Cas has been identified to be a major physiological substrate of PTP-PEST (Garton 
et al., 1996; Angers-Loustau et al., 1999). Both gene ablation and overexpression of 
PTP-PEST inhibit cell mobility (Angers-Loustau et al., 1999). Further investigation 
has shown that PTP-PEST regulates cell migration via modulating the activity of Rac1, 
as overexpression of PTP-PEST in fibroblasts suppresses Rac1 activity upon integrin 
stimulation (Sastry et al., 2002). An interaction of PTP-PEST with paxillin appears to 
be essential for the regulation of PTP-PEST in cell spreading and migration, as the 
disruption of paxillin and PTP-PEST association abolishes the effect of PTP-PEST on 
cell migration (Jamieson et al., 2005). A recent study shows that reduced cell mobility 
of PTP-PEST-/- cells is the result of defective tail retraction during cell migration. 
Increased Rac1 activity and inhibited RhoA activity in PTP-PEST-/- cells disturb the 
equilibrium between forward protrusion and tail retraction, an important balanced 
process for cell migration (Sastry et al., 2006). Taken together, these results suggest 
that the localization of PTP-PEST or its activity is regulated to coordinate the balance 
between forward protrusion and formation of new adhesions at the leading edge versus 
detachment and release as the tailing edge of the cell is retracted during migration. 
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1.7.2.5 PTEN 
PTEN (phosphatase and tensin homology on chromosome 10) is a tumor suppressor 
gene that is frequently inactivated by somatic mutation in sporadic tumors of brain, 
endometrium and prostate, and with lower frequency in other tumor types (Ali et al., 
1999). PTEN contains the PTP catalytic signature motif and functions as a tyrosine 
phosphatase and lipid phosphatase in vitro (Myers et al., 1997; Myers et al., 1998). 
PTEN plays an important role in growth regulation relevant to tumorigenesis as well as 
in the normal development of multiple tissues. PTEN is a lipid phosphatase that 
dephosphorylates the 3 position of phosphatidylinositol 3,4,5-trisphosphate (PIP3) to 
form phosphatidylinositol 4,5-bisphosphate (PIP2), in the process reversing the 
phosphorylation catalyzed by PI3-K (Maehama et al., 1998). Fibroblasts deficient in 
PTEN display increased cell migration, but overexpression of PTEN in NIH3T3 cells 
can inhibit cell spreading, migration and focal adhesion formation upon integrin 
stimulation (Tamura et al., 1998; Liliental et al., 2000), suggesting a negative 
regulatory role of PTEN in cell migration. PTEN has been shown to directly interact 
with FAK by using a trapping mutant form of PTEN, and to dephosphorylate phospho-
FAK Tyr397 during cell detachment (Tamura et al., 1998; Tamura et al., 1999). 
PTEN-deficient cells have increased activity of Rac1 and Cdc42, two small GTPases 
involved in regulating actin organization. The enhanced migration of PTEN-/- cells can 
be restored by overexpression of a dominant negative mutant form of Rac1 or Cdc42, 
suggesting that PTEN negatively regulates cell migration by activating Rac1 and 
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1.7.3 Summary of integrin-induced signaling events 
Integrin engagement initiates signaling events that include transduction of mechanical 
forces to the cytoskeleton and spatial compartmentalization of signaling complexes. A 
hierarchy of recruitment of signaling proteins and cytoskeletal molecules to integrins 
has been demonstrated using immunocytochemical approaches. Integrin-induced 
signaling events are initially linked to the activation of the SFKs Src/Fyn, and 
activated Src/Fyn associates with integrin-dependent cytoskeletal complexes (Clark et 
al., 1994; Schlaepfer et al., 1994). The earliest event detected when fibroblasts are 
plated onto FN is phosphorylation at FAK Tyr397, creating a binding site for Src and 
Fyn via their SH2 domains (Parsons 2003). The recruited Src and/or Fyn further 
phosphorylate other tyrosine residues within FAK to fully activate FAK, and the SFK-
FAK complex phosphorylates other signaling and scaffolding proteins such as p130Cas 
and paxillin. Phosphorylated FAK can recruit other signaling proteins like Grb2 and 
p130Cas to form a multi-phosphocomponent signaling complex localized at focal 
adhesions (Fig. 1.7). The integrin-induced signaling cascade leads to downstream 
events such as cell adhesion and spreading as well as migration. In addition, Fyn can 
associate with the α subunit of integrins, probably through caveolin, and is activated 
upon integrin stimulation (Wary et al., 1998). Activated Fyn can phosphorylate another 
adaptor protein, Shc, and thus recruit Grb2. This Fyn-Shc-Grb2 complex leads to the 
activation of Erk in integrin-mediated signaling transduction (Wary et al., 1998). The 
molecular mechanisms regulating these early events in the above signaling cascade and 
linking them to the membrane integrins are unclear. Some key early events in integrin-
induced tyrosine phosphorylation and signaling cascades are shown in Figure 1.7. 
 
 









































Figure 1.7. Integrin-stimulated tyrosine phosphorylation and signaling events. 
Integrin engagement by ligands such as fibronectin (FN) stimulates FAK 
autophosphorylation at Tyr397, creating a binding site for the SH2 domain of SFKs. 
Recruitment of SFKs can lead to enhanced phosphorylation of FAK at other sites such 
as Tyr576/577 or Tyr925, then fully activating FAK and creating binding sites for 
other signaling proteins. Integrin-stimulated activation of Src and FAK leads to the 
phosphorylation of other proteins such as p130Cas, and the phosphotyrosyl-dependent 
assembly of multicomponent signaling complexes that activate downstream pathways. 
Fyn associates with the α subunit of integrins via caveolin, and is activated upon 
integrin stimulation. The activated Fyn can phosphorylate Shc (another adaptor 
protein), leading to Erk activation. The molecular mechanisms regulating many of the 




1.8 Research rationale and objectives 
The present understanding of functions and interactions of PTPα and Src in biological 
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embryogenesis and organogenesis and that their interaction is involved in many cell 
signaling events. 
 
Previous studies have shown that PTPα is not essential for embryonic development 
(Ponniah et al., 1999; Su et al., 1999), and that SFKs, especially Src, Fyn, and Yes, 
share redundant and specific functions in this process (Stein et al., 1994; Klinghoffer et 
al., 1999). As a positive regulator of the SFKs Src and Fyn, PTPα-mediated activation 
of these kinases is likely to be involved in many cellular activities. PTPα-deficient 
mice possess reduced Src and Fyn activity (Ponniah et al., 1999; Su et al., 1999), and 
less than 50% Fyn and/or Yes activity is predicted to remain in mice with a dual 
ablation of both PTPα and Src. Much lower SFK activity in PTPα-/-Src-/- mice may 
result in embryonic lethality or in more severe defects, as previous studies have 
revealed that residual Yes activity in Src/Fyn-deficient animals or residual Fyn activity 
in Src/Yes-deficient animals is insufficient for mouse maturation to adulthood (Stein et 
al., 1994). To test the hypothesis that the combined ablation of PTPα and Src results in 
embryonic lethality, mice with a dual deficiency of PTPα and Src (PTPα-/-Src-/-) were 
generated and used to investigate the outcome of reduced SFK activity in embryonic 
development and organogenesis.  
 
In addition, many investigations have shown that PTPα and Src are involved in 
integrin signaling (Klinghoffer et al., 1999; Su et al., 1999; Zeng et al., 2003), which is 
important in many cellular activities including embryogenesis. PTPα-mediated SFK 
activation is required for efficient integrin-induced signaling, and PTPα-/- and Src-/- 
cells share some similar defects, such as delayed cell spreading and cytoskeletal 
organization on FN, and reduced cell migration towards FN (Kaplan et al., 1995; Su et 
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al., 1999; Zeng et al., 2003). However, PTPα-/- and Src-/- cells also display distinct 
defects on FN. The difference between PTPα-/- and Src-/- cells in response to integrin 
stimulation may result from disparate levels of residual SFK activity, and/or from 
distinct roles of Src and Fyn in integrin signaling. To further understand how PTPα 
and SFKs co-ordinately function, and to distinguish the different requirements of Src 
and Fyn in integrin signaling, PTPα-/-Src-/- mouse embryonic fibroblasts were isolated 
from double mutant mice. These double mutant cells were spontaneously immortalized 
and their responses to integrin stimulation were investigated. 
 
The first part of this thesis focuses on the effects of a dual deficiency of PTPα and Src 
on embryonic development and organogenesis. The responses of PTPα-/-Src-/- double 
mutant fibroblasts to fibronectin (FN) are described in the second part of this thesis, 
and are compared to those of wild type and PTPα-/- or Src-/- cells. PTPα-mediated SFK 
activation is important for efficient integrin signal transduction, but how PTPα is 
regulated by integrin stimulation to transduce signals to SFKs is still unclear. The third 
part of this thesis focuses on the investigation of the molecular mechanisms by which 
PTPα is regulated upon integrin stimulation, and on the linkage of PTPα to integrin-























2.1 Mouse genotyping 
The genotypes of mice, with respect to PTPα and Src, were determined by PCR 
(polymerase chain reaction) using DNA extracted from mouse tail tips or embryonic 
yolk sacs. 
 
2.1.1 DNA extraction from mouse tail tips or embryonic yolk sacs 
The tissue from the tail tip of each mouse was removed at weaning or the embryonic 
yolk sac was removed during embryo collection from pregnant females. The tail tip or 
yolk sac was placed in a 0.65 μl Eppendorf tube. The digestion buffer (50 μl) (0.67 
mM Tris pH 8.8, 1.66 mM (NH4)2SO4, 0.067 mM MgCl2, 0.1% gelatin, 1% β-
mercaptoethonal (β-ME), 0.5% Triton X-100) with 2 μg/μl proteinase K (Sigma) was 
added to each tube. The tube was incubated for 3 h in a 55 °C water bath, with 
occasional mixing using a vortex, and then the digested sample was heated for 10 min 
at 100 °C to inactivate proteinase K (Sigma). The supernatant containing the extracted 
DNA was collected by centrifugation and transferred to another tube. The extracted 
DNA was kept at -20 °C until further use. 
 
2.1.2 Genotyping for PTPα and Src 
Each embryo or pup was genotyped for PTPα and Src by PCR. Primer sequences for 
PTPα and Src are shown in Table 2.1. The primers were from Oligos Etc. 
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PTPα genotyping 
PCR reactions contained 2.5 μl of 10 x PCR reaction buffer (Roche), 2 μl of 2.5 mM 
dNTPs (Invitrogen), 0.75 µl of a 20 μM stock solution of each primer (E13F forward, 
14RC5 reverse, and PTPαNEO reverse primers), 1 unit of Taq polymerase (Roche) 
and 1 μl of extracted DNA. The thermocycling steps were as follows: 95 °C-2 min, 40 
cycles (94 °C-30s, 60 °C-40s, 72 °C-90s) and 72 °C-10 min. 
 
Src genotyping 
PCR reactions contained 2.5 μl of 10 x PCR reaction buffer, 2 μl of 2.5 mM dNTPs, 3 
µl of a 5 μM stock solution of each primer (Exon2 forward, Exon2-3 reverse, and 960 
3 reverse primers), 0.5% β-ME (Sigma), 1 unit of Taq polymerase, and 1 μl of 
extracted DNA. The thermocycling steps were as follows: 95 °C-2 min, 40 cycles (93 
°C-30s, 58 °C-40s, 65 °C-90s) and 65 °C-10 min. 
 
2.2 Generation of PTPα/Src double mutant mice  
PTPα-null mice (PTPα-/-Src+/+) with a 129SvEv background (Ponniah et al., 1999) 
were crossed with PTPα+/+Src+/- mice with a hybrid C57BL6J/129SvEv background 
(Jackson Laboratory) to obtain parental heterozygous PTPα/Src mice (PTPα+/-Src+/-) 
or homozygous PTPα/heterozygous Src mice (PTPα-/-Src+/-). These mice were further 
intercrossed to obtain double mutant PTPα and Src mice (PTPα-/-Src-/-). 
 
The PTPα+/-Src+/- mice were intercrossed to obtain PTPα/Src double mutants. Double 
homozygous mutants (PTPα-/-Src-/-) would be predicted to result at a frequency of 1 in 
16. To increase the frequency of obtaining double mutants, parents homozygous for 
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PTPα and heterozygous for Src (PTPα-/-Src+/-) were intercrossed to obtain PTPα/Src 
double mutants. Utilizing the later strategy, one in four progeny would be predicted to 




Table 2.1. Primer sequences used in PCR reactions for mouse PTPα and Src 
genotyping. Three primers were used for PTPα or Src. Primer solutions for PTPα 
were prepared at a stock concentration of 20 µM, and primer solutions for Src were 





 Primer length 
(bp) 
   14RC5 (reverse): 
   5’-GCCAGTGCGCCCTACACCTGC-3’ 
 
21 
   E13F (forward): 
   5’-CACAGCGCCTCATCACTCAGTTC-3’ 
 
23 PTPα 
   PTPα NEO (reverse): 
   5’GCTACCCGTGATATTGCTGAAGAG-3’ 
 
24 
   Exon 2 (forward): 
   5’-AGCAACAAGAGCAAGCCCAAGGAC-3’ 
 
24 
   Exon 2-3 (reverse): 
   5’-GTGACGGTGTCCGAGGAGTTGAAG-3’ 
 
24 Src 
   960 3 (reverse): 
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2.3 Embryonic dissection 
The desired crosses were initiated, and the plugged day was set as embryonic day 1.5 
(E1.5). Pregnant females were sacrificed at E12.5. Embryos and placenta were 
removed from the mouse uterus, and washed with cold PBS. The yolk sac of each 
embryo was kept in a sterile Eppendorf tube for genotyping. 
 
2.4 Mouse growth observation 
Each pup was genotyped at seven days after birth, and numbered by ear clipping. Pups 
of each of four genotypes (PTPα+/+Src+/+, PTPα-/-Src+/+, PTPα+/+Src-/-, PTPα-/-Src-/-) 
were weighed every three to four days until they reached three weeks of age. 
 
2.5 Histological staining 
Organs including brain, lung, liver, kidney, thymus, spleen, pancreas, and heart were 
removed from each mouse at three weeks of age, and weighed. These tissues were 
fixed in 10% neutral buffered formalin. 
 
The fixed tissues were processed for paraffin embedding by an auto-processor machine. 
They were processed according to the following steps listed (slightly modified 
according to different organs): 1) 80% ethanol, 1 h; 2) 90% ethanol, 1 h; 3) 95% 
ethanol, 1 h; 4) 100% ethanol I, 1.5 h; 5) 100% ethanol II, 1.5 h; 6) Xylene I, 1 h; 7) 
Xylene II, 1 h; 8) Wax I, 1 h; 9) Wax II, 1 h; and 10) Wax III, 1 h. The paraffin 
embedded tissues were then sectioned and placed on a slide for hematoxylin (H) and 
eosin (E) staining (H&E staining). 
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The paraffin embedded sample on the slide was heated at 55 ºC on a heat block until 
the paraffin turned soft, and de-paraffinized in Xylene (Sigma) for 5 min. After this, 
the sample was rehydrated by sequential incubation in three different concentrations of 
ethanol solution (95%, 90%, and 80%) for 5 min each, and rinsed with tap water for 5 
min. The deparaffinized and rehydrated sample was then stained with hematoxylin for 
3 min. The hematoxylin stained sample was rinsed with tap water for at least 5 min, 
allowing the stain to develop. After developing, the hematoxylin stained sample was 
counter stained with 0.1% eosin for 30s. The H&E stained sample was soaked 
sequentially in 95% ethanol and 100% ethanol for 3 min each, and then in Xylene for 5 
min. Finally, the stained sample was mounted with mounting media dissolved in 
Xylene, and observed under a phase contrast microscope. All staining processes are 
done at room temperature. 
 
2.6 Experiments with mouse embryonic fibroblasts 
Mouse embryonic fibroblasts with genotypes of interest, including PTPα+/+Src+/+, 
PTPα-/-Src+/+, PTPα+/+Src-/-, and PTPα-/-Src-/-, were derived from mouse embryos. 
These fibroblasts were spontaneously immortalized by repeated passage. The cells 
were immortalized at around passage 27, and cells from passage 30-40 were utilized in 
the studies described in this thesis. 
 
2.6.1 Derivation of mouse embryonic fibroblasts 
 
Mouse embryonic fibroblasts were isolated from mouse embryos with different 
genotypes. Embryos from combined heterozygous PTPα+/-Src+/- intercrosses were used 
to obtain PTPα+/+Src+/+, PTPα-/-Src+/+, PTPα+/+Src-/- cells, while embryos from PTPα-/-
Src+/- intercrosses were used to obtain PTPα-/-Src-/- cells. Each E14 embryo was 
removed under sterile conditions from the pregnant female. The liver and heart of each 
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embryo was removed, and the remaining tissue was rinsed with cold PBS to remove as 
much blood as possible. The washed tissue was transferred to a 100-mm cell culture 
dish, and teased apart with forceps. The tissue was digested at 4 °C overnight with 5 
ml 0.05% trypsin-EDTA solution (0.05% trypsin type XI, 8 g/l NaCl, 0.4 g/l KCl, 1 g/l 
glucose, 0.4 g/l NaHCO3, and 0.22 g/l Na2-EDTA, pH 7.0), and then most of the 
trypsin-EDTA solution was aspirated off without disturbing the tissue pellet. The 
digested tissue was incubated in a 37 °C incubator for 30 min, and disrupted by 
vigorous pipetting in 10 ml Dulbecco’s modified Eagle medium (DMEM, high glucose, 
Gibco) containing 0.1 mM β-ME and 10% fetal bovine serum (FBS). This was then 
transferred to a 15 ml Falcon tube and centrifuged at 130 x g for 1 min to remove 
remaining clumps. The supernatant, containing fibroblasts, was then transferred to 
another 15 ml Falcon tube and collected by centrifugation. The cells were plated onto 
100-mm cell culture dishes, and cultured at 37 °C with 5%CO2 in DMEM 
supplemented with 10% FBS, 50 U/ml penicillin, and 50 μg/ml streptomycin (Gibco). 
 
2.6.2 Other mouse embryonic fibroblasts  
Mouse embryonic fibroblasts with other genetic backgrounds, including SYF (Src-/-
Fyn-/-Yes-/-), Src+/+ (Src+/+Fyn-/-Yes-/-), and FAK+/+ as well as FAK-/- cells, were 
acquired from ATCC (American Type Culture Collection). SHP2+/+ and SHP2-/- cells 
were gifts from Dr G.S. Feng (Burnham Institute, USA). These cells were grown in 
10% FBS in DMEM (high glucose) with penicillin and streptomycin. 
 
2.6.3 Cell proliferation assay 
Cells were plated in duplicate on six-well plates at 1.55 x 104 cells per well, and 
supplemented with 10% FBS in DMEM. The day when the cells were plated was set as 
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day 0. Cells in each well were counted every 24 h using a hemacytometer. Cell culture 
medium was replaced every other day. The proliferation rates of cells were evaluated 
by calculating the doubling times as follows: Ti x log2 / log (Ni/N0), where Ti = 
interval time (hours), Ni = initial cell number, and N0 = final cell number. 
 
2.6.4 Cell stimulation with extracellular matrix (ECM) components 
Cell culture dishes or glass coverslips used for cell plating were coated with desired 
matrix component at 4 °C overnight. Coating solutions included 10 µg/ml fibronectin 
(FN) (Chemicon International), and 20 µg/ml poly-L-lysine (PLL) (Sigma) or BSA 
(bovine serum albumin) (Sigma), all in PBS. Before plating cells on these matrix-
coated dishes or glass coverslips, the coated dishes or glass coverslips were rinsed 
twice with PBS, and pre-warmed in a 37 ºC incubator. 
 
95% confluent cells were serum-starved (0.5% FBS in DMEM) overnight, and 
detached by a 0.05% trypsin treatment followed by inactivation of trypsin with 
soybean trypsin inhibitor (0.5 mg/ml; Gibco) in serum-free DMEM containing 0.5% 
BSA. The cells were collected by centrifugation and resuspended in serum-free 
DMEM containing 0.1% BSA. After being held in suspension for 1 h at 37 °C with 
occasional mixing, the cells were either left suspended or plated onto matrix-coated 
dishes or glass coverslips, and incubated in a 37 °C incubator for the desired period. 
 
2.6.5 Cell adhesion, spreading and migration assays 
2.6.5.1 Cell adhesion assay 
The serum-starved fibroblasts were trypsinized and resuspended (1 x 106 cells/ml) in 
serum-free DMEM for 1 h. Cell suspension (100µl containing 1 x 105 cells), together 
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with 400 µl serum-free DMEM, was placed into each well of the matrix-coated 24-
well plate and then incubated at 37 °C for the indicated times to allow the cells to 
attach. After incubation, the wells were very gently rinsed three times with cold PBS to 
remove any unattached cells. The adherent cells were then stained with 500 µl crystal 
violet staining solution (0.1% crystal violet, 0.1M borate acid pH 9.0, 2% ethanol-
freshly made and filtered) for 30 min. After staining, the cells were carefully washed 
three times with PBS until PBS ran clear, and left to air-dry. Then 500 µl of 10% 
acetic acid solution was added to each well to de-stain the cells. The de-staining 
solution was collected into a cuvette, and the absorbance at 600 nm was measured 
using a spectrophotometer (Pharmacia Biotech 3000). A high absorbance reflects a 
high number of adherent cells. 
 
2.6.5.2 Cell spreading assay 
The serum-starved fibroblasts (5 x 105 cells/ml) were resuspended in serum-free 
DMEM, and plated onto FN (10 µg/ml)-coated 30-mm dishes. The plated cells were 
allowed to spread for the indicated times at 37 °C. The cells were fixed and stained 
with crystal violet staining solution. After 30 min, the cells were de-stained with 10% 
acetic acid solution and rinsed twice with PBS. The dishes were left at room 
temperature to air-dry. Pictures of the cells were taken under a light microscope. 
 
2.6.5.3 Cell migration assay 
For haptotactic migration assays, the undersurface of Transwell (Costar) polycarbonate 
insert chamber was coated with FN (10 µg/ml in PBS) for 2 h at 37 °C. The coated 
chamber was washed in PBS to remove excess FN and placed into the well of a 24-
well plate. Serum-starved cells, including wild type cells, PTPα-/- cells, and PTPα-/- 
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cells re-expressing wild type and mutant PTPα (WT, DM or Y789F) via adenoviral 
infection, were harvested by trypsinization. The suspended cells were washed twice 
with serum-free DMEM containing trypsin inhibitor (0.5 mg/ml), and once with 
serum-free DMEM. The cells were resuspended in migration media (serum-free 
DMEM containing 0.5% BSA) at 1 x 106 cells/ml. Cell suspension (100 µl containing 
1 x 105 cells) was placed in each prepared insert chamber, and this was inserted into a 
well containing 500 μl migration media. The cells were incubated at 37 °C and 
allowed to migrate towards FN for 2 h. After incubation, the insert was washed with 
PBS and the migrated cells were fixed in ice-cold 4% paraformaldehyde for 15 min at 
room temperature. The fixed cells were washed with PBS and then stained with 
Giemsa solution (Gibco) for 40 min at room temperature. The unmigrated cells on the 
upper surface of the chamber membrane were removed using cotton buds. The number 
of migrated cells was counted under a 20 x objective (cells /field). 
 
2.7 Immunofluorescent staining 
For single or double immunofluorescent staining, cells on extracellular matrix-coated 
glass coverslips were washed with PBS and fixed with ice-cold 4% paraformaldehyde 
for 20 min at room temperature. The fixed cells were permeabilized with 0.02% Triton 
X-100 (Sigma) in PBS for 10 min and incubated in a blocking solution of 5% BSA in 
PBS for 20 min at room temperature. Antibodies, including anti-vinculin antibody 
(Sigma, 1:200), FITC-conjugated anti-paxillin antibody (BD Transduction Laboratory, 
1:250), or anti-cortactin antibody (Santa-Cruz, 1:200), were diluted in 1% BSA in PBS 
and these solutions were carefully overlaid on each coverslip. The cells were incubated 
with the indicated antibody for 2 h at room temperature, and then extensively washed 
three times with PBS. After washing, the cells were incubated with an appropriate 
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Alexa Fluor 594- or 488-conjugated second antibody (Molecular Probes Inc, 1:200-
1:500) for another hour at room temperature in the dark. Alexa Fluor 594- or 488-
conjugated phalloidin, diluted in PBS containing 1% BSA (2 µl /500 µl, Molecule 
Probes Inc), was used to visualize F-actin, and the cells were incubated with this 
solution for 1 h at room temperature. Before mounting, the stained cells were 
extensively washed at least three times with PBS and then left to dry for 5 min. Finally, 
the coverslips with stained cells were mounted facedown on slides in Vectashield 
mounting medium (Vector Laboratories), and stored in the dark. Confocal or 
immunofluorescence microscopy was used to visualize staining. 
 
2.8 Protein Analysis 
2.8.1 Cell lysis 
Adherent, suspended, or FN-stimulated cells were lysed in modified RIPA lysis buffer 
(50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% sodium 
deoxycholate, 0.1% SDS, 1 mM Na3VO4, 1 mM PMSF, 10 µg/ml aprotinin and 
leupeptin). The cell debris was pelleted by centrifugation at 16,000 x g at 4 °C for 20 
min, and the supernatant was retained and termed as total cell lysate. 
 
2.8.2 Determination of protein concentration 
Protein levels of total cell lysates were determined by a colorimetric assay using 
Bradford reagent (Bio-Rad). In a typical assay, 200µl Bradford reagent was added to 
800µl protein solution (cell lysate diluted with H2O) and the absorbance of the 
resulting mixture was measured at 595 nm using a spectrophotometer. Protein 
standards were prepared using known amounts of bovine serum albumin (BSA). 
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2.8.3 Immunoblotting 
A defined amount of protein from each sample was mixed with an equal volume of 2 x 
Laemmli sample buffer, boiled, and loaded into wells of SDS-polyacrylamide gels and 
electrophoresed. After the resolving process, the proteins in the gel were transferred to 
a PVDF (polyvinylidene difluoride) membrane (Manopore Inc) for 70 min at 100 V. 
The PVDF membrane was blocked by incubation in 1% BSA or 5% non-fat milk in 
PBS with 0.1% Tween (Sigma) for 1 h at room temperature. The membrane was then 
incubated with the indicated antibody, diluted in 1% BSA in PBS with 0.1% Tween, at 
4 °C overnight with continuous shaking. The membrane was then washed three times 
with 0.1% Tween in PBS for 10 min/wash, and incubated with an appropriate HRP-
conjugated second antibody (Sigma) for 1 h at room temperature. After the second 
antibody incubation, the membrane was washed three times with 0.1% Tween in PBS 
for 10 min/wash. Finally, the immunoreactive proteins were visualized by ECL 
(enhanced chemiluminescence), and their sizes were estimated by using protein 
molecular weight markers from New England Biolabs. 
 
2.8.4 Immunoprecipitation 
A defined amount of total cell lysate protein was diluted with RIPA lysis buffer to a 
final volume of 600 µl. The desired antibody was added to the tube and incubated at 4 
°C overnight with slow rotation. Protein G plus Protein A agarose beads (Oncogene 
Research Products) was added to the tube and incubated at 4 °C for another 2 h with 
slow rotation. The beads carrying the precipitated protein complexes were pelleted by 
centrifugation and washed once in RIPA lysis buffer and twice in RIPA lysis buffer 
lacking detergent, all carried out at 4 °C. After washing, 20 μl 2 x Laemmli sample 
buffer was added to the precipitated beads, and the mixture was boiled. The 
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immunoprecipitated proteins were resolved by SDS-PAGE and detected by 
immunoblotting. 
 
2.8.5 Quantification of proteins 
Quantification of immunoreactive bands was performed using Bio-Rad Quantity One 
software. Films were scanned with a Fluor-s™ multi-imager scanner, and the images 
were imported into Quantity One for quantification. 
 
2.9 Transient transfection 
2.9.1 Plasmid amplification and purification 
Single colonies of E.coli transformed with one of the following expression plasmids 
(encoded PTPα proteins shown in Fig. 2.1); pXJ41-PTPαWT (Zheng et al., 1992), 
pXJ41-PTPαDM (Bhandari et al., 1998), pXJ41-PTPαY789F generated by X.N. Si, 
and pXJ41-SrcY527F (the SrcY527F was a gift of J.S. Brugge, and it was cloned into 
the PXJ41 plasmid by W.P. Yu), were each inoculated in 4 ml LB containing 100 
µg/ml ampicillin, and incubated at 37 °C with continuous shaking (225 rpm). After 8 h 
incubation, the bacterial cultures were transferred to 200 ml LB with ampicillin and 
incubated with shaking at 37 °C overnight. The bacteria were collected by 
centrifugation and the plasmid DNAs were extracted using the QIAprep kit (QIAGEN 
Inc) according to the manufacturer’s instructions. The extracted plasmid DNA was 
resolved by 1% agarose gel electrophoresis in TAE buffer (0.04M Tris-acetate, 0.01M 
EDTA) containing 0.05 mg/ml ethidium bromide. The 1kb ladder DNA size marker 
from New England Biolabs was used as a molecular weight standard. The plasmid 
DNA concentration was measured using a spectrophotometer. 
 
 








Figure 2.1. Schematic diagrams of PTPα and mutants. PTPα contains two 
cytoplasmic catalytic domains (shaded) termed D1 and D2, and within each domain 
lies the PTP active site CX5R (black). PTPα with mutations of both cysteine residues 
within the active site (C433S/C723S) is catalytically inactive and is termed double 
mutant PTPα (DM). The mutation of the C-terminal tyrosine 789 to phenylalanine 




2.9.2 Cell culture and transient transfection 
Fibroblasts were transiently transfected with the desired plasmid DNAs using 
Lipofectamine™ reagent (Gibco), and all transfections were done according to the 
manufacturer’s instructions. Briefly, the day before transfection, mouse embryonic 
fibroblasts were plated on 100-mm dishes at a density such that cells reached ~75% 
confluence on the second day, and maintained in 10% FBS in DMEM. The next day, 
the cells were washed and the media replaced with serum-free DMEM (5 ml/dish). The 
desired amount of DNA was diluted with 100 µl serum-free media in a 1.5 ml tube, 
called tube A. Lipofectamine™ reagent (30 µl) was mixed with 70 µl serum-free 
DMEM in another 1.5 ml tube, called tube B. Tubes A and B were incubated for 30 
min at room temperature. After incubation, the contents of tube A and tube B were 
mixed to generate the DNA-lipid complexes. The mixture was kept at room 
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After 5 h incubation, the serum-free media was replaced with full growth media, and 
the cells were allowed to grow for another 24 h. 
 
After 24 h incubation, the transfected cells were serum starved overnight. The cells 
were suspended by trypsinization and replated onto FN-coated dishes for the indicated 
period, and harvested in RIPA lysis buffer. Cell lysates were kept at -80 °C until 
further analysis. 
 
2.10 Treatment of cells with inhibitors 
2.10.1 PP2 and PP3 treatments 
PTPα-/- fibroblasts were transiently transfected with PTPαDM alone or cotransfected 
with constitutively active Src (SrcY527F), and then serum-starved overnight. Before 
trypsinization, the cells were left untreated or treated either with 10 μM PP2 (Tocris 
Cook Inc) or with 10 μM PP3 (Calbiochem) for 15 min (PP2 and PP3 were dissolved 
in DMSO at a stock concentration of 100 mM). Following detachment from the dishes, 
the cells were held in suspension with or without PP2 or PP3 for 45 min at 37 °C. The 
untreated and PP2- or PP3- treated cells were lysed in RIPA lysis buffer.  
 
The total lysates were immunoprecipitated with anti-PTPα antibody, and the 
immunoprecipitates were probed with anti-phosphotyrosine antibody (4G10: Upstate; 
or PY-20: Transduction Laboratory). 
 
2.10.2 Cytochalasin D treatment 
95% confluent wild type fibroblasts were serum starved overnight. The cells were 
treated or untreated with 3 μM cytochalasin D (Sigma) for 20 min at 37 °C before 
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trypsinization (adherent cells), and then were held in suspension with or without 
cytochalasin D for 45 min at 37 ºC. The suspended cells were plated on FN-coated 
dishes for 30 min in medium with or without cytochalasin D. The adherent, suspended 
and FN-stimulated cells were lysed in RIPA lysis buffer. The total lysates were 
immunoprecipitated with anti-PTPα antibody and probed for phosphotyrosine. The 
total lysates were also immunoprecipitated with anti-FAK antibody (BD, Transduction 
Laboratory) and probed for phospho-FAK397 (Biosource). 
 
2.11 PTPα adenovirus expression system 
 
2.11.1 Generation of pKS-PTPαY789F (UPac) 
The plasmids pKS-PTPαWT (UPac) and pKS-PTPαDM (UPac) (Zeng et al., 2003) 
were amplified and purified from the transformed bacterial stocks. The plasmid pKS-
PTPαY789F (UPac) was generated by making the Y789F point mutation in the 
plasmid pKS-PTPαWT using the Quickchange site-directed mutagenesis technique 
(Stratagene). Primer sequences (Invitrogen) designed for the generation of 
PTPαY789F are shown in Table 2.2. Briefly, the plasmid pKS-PTPαWT (UPac) was 
used as a template, and the Y789F mutagenic primers were extended and incorporated 
using the nonstrand-displacing action of Pfu Turbo DNA polymerase. The 
thermocycling steps were as follows: 95°C-30s, 16 cycles (95 °C-30s, 55 °C-1 min, 68 
°C-6 min). After the reaction, the template plasmid pKS-PTPαWT (UPac) was 
digested with the restriction enzyme DpnI that only cleaves the methylated, non-
mutated parental DNA. The mutated and uncleaved plasmid pKS-PTPαY789F (UPac) 
was transformed into XL1-blue super-competent cells. The transformation reaction 
solution (250 μl) was plated onto a LB-ampicillin agar plate containing 80 μg/ml X-gal 
and 20mM IPTG. The plate was incubated at 37 °C overnight. Six individual colonies 
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were isolated and cultured, and the plasmid was extracted using the Miniprep kit 




Table 2.2. Sequences of primers used to generate the PTPαY789F mutant. The 
primer solutions were made at a stock concentration of 20 μM. 
 
               Primer Sequence 
 Primer Length 
(bp) 
Forward 
 5’-GAT GCA TTC TCA GAT TTC 




 5’-CGC TTA CTT GAA GTT GGC 






2.11.2 pAdEasy transfer vector (pShuttleCMV) subcloning 
The cDNAs encoding different forms of PTPα, including wild type (WT), catalytically 
inactive (DM), or unphosphorylatable (Y789F) PTPα, were excised from the plasmids 
described in section 2.11.1. The fragments were subcloned into the SalI and NotI sites 
of the pShuttleCMV plasmid (Qbiogene). The presence and orientation of the inserts 
were validated by restriction enzyme digestion and by transient expression of the 
encoded proteins in fibroblasts. After validation, each resulting plasmid (10 μg) was 
linearized with PmeI (New England Biolabs). The linearized DNAs were gel purified 
and dephosphorylated by calf intestine phosphatase (CIP, Invitrogen), and then gel 
purified and resuspended in 30 μl distilled water. 
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2.11.3 Generation of pAdEasy recombinant plasmids in bacterial cells 
pAdEasy (UE1/E3) vector (1.0 μl) (Qbiogene, 100 ng/μl) was mixed with 5 μl of the 
linearized and dephosphorylated pAdEasy transfer vector (pShuttleCMV-PTPαWT, 
pShuttleCMV-PTPαDM, or pShuttleCMV-PTPαY789F). The DNA was transformed 
into bacterial cells by electroporation. Briefly, the mixture was added to 40μl BJ5183 
electro-competent bacterial cells (Qbiogene), and then transferred to a 2 mm ice-cold 
electroporation cuvette (VWR). Electroporation was performed using a Bio-Rad 
electroporator and under the conditions of 200 Ohms, 25 μF, and 2.5 KV. After 
transformation, each mixture was resuspended in 1 ml LB and incubated with shaking 
at 37 °C for 60 min. Either 300 μl or 600 μl transformation solution was plated onto a 
LB agar plate containing 50 μg/ml kanamycin, and allowed to grow at 37 °C for 24 h. 
After incubation, 12 individual colonies were picked up, and the cells were cultured in 
4 ml LB with kanamycin for 20 h. The plasmids were extracted and the size of the 
supercoiled plasmids was verified by 0.7% agarose gel electrophoresis. Due to a low 
yield of DNA from the BJ5183 cells, the correctly sized recombinant plasmid was then 
transferred to DH5α electro-competent bacteria by electroporation. Three individual 
colonies representing each potential recombinant viral plasmid were picked up, and the 
DNAs were extracted using the QIAprep kit. The size of the recombinant plasmid was 
verified after the PacI digestion (New England Biolabs), and the appropriate colony 
was amplified. The recombinant viral plasmid was digested with PacI, and then gel 
purified. The digested and purified DNA was kept for future transfection.  
 
2.11.4 Transfection of recombinant pAdEasy plasmid into Qbi-293A cells 
Qbi-293A cells (Qbiogene), an adenovirus packaging cell line, were plated on a 60-
mm cell culture dish 24 h prior to transfection. Each dish contained 7.5 x 105 cells, and 
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the cells were transfected as described in section 2.9.2. The linearized recombinant 
viral plasmid (5 μg) and 15 μl Lipofectamine™ reagent were used for each transfection. 
The DNA-lipid complexes were incubated with the cells in serum-free media for 5 h, 
and then the media was replaced with 5% FBS in DMEM. The cells were allowed to 
grow in the full media, and the media were replaced every three days until a complete 
CPE (cytopathic effect) was achieved. This occurred at around 10 days post-
transfection, at which time the cells were collected by centrifugation, and resuspended 
in 500 μl PBS. To release virus from the cells, three cycles of freezing at -20°C and 
thawing at 37 °C were performed. Cell debris was pelleted by centrifugation and the 
supernatants were kept at -80 °C. This preparation was called the viral stock of the first 
amplification. 
 
2.11.5 Confirmation of adenoviral-mediated PTPα expression  
Qbi-293A cells were plated on a 24-well plate the day before adenovirus infection. 
Each well contained 5 x 105 cells, and the cells were infected with 100 μl of the viral 
stock of the first amplification for 48 h. The infected cells were collected by 
centrifugation at 130 x g for 5 min, and lysed in 300 μl RIPA lysis buffer. Cell lysate 
(5 μl) was loaded onto a 7.5% acrylamide gel, and the proteins were resolved by one 
dimensional SDS-PAGE. The blot was probed with anti-PTPα antibody. 
 
2.11.6 Amplification of viral particles 
A large scale production of adenovirus was produced by a sequential increase in the 
cell culture and adenovirus infection cycle. Viral stock (200 μl) from the first 
amplification was brought to 1ml with 5% FBS in DMEM. The preparation was used 
to infect 95% confluent Qbi-293A cells plated on a 100-mm petri dish. The infected 
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cells were incubated at 37 °C. A complete CPE was achieved 24 to 48 h after infection, 
and virus was released from the cells by three freeze / thaw cycles. Cells debris was 
pelleted by centrifugation at 3,200 x g for 10 min and the supernatant was retained. A 
total volume of 10 ml was obtained and 1 ml aliquots were stored at -80 °C. The 
second round amplification was performed using 2 ml of this stock, diluted to 10 ml 
with 5% FBS in DMEM. Two 150-mm dishes of Qbi-293A cells were infected with 
the diluted virus solution at 5 ml per dish. A total volume of 50 ml viral stock solution 
was obtained at the second round amplification. For the third round amplification, 50 
ml viral stock was diluted to 150 ml with 5% FBS in DMEM. Cells plated on 30 150-
mm cell culture dishes were infected using 5 ml solution per dish. Virus was released 
by freeze / thaw cycles. Adenovirus obtained from the third round amplification was 
ready for purification and fibroblast infection. 
 
2.11.7 Cesium chloride (CsCl) purification of recombinant adenovirus 
The 30 dishes of infected cells (above) were harvested and the cells collected in two 50 
ml Falcon tubes by centrifugation at 290 x g for 5 min. The cell pellets were each 
resuspended in 10 ml PBS and vigorously mixed to make a uniform suspension. Four 
freeze / thaw cycles were performed to release the virus. After centrifugation at 3,200 
x g 10 min, the cell debris was discarded. To purify the virus, 8 ml of clear virus 
supernatant was transferred to each of two 50 ml Falcon tubes containing 4.4 g CsCl, 
followed by continuous mixing to dissolve all the CsCl. The CsCl plus virus solution 
was transferred to a 12 ml polyallomer tube and overlaid with 2 ml mineral oil. The 
tubes were centrifuged in a SW41 rotor (Baxter) at 120,000 x g at 14 °C for 18 h. The 
virus (appointed as a white band in the middle of the tube) was collected from the side 
of the centrifuge tube with an 18G needle attached to a 3 ml syringe. The collected 
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virus fraction was desalted using a PC10 column (Pharmacia Biotech). The desalted 
virus was titrated and stored in small aliquots (100 μl/vial) at -80 °C. 
 
2.11.8 Viral particle titration 
Tissue culture infectious dose 50 (TCID50) was used to titrate the viral particles. Qbi-
293A cells (1 x 105 cells/ml, 100 µl/well) were plated on two 96-well flat bottomed 
plates the day before infection. Twelve serial dilutions of purified recombinant 
adenovirus stock were prepared in 5 ml tubes. DMEM with 2% FBS (900 µl) was 
dispensed into the first tube, and 1.8 ml into other tubes. Virus stock (100 µl) was 
added into the first tube and mixed completely. This solution was termed the 10-1 
dilution. The 10-1 dilution (200 µl) was taken and transferred into the second tube. The 
dilutions were repeated, up to the highest dilution of the 10-12. For each row of the 96-
well plate, diluted virus at 100 μl per well was dispensed (columns #1 to #10) for the 
eight highest dilutions. Columns #11 and #12 were used for the negative control and 
100 μl 2% FBS in DMEM without virus was added to each of these wells. This was 
done in duplicate. The plates were centrifuged at 1,500 x g at 4 °C for 90 min, and then 
incubated at 37 °C in a CO2 incubator. After 10 days incubation, observable CPE were 
counted per row. The well was still counted as positive even if a small spot or only a 
few cells showed evident CPE. The ratio of positive wells per row was determined. 
The formula used to calculate the titer of the virus was as follows: 101+d (S-0.5), where d 
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2.11.9 Re-introduction of wild type and mutant PTPα into PTPα-/- cells by 
recombinant adenovirus infection 
PTPα-/- fibroblasts were plated onto cell culture dishes and cultured until reaching ~ 
90% cell density before viral infection. The desired amount of adenovirus (around 104 
viral particles / cell) was diluted in 10% FBS in DMEM. The diluted virus, 1 ml for a 
100-mm or 5 ml for a 150-mm cell culture dish, was dispensed onto the cells. The cells 
with virus were incubated at 37 °C for 90 min with occasional gentle mixing of the 
media, and then supplied with a normal level of the full growth media and allowed to 
grow for 24 h. PTPα was expressed (as determining by immunoblotting of cell lysates) 
































Many investigations of the functions of tyrosine kinases and phosphatases are based on 
the analysis of immortalized cell lines or overexpression systems. However, such 
studies do not provide reliable insight into the biological activity of specific proteins at 
their endogenous levels due to the possibility of overexpression artifacts. Thus, reverse 
experiments such as loss-of-function/expression in mice or cells are helpful in 
understanding the biology of such signaling proteins under physiological conditions. 
 
PTPα has been shown to play a role in neural crest cell differentiation, and cerebellar 
granule cell migration in vitro (den Hertog et al., 1993; Yang et al., 2002), but PTPα 
knockout mice are viable and display no gross phenotypic abnormalities. Further 
investigations have revealed defects in hippocampal neuron migration in PTPα-/- mice, 
and behavioral studies indicate that PTPα-/- mice show deficits in Morris maze learning, 
decreased locomotor activity and anxiety (Petrone et al., 2003; Skelton et al., 2003). 
These findings indicate that PTPα is not essential for embryonic development, but is 
required for normal hippocampus development and function. There is an enhanced 
phosphorylation of the C-terminal tyrosine residues of the Src family tyrosine kinases 
(SFKs) Src and Fyn that is accompanied by a ∼50% reduction of Src and Fyn kinase 
activity in brain and fibroblasts obtained from PTPα-/- mice (Ponniah et al., 1999; Su et 
al., 1999). These results suggest that PTPα is a physiological positive regulator of Src 
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and Fyn, acting to dephosphorylate the negative regulatory phosphotyrosine residue 
near the C-termini of these kinases to effect their activation. However, the 
consequences of reduced Src/Fyn kinase activity in PTPα-/- mice are largely unknown. 
Studies of mice with single or combined knockout of the ubiquitously expressed Src, 
Fyn and Yes SFKs have revealed that these kinases share a high degree of functional 
redundancy and play crucial roles in embryonic development. Single or double 
knockout of Src, Fyn or Yes does not result in embryonic lethality, while triple 
knockout of Src, Fyn and Yes leads to severe developmental defects and lethality at 
embryonic day 9.5 (E9.5) (Soriano et al., 1991; Grant et al., 1992; Stein et al., 1994; 
Klinghoffer et al., 1999). How PTPα affects SFKs during embryonic development is 
unclear. A combined gene ablation of PTPα and Src in mice is useful to investigate 
how PTPα-mediated SFK activation functions in embryonic development and 
organogenesis. This model system can be used to determine whether the predicted 
residual Fyn and Yes activities in PTPα/Src double knockout mice are sufficient for 
embryonic development, because most Src/Fyn and Src/Yes double mutant mice die 
perinatally (Stein et al., 1994). This chapter describes the generation and phenotype of 
PTPα/Src double mutant (PTPα-/-Src-/-) mice. 
 
3.2 Results  
3.2.1 Combined ablation of PTPα and Src does not result in embryonic lethality 
PTPα knockout mice (PTPα-/-Src+/+) with a 129SvEv background (Ponniah et al., 1999) 
were crossed with Src heterozygous mice (PTPα+/+Src+/-) having a hybrid background 
(C57BL6J/129Sv) to obtain parental PTPα and Src heterozygous mice (PTPα+/-Src+/-) 
for further breeding. These parental mice, heterozygous for both PTPα and Src 
(PTPα+/-Src+/-), were intercrossed to obtain PTPα/Src double knockout mice (PTPα-/-
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Src-/-). The production of double homozygous mutant progeny (PTPα-/- Src-/-) from this 
cross was predicted to occur at a frequency of 1 in 16. To determine whether the 
combined ablation of PTPα and Src expression resulted in embryonic lethality, 
embryos were collected for analysis at embryonic day 12.5 (E12.5) during the mid-
gestation stage of mouse embryonic development. Pregnant females were sacrificed for 
embryo harvesting, and the embryonic yolk sacs were saved for genotyping. All of the 
embryos that were recovered at E12.5 appeared normal and were approximately 
similar in size. A total of 169 embryos was obtained, but only one was a PTPα/Src 
double mutant (PTPα-/-Src-/-) embryo. This was much lower than expected (10 of 169 
predicted to be double knockout mutant progeny) (Table 3.1). Surprisingly, only one of 
the 169 embryos was wild type (PTPα+/+Src+/+), although about 10 wild type embryos 
were also expected (Table 3.1). Due to this aberrant frequency of wild-type embryo 
production, representing a positive control, it was difficult to draw any conclusion 
about the viability of dual PTPα and Src deficient embryos. 
 
Table 3.1. Embryos obtained from heterozygous PTPα/Src intercrosses (PTPα+/-
Src+/-)x(PTPα+/-Src+/-). Genotypes of embryos were determined by PCR using the 
DNA extracted from E12.5 yolk sacs. A total of 169 embryos was obtained from 35 
breeding females.  
 
Actual  Expected 
Genotype 
# Mice Frequency  # Mice Frequency
       PTPα-/-   Src-/- 1 1:169  10.5 1:16 
 PTPα+/+  Src+/+ 1 1:169  10.5 1:16 
       PTPα+/+  Src-/- 27 1:6  10.5 1:16 
 PTPα-/-   Src+/+ 19 1:9  10.5 1:16 
       PTPα+/-   Src-/- 18 1:9  21 1:8 
PTPα-/-   Src+/- 13 1:13  21 1:8 
PTPα+/-   Src+/- 63 1:3  42 1:4 
 PTPα+/-   Src+/+ 16 1:10  21 1:8 
 PTPα+ /+   Src+/- 11 1:15  21 1:8 
Total 169     
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To increase the predicted frequency of obtaining double mutant progeny, parents 
homozygous for PTPα and heterozygous for Src (PTPα-/-Src+/-) were intercrossed. 
Double mutant progeny were predicted to result from this breeding at a frequency of 
one in four. Using this strategy, thirty-three embryos at E12.5 and nine newborn pups 
were obtained. Nine of the thirty-three embryos were homozygous mutant for PTPα 
and Src, which was equivalent to the predicted number of 8 of 33, according to a 
frequency of one in four (Table 3.2). PTPα/Src double mutant embryos looked similar 
to their littermates with respect to morphology, size and colour. All embryos had a 
placenta and yolk sac that appeared normal and were well vascularized, and the 
embryos also showed a normal heart beat. Furthermore, nine newborn pups were 
examined carefully and genotyped. The expected number of double mutant newborn 
pups was obtained (four of nine) and they all looked normal. Taken together, these 




Table 3.2 Embryos obtained from homozygous PTPα/heterozygous Src 
intercrosses (PTPα-/-Src+/-)x(PTPα-/-Src+/-). Genotypes of embryos were determined 
by PCR using the DNA extracted from E12.5 yolk sacs. A total of 33 embryos was 
obtained from 3 breeding females.  
 
 
Actual  Expected 
Genotype 
# Mice Frequency  # Mice Frequency
PTPα-/-   Src-/- 9 1:4  8 1:4 
PTPα-/-   Src+/- 15 1:2  16 1:2 
PTPα-/-   Src+/+ 9 1:4  8 1:4 
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3.2.2  Post-natal survival and growth of double mutant PTPα-/-Src-/- mice  
Having established that the combined ablation of PTPα and Src does not result in 
embryonic lethality, the general phenotype of the double knockout mice was evaluated 
post-natally with respect to the parameters of survival and growth. 
 
Two groups of pups, obtained from intercrosses of PTPα-/-Src+/- mice, were utilized to 
assess postnatal survival by examining the expected versus actual Mendelian ratio of 
double homozygous pups present in Group 1 (obtained from 10 breeding females) at 
three weeks of age and in Group 2 (obtained from 15 breeding females) at four weeks 
of age. Genotyping of the 54 three week old pups in Group 1 revealed 10 animals (1:5) 
to be double homozygous mutants, slightly below the expected Mendelian ratio of 1:4 
(Table 3.3). Genotyping of the 61 four week old pups in Group 2 revealed 6 animals 
(1:10) to be double homozygous mutants, well below the expected Mendelian ratio of 
1:4 (Table 3.3). In both Groups 1 and 2, the numbers of mice of the other possible 
genotypes (PTPα-/-Src+/- and PTPα-/-Src+/+) that were obtained conformed to or slightly 
exceeded the expected frequencies of 1:2 and 1:4, respectively (Table 3.3). These data 
suggested that about 50% of the double homozygous mutant (PTPα-/-Src-/-) mice died 
between postnatal days 21 and 28 (P21-P28), and that this mortality was genotype-
specific. Indeed, while 61 Group 2 pups were alive at 4 weeks of age when genotyping 
was carried out, nine additional Group 2 pups had died between birth and genotyping. 
Four of these nine pups died within 1-2 days of birth, and tissue from one was 
recovered for use in genotyping and the dead pup determined to be PTPα-/-Src-/-. Five 
of the nine pups died a few days before attaining the age of four weeks, and tissues 
from four of these were recovered for use in genotyping. All were determined to be 
double homozygous PTPα-/-Src-/-animals. The other missing and presumed dead pups 
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were not recovered for genotyping, likely because the dead animals were consumed by 
the mothers. Thus at least four PTPα-/-Src-/- pups died between P21 and P28 and one at 
P1-2, bringing the known ratio of (dead and alive) double homozygous animals to 1:6 
(11/66), much closer to that observed with the three week old Group 1 animals (1:5). 
Very early mortality close to or immediately following birth may also account for the 
slightly lower than predicted 1:5 ratio observed in Group 1 three week old PTPα-/-Src-/- 
animals. In conclusion, it is likely that a few double homozygous animals die shortly 
after birth, with another period of mortality occurring between three and four weeks 
after birth (P21-28). 
 
 
Table 3.3. Pups obtained from homozygous PTPα/heterozygous Src intercrosses 
(PTPα-/-Src+/-)x(PTPα-/-Src+/-). Genotypes were determined by PCR using DNA 
extracted from mouse tail tips at time of weaning. Group 1 pups were weaned and 
genotyped at three weeks of age. Group 2 pups were weaned and genotyped at four 





Actual  Expected 
Genotype 
# Mice Frequency  # Mice Frequency
PTPα-/-   Src-/- 10 1:5  13.5 1:4 
PTPα-/-   Src+/- 29 1:2  27 1:2 
PTPα-/-   Src+/+ 15 1:4  13.5 1:4 




Actual  Expected 
Genotype 
# Mice Frequency  # Mice Frequency
PTPα-/-   Src-/- 6 1:10  15 1:4 
PTPα-/-   Src+/- 31 1:2  30 1:2 
PTPα-/-   Src+/+ 24 1:3  15 1:4 
Total  61     
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As the survival of the double homozygous PTPα-/-Src-/- mice appeared relatively 
normal from at least one to three weeks of age, the growth rate of these mice was 
monitored at ages up to three weeks. Pups were obtained from heterozygous PTPα+/-
Src+/- intercrosses that gave rise to all four homozygous null or wild-type PTPα/Src 
genotypes and, to increase the frequency of production of double homozygous mutant 
pups, also from intercrosses of PTPα-/-Src+/- animals. Pups were genotyped and 
uniquely identified at postnatal day 7 (P7) and weighed at intervals between (P7) and 
postnatal day 21 (P21). During this period, all pups remained with their mothers. As 
shown in Fig. 3.1, all mice, regardless of genotype or gender, had similar body weights 
of about 4.2g at P7. However, with progressing time it was noticeable that the body 
weights of double homozygous PTPα-/-Src-/- mice and single homozygous Src-/- mice, 
both male and female, did not increase as much as did those of single homozygous 
PTPα-/- mice. This difference became most pronounced between P11 and P21 
(p<0.001). At P21, the PTPα-/-Src-/- mice had an average weight of 7.2 ± 0.93g (male) 
or 6.5 ± 1.0g (female) and appeared weaker in their body movements compared to 
single homozygous PTPα-/- mice that had an average body weight of 11.3 ± 1.0g (male) 
or 10.8 ± 1.2g (female). Over the three week period the PTPα-/-Src-/- mice showed no 
significant differences in body weights from the Src-/- mice, suggesting that this growth 
retardation is attributable to the ablation of Src rather than arising from, or exacerbated 




























































Figure 3.1. Body weights of wild type (PTPα+/+Src+/+), single PTPα/Src mutant 
(PTPα-/-Src+/+ and PTPα+/+Src-/-), and PTPα/Src double mutant (PTPα-/-Src-/-) 
mice at 7 to 21 days after birth. (A) Growth curve of male mice (WT: n=5; PTPα-/-: 
n=8; Src-/-: n=2; and PTPα-/-Src-/-: n=10). (B) Growth curve of female mice (WT: n=1; 
PTPα-/-: n=15; Src-/-: n=7; and PTPα-/-Src-/-: n=11). Mean body weight ± SD is shown. 
As reported, single mutant PTPα-/- mice showed no gross abnormalities, and also no 
growth retardation (Ponniah et al., 1999; Su et al., 1999). The weight difference 
between PTPα single mutant and PTPα/Src double mutant mice was significant 
(p<0.001) at 11, 14, 17 and 21 days after birth, as determined by T test. However, no 
significant differences between single Src knockout and PTPα/Src double mutant mice 
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The double mutant PTPα-/-Src-/- mice shared another phenotypic feature with the single 
knockout Src-/- mice, in that they were toothless. This tooth eruption failure is due to 
osteopetrosis resulting from the loss of Src (Soriano et al., 1991). The lack of teeth 
prevented ready monitoring of survival, body weight, and other parameters of these 
mice after the age of four weeks, as the animals are unable to survive on a diet of solid 
food post-weaning. 
 
3.2.3 The combined ablation of PTPα and Src does not affect organogenesis 
To determine if the combined lack of PTPα and Src gave rise to any developmental 
abnormalities that affected major body organs, the brain, spleen, kidney, liver, thymus, 
lung, and pancreas of three week old mice of all four genotypes were weighed and 
fixed for histological analysis. 
 
The livers, hearts, spleens, and kidneys obtained from mice lacking Src (PTPα-/-Src-/- 
or PTPα+/+Src-/-) generally weighed less than these organs from mice that expressed 
Src (PTPα+/+Src+/+ or PTPα-/-Src+/+) (Table 3.4). However, no differences in the 
percent body weight represented by liver, heart, or spleen were apparent between mice 
with or without Src (Table 3.5), suggesting that reduced weight is a function of smaller 
body size. Mice lacking only PTPα had bigger spleens and kidneys than even wild-
type mice (Table 3.4), and this was perpetuated, especially with spleen, as a larger 
percentage of body weight (Table 3.5). This indicates that PTPα ablation inclines to 
spleen and kidney enlargement. In the case of spleen, but not of kidney, the combined 
ablation of Src overcomes this effect to produce spleens in double homozygous 
knockout animals that are of normal size in proportion to body weight (Table 3.5). 
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Overall however, the combined lack of PTPα and Src did not result in any unique 
effects on the weight or percent body weight of these four types of organs. 
 
Brains of mice lacking Src were consistently smaller than those of mice with Src, but 
the brains of Src-deficient mice were determined to actually represent a higher 
percentage of mouse body weight than did brains of mice expressing Src (Tables 3.4 
and 3.5). Similarly, but only in female mice, the lungs of Src-deficient animals 
represented a higher percentage of body weight than those of animals with Src (Table 
3.5). This suggests that the growth of brain and lung was not affected as much as that 
of other organs, such as liver, heart, and spleen, by the general growth retardation 
resulting from the absence of Src. No specific effects of the combined ablation of 
PTPα and Src were apparent in brain or lung. 
 
Notably, thymus was the only organ in which a combined PTPα and Src deficiency 
resulted in a specific effect that was not apparent in thymi of mice lacking either PTPα 
or Src alone. Thymi from both PTPα+/+Src-/- and PTPα-/-Src-/- mice, and particularly 
from the latter animals, weighed less than those of mice that expressed Src (Table 3.4). 
When determined as a percentage of body weight, only the double homozygous 
knockout mice exhibited a clear reduction in thymus weight relative to total body 
weight (Table 3.5). However, the populations of CD4-positive (CD4+/CD8-) or CD8-
positive (CD4-/CD8+) and double CD4/CD8-positive (CD4+/CD8+) thymocytes were 
not altered in PTPα-/-Src-/- mice (data not shown). These results suggest that thymocyte 
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The visual examination of all types of the above organs revealed no differences in 
shape, colour, and general appearance. Furthermore, histological examination of tissue 
sections stained with hematoxylin and eosin (H&E) revealed no readily detectable 
abnormalities. As shown in Fig. 3.2, kidneys of mice of all genotypes had well-
developed glomeruli. Livers of all mice had blood sinuses, and hepatocytes were well 
organized along liver sinuses. Pulmonary alveoli in lung samples were well developed, 
completely air inflated, and isolated by single cell layers in all mice. Organized and 
mature islets were present in pancreas regardless of genotype. The examination of 
sections from thymus, brain, and spleen (not shown) revealed apparently normal 
development. This indicates that neither PTPα nor Src, alone or together, are essential 
for organogenesis during embryonic development and in the three weeks following 
birth. Therefore, the above described reduced weights and/or percentages of body 
weights appear to result from general growth retardation rather than from specific 
formative developmental abnormalities. 
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Table 3.4. Weights of organs. Weights of organs are shown as mean ± SD in grams. 
Genotype Sex Liver Heart Spleen Kidney Brain Lung Thymus 
     PTPα-/-   Src-/- F (8) 0.27±0.04 0.06±0.01 0.04±0.01 0.10±0.02 0.36±0.03 0.12±0.02 0.02±0.02 
M (4) 0.31±0.02 0.06±0.01 0.05±0.01 0.11±0.01 0.39±0.03 0.09±0.03 0.04±0.01 
     PTPα-/-   Src+/+ F (7) 0.48±0.08 0.08±0.02 0.09±0.03 0.16±0.01 0.43±0.04 0.10±0.02 0.07±0.01 
M (5) 0.55±0.04 0.08±0.01 0.10±0.04 0.18±0.01 0.44±0.00 0.10±0.02 0.08±0.01 
     PTPα+/+  Src-/- F (10) 0.30±0.04 0.05±0.01 0.04±0.01 0.10±0.01 0.37±0.04 0.10±0.02 0.05±0.01 
M (3) 0.29±0.03 0.06±0.01 0.04±0.01 0.10±0.01 0.39±0.03 0.09±0.03 0.05±0.01 
     PTPα+/+   Src+/+ F (4) 0.42±0.06 0.07±0.02 0.06±0.01 0.13±0.02 0.40±0.01 0.11±0.02 0.06±0.02 
M (7) 0.46±0.06 0.07±0.01 0.07±0.01 0.14±0.02 0.42±0.01 0.11±0.02 0.07±0.01 
 
 
Table 3.5. Organ weight as a percentage of body weight. The mean weight of each type of organ is shown as a percentage of body weight. 
 
Genotype Sex Liver Heart Spleen Kidney Brain  Lung Thymus 
      PTPα-/-   Src-/- F (8) 4.2% 0.9% 0.6% 1.6% 5.6% 1.8% 0.3% 
M (4) 4.0% 0.8% 0.6% 1.4% 5.0% 1.1% 0.5% 
      PTPα-/-   Src+/+ F (7) 4.4% 0.8% 0.8% 1.5% 4.0% 1.0% 0.6% 
M (5) 4.8% 0.8% 0.9% 1.6% 3.9% 0.9% 0.7% 
      PTPα+/+  Src-/- F (10) 4.3% 0.7% 0.6% 1.4% 5.3% 1.5% 0.7% 
M (3) 3.8% 0.8% 0.5% 1.3% 5.1% 1.2% 06% 
      PTPα+/+   Src+/+ F (4) 4.2% 0.7% 0.6% 1.3% 4.0% 1.1% 0.6% 
 M (7) 4.2% 0.6% 0.6% 1.3% 3.9% 1.1% 0.6% 
 
A total of 48 mice were sacrificed at three weeks of age. All organs are collected and weighed before they were fixed in 10% formalin 
for further histological analysis.
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Figure 3.2. Histological analysis of organs obtained from mice with different 
genotypes (PTPα+/+Src+/+, PTPα-/-Src+/+, PTPα+/+Src-/-, PTPα-/-Src-/-) at three 
weeks of age. Organs were fixed with 10% neutral buffered formalin and processed 
for paraffin embedding. Sections of each organ were prepared and stained with 
hematoxylin and eosin. (A) Kidney with the renal glomerulus in the middle indicated 
by the arrow, (B) liver, (C) lung with pulmonary alveoli shown and (D) pancreas, with 






PTPα+/+Src+/+ PTPα-/-Src+/+ PTPα+/+Src-/- PTPα-/-Src-/- 
  81  
3.3 Discussion 
The generation of mice with a combined deficiency in PTPα and one of its 
downstream targets, Src, was utilized to determine the requirement for the dual 
expression of PTPα and Src in mouse embryogenesis, organogenesis, and general 
post-natal survival and development. 
 
A single deficiency in either PTPα or Src does not affect embryonic viability (Soriano 
et al., 1991; Ponniah et al., 1999; Su et al., 1999). Double homozygous PTPα-/-Src-/- 
embryos were found at the expected frequency at E12.5 and appeared normal. Also, 
double homozygous knockout pups were born in or close to the expected numbers. 
Thus, the combined lack of PTPα and Src does not result in embryonic lethality. 
 
Two periods of post-natal mortality were observed in the double knockout mice, the 
first occurring shortly after birth and the second occurring between the third and fourth 
weeks after birth. Five of 11 PTPα-/-Src-/- pups that were born alive had died by the age 
of four weeks, representing a 45% mortality rate. A similar mortality was not found 
with mice that lacked PTPα but that were heterozygous or wild-type for Src, indicating 
that this was not due solely to the absence of PTPα and consistent with the normal 
viability reported for PTPα-null mice (Ponniah et al., 1999; Su et al., 1999). Mice 
lacking only Src were not available in these experiments for comparison of post-natal 
survival due to the breeding strategy used to generate the double homozygous 
knockout mice. However, one in five Src-null mice is reported to die by the age of 
three weeks, and a 30% mortality rate is observed by the age of five weeks (Soriano et 
al., 1991). This difference between the 45% mortality observed with PTPα-/-Src-/- mice 
(and potentially increasing up to 60% if some or all of the deceased but unrecovered 
 
  82  
pups were also double homozygous knockout) and the 20-30% mortality reported for 
Src-/- mice could be due to differences in genetic background, as the parental PTPα+/-
Src+/- heterozygous mice had a mixed strain background of 129SvEv and C57BL6J 
while Src-/- mice were inbred 129Ev. This seems unlikely, as hybrid Src-null mice are 
reported to survive longer than inbred 129Ev Src-null mice (Soriano et al., 1991). 
Additionally, the above experiments were conducted in different animal facilities, and 
mortality differences might reflect these different environments. However, these 
differences could also be due to an enhanced mortality resulting from the additional 
deletion of PTPα together with Src, most likely manifested by the reduced activities of 
SFKs that are PTPα targets combined with the total absence of Src. Three SFKs, Src, 
Fyn and Yes, are ubiquitously expressed (Brown et al., 1996). PTPα ablation reduces 
the activities of Fyn and Src to less than 50% of that observed in the presence of PTPα 
(Ponniah et al., 1999; Su et al., 1999). While Yes activity has not been specifically 
determined in PTPα-null mice, the phosphorylation of Yes at its inhibitory C-terminal 
tyrosine residue is enhanced 2.5-fold in PTPα-/- synaptosomes, similar to the observed 
fold-enhancement of the corresponding tyrosine residue in synaptosomal Src and Fyn 
in PTPα-/- mice (Le et al., 2006). Thus, PTPα is a physiological upstream regulator of 
these three SFKs, and likely of others as well (Le et al., 2006). Functional redundancy 
operates between these three SFKs. While the triple ablation of Src, Fyn, and Yes 
results in embryonic lethality (Klinghoffer et al., 1999), single and double mutant 
embryos are viable and born at the expected frequencies (Soriano et al., 1991; Stein et 
al., 1994). However, many Fyn/Src, Src/Yes and Yes/Fyn double mutant pups die 
shortly after birth, and the surviving mutants are very small in size, especially the 
Fyn/Src double mutants that weigh less than half than their wild-type littermates at 
three weeks of age and do not survive past this age (Stein et al., 1994). Some Src/Yes 
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mutants are able to survive longer, and the two-thirds of Fyn/Yes mutants that survive 
the period immediately following birth are smaller at weaning but show no other defect 
up to 3-5 months of age (Stein et al., 1994). Thus, while Fyn/Src-deficient mice exhibit 
severely curtailed survival, demonstrating that Yes alone cannot sustain maturation and 
survival to adulthood, Src/Yes and Fyn/Yes double mutant mice also show reduced 
survival compared to single SFK mutant mice. The double mutant PTPα-/-Src-/- mice 
that I have generated lack Src, and due to the absence of PTPα have less than half the 
normal level of Fyn activity (Ponniah et al., 1999; Su et al., 1999) and would be 
predicted to have at least 50% reduced Yes activity. Overall, this would combine to 
reduce the level of expression (Src) and function (Fyn, Yes) of these three SFKs, 
perhaps to a total approximating that of a double SFK (Src, Fyn, or Yes)-deficient 
animal. The residual Fyn/Yes activity of the PTPα-/-Src-/- mice may be insufficient for 
maturation and survival post-three weeks of age. 
 
Growth retardation was readily apparent in the PTPα-/-Src-/- mice by two and a half 
weeks of age. This may be due to an intrinsic metabolic defect(s), to inefficient 
nutrition due to non-competitive suckling by these pups, or to rejection by mothers. 
This smaller size is a feature also observed in Src-null mice (Soriano et al., 1991) and 
in all double SFK mutant mice (Stein et al., 1994). It is unlikely to be the sole cause of 
the double PTPα/Src mutant mortality that occurred between three and four weeks of 
age, as Src single mutant pups that were monitored in parallel showed a similar growth 
retardation (also observed by others) (Soriano et al., 1991), but as described above, 
only 20-30% die between three and five weeks of age. In accord with the reduced 
growth shared by double mutant PTPα/Src-null mice and single mutant Src-null mice, 
no specific effects of the combined PTPα/Src ablation were apparent in most major 
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body organs, either in terms of organ weight, organ weight as a percentage of body 
weight, or development as determined upon histological examination. The exception to 
this was PTPα-/-Src-/- thymus. Although normal in appearance upon visual and 
histological examination, these thymi had a reduced size that was apparent even when 
calculated in relation to total body weight compared to those from either PTPα or Src 
single mutant mice. The reason for this is unknown, and thymocyte development 
occurs normally in PTPα/Src double mutant mice, as is also reported in PTPα-
deficient (Maksumova et al., 2005) and in Fyn-deficient mice (Stein et al., 1992). 
However, thymocyte proliferation in response to T cell receptor stimulation is 
impaired in both PTPα-/- and Fyn-/- mice, and aberrant Fyn activity is observed in 
unstimulated thymocytes of PTPα-null mice (Stein et al., 1992; Maksumova et al., 
2005). Furthermore, mature double mutant Fyn/Yes-deficient mice develop renal 
abnormalities that are postulated to result from autoimmune disease (Stein et al., 1994). 
 
In addition to the redundant functions of SFKs in embryonic development and 
organogenesis, the compensatory actions of other PTPs in the absence of PTPα may 
account for the absence of more severe phenotypes observed in double mutant PTPα-/-
Src-/- mice. SFKs can be activated by other PTPs such as CD45, PTP1B or SHPs 
(Gould et al., 1988; Thomas et al., 1999; Cheng et al., 2001), and this would be 
expected, in PTPα-/- mice, to occur as usual in SFK-mediated signaling pathways that 
do not involve PTPα. In addition, the unaltered activity of such other PTPs may 
provide sufficient regulation/activation of SFK-mediated signaling pathways that 
normally but not exclusively involve PTPα, and/or potentially could also exhibit 
extraordinary compensatory activities (induced by the absence of PTPα) in the former 
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type of pathways or in the PTPα-regulated signaling pathways in which such other 
PTPs are usually not involved. 
 
In summary, no embryonic lethality is associated with the combined loss of PTPα and 
Src. PTPα/Src double homozygous mutant mice share several defects with Src-null 
mice, including toothlessness, growth retardation manifested in reduced overall body 
weight and reduced weight of many major organs, and an elevated frequency of 
premature death that in some animals occurs within a few days after birth and in others 
occurs between three and five weeks of age. However, the mortality rate post-three 
weeks (at least 45%) may be elevated in PTPα-/-Src-/- mice compared to Src-/- mice 
(20%) due to the reduced activity of remaining SFKs such as Fyn and Yes, although it 
is not as severe as that reported in Fyn/Src double mutant mice that all die by three 
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4.1  Overview 
Integrins are the major receptors for extracellular matrix (ECM) proteins, and play 
roles in many cellular biological processes including embryonic development, 
programmed cell death, tumor cell growth and metastasis (Juliano et al., 1993). 
Activation of integrins by binding to ECM components such as FN induces many 
cellular responses like cell adhesion and spreading, migration, and proliferation. More 
than 50 molecules are involved in integrin signaling, and SFKs as well as PTPα are 
important intermediates in this signaling network. 
 
Src and PTPα are not essential for embryonic development, but fibroblasts derived 
from either Src-/- or PTPα-/- mice display defects in integrin-induced signaling events 
(Soriano et al., 1991; Kaplan et al., 1995; Ponniah et al., 1999; Su et al., 1999). Src-/- 
cells display a reduced rate of cell adhesion and spreading when plated on FN (Kaplan 
et al., 1995). Increased tyrosine phosphorylation of many signaling and cytoskeletal 
proteins is critical and is among the earliest events triggered by integrin engagement. 
Fibroblasts lacking Src, Fyn and Yes (SYF) demonstrate drastically reduced tyrosine 
phosphorylation of many signaling proteins, including FAK, upon integrin stimulation 
and displaying reduced migration towards FN, suggesting that SFKs play essential 
roles in optimal responses in integrin signaling (Klinghoffer et al., 1999). Reduced 
FAK Tyr397 phosphorylation is detected in PTPα-/- cells, and this results in less 
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Src/Fyn association with FAK upon integrin stimulation. This is accompanied by 
reduced cell spreading and delayed cytoskeletal organization (Zeng et al., 2003). 
 
The combined ablation of PTPα and Src does not result in embryonic lethality, but 
may increase premature mortality between birth and three weeks of age, as described 
in Chapter 3. Aside from this however, no distinct and additional effects of the dual 
absence of PTPα and Src, as compared to the single ablation of either gene, were 
observed at the level of the whole animal in terms of development and organogenesis. 
To determine whether the combined lack of PTPα and Src resulted in novel defects at 
the molecular and/or cellular levels, the ability of fibroblasts from PTPα-/-Src-/- mouse 
embryos to respond to integrin stimulation was investigated. This signaling pathway 
was chosen for study because, as briefly outlined above, both PTPα and Src (as well as 
other SFKs) play important roles in integrin signaling, and although these roles are 
interconnected, the precise molecular mechanisms linking the actions of this PTP and 
PTK are unclear. 
 
4.2 Results 
4.2.1 Mouse embryonic fibroblasts deficient in both PTPα and Src display a 
distinctive morphology after spontaneous immortalization 
Double knockout PTPα-/-Src-/- (henceforth termed α/s DKO) mouse embryonic 
fibroblasts and three other fibroblast cell lines (WT, PTPα-/-, and Src-/-) were prepared 
from embryos at day E14 as described (see Materials and Methods, section 2.6.1), and 
spontaneously immortalized by repeated passage. These cells were normally 
immortalized by passage 30, and their genotypes were confirmed by both PCR and 
Western blotting (data not shown). Immortalized α/s DKO cells presented an atypical 
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fibroblastic morphology distinct from that of wild type, and PTPα (PTPα-/-) or Src 
(Src-/-) single knockout cells. As shown in Fig. 4.1A and B (top panels), the α/s DKO 
cells were not well spread 12 h after plating on cell culture dishes, and they still 
appeared smaller, less flattened and more refractile, and more tightly packed than 
either PTPα or Src single knockout cells three days after plating on plastic culture 
dishes. 
 
The morphology of α/s DKO cells resembled transformed cells, however, unlike many 
transformed cell lines, the withdrawal of serum from the culture media prevented the 
proliferation of the α/s DKO cells. Cell proliferation assays revealed that α/s DKO 
cells attained a higher cell density at confluence than any of the other cell types, likely 
due to the readily apparent smaller size of the α/s DKO cells. Wild type, PTPα-/-, and 
Src-/- cells exhibited a lower density at confluence that was similar in all three of these 
cell lines (Fig. 4.2A and B). Cell proliferation rates were evaluated by calculating the 
doubling time from intervals on the growth curves shown in Fig. 4.2B that 
corresponded to linear cell growth (see Materials and Methods, section 2.6.3). The 
doubling times of wild type and PTPα-/- cells (day 1-3) were 17 h and 19 h respectively. 
A reduced doubling time of 38 h (day 1-4) was observed for Src-/- cells. This is 
consistent with a report that Src is involved in cell cycle regulation, and implicated in 
playing an important role in mitotic division at the G2-M transition (Klinghoffer et al., 
1999). The proliferation rate of α/s DKO cells was comparable to that of wild type or 
PTPα-/- cells, with a doubling time of 21 h (day 2-7). 
 
The filamentous actin organization and distribution of focal contact-associated proteins 
such as paxillin and cortactin were investigated in growing α/s DKO cells. 12 h after 
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plating, wild type fibroblasts displayed well-organized actin stress fibers that were 
oriented in bundles at the edges of the polarized cells. Putative focal adhesion sites at 
the end of these stress fibers were visualized by paxillin and cortactin staining. The 
actin stress fiber organization and the distribution of paxillin and cortactin observed in 
PTPα-/- or Src-/- cells appeared no different from those of wild type fibroblasts, either 
12 or 72 h after plating (Fig. 4.1). In contrast, the α/s DKO cells were much less well 
spread. There was a lack of actin stress fibers at the edge of the cells 12 h after plating. 
The α/s DKO cells had more compact cytoplasmic paxillin and cortactin staining, 
consistent with a lack of focal adhesion formation. After 72 h incubation in FBS-
containing medium, F-actin-rich membrane ruffles were detected around the cell 
periphery in the α/s DKO cells, but the cells still had more cytoplasmic paxillin and 
cortactin staining (Fig. 4.1). 
 
The distinct morphology and cytoskeletal organization observed in α/s DKO cells, 
compared to wild type, PTPα-/- and Src-/- cells, may result from the combined ablation 











































Figure 4.1. Cell morphology, filamentous actin organization, and localization of 
paxillin and cortactin in WT (wild type), PTPα-/-, Src-/- and α/s DKO (PTPα-/-Src-/-) 
fibroblasts. Cells were grown in DMEM containing 10% FBS, trypsinized, and re-
plated on 60 mm cell culture dishes for 12 (A) or 72 (B) h. Cells were fixed and 
labeled with FITC-phalloidin (green) to visualize actin, and with mouse monoclonal 
anti-paxillin antibody (green) or rabbit polyclonal anti-cortactin antibody (red) to 
detect focal adhesions. Representative images of cells and staining were taken under 
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Figure 4.2 Cell proliferation assay. Cells of the four genotypes of interest (WT, 
PTPα-/-, Src-/-, and α/s DKO) were plated in duplicate on 6 well plates at 1.55X104 
cells per well. Cells were grown in DMEM containing 10% FBS, and were counted 
every day. Curves are representative of the cell growth rate of each individual cell line. 
The graph shown in (A) is the actual cell number and in (B) is the logarithmic 
calculation of cell number, correlating to each cell line at the indicated day. 
 
 
4.2.2 α/s DKO cells are defective in FN-induced cell adhesion and spreading 
Cell adhesion and spreading are important cellular responses to integrin stimulation 
and initial steps in many biological processes. As PTPα is required for efficient 
integrin-induced cell spreading (Su et al., 1999; Zeng et al., 2003), and Src is required 
for both cell adhesion and spreading (Kaplan et al., 1995), the effects of combined 
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ablation of these two molecules on these integrin-regulated processes were 
investigated. 
Integrin-induced cell adhesion was evaluated by crystal violet staining of cells that had 
been plated on FN-coated dishes for different times. As depicted in Fig. 4.3A, wild 
type cells started to adhere to the substrate within 10 min, and more than 90% cells 
adhered after 30 min on FN. As previously reported (Su et al., 1999), PTPα-/- cells 
attached at the same rate as wild type cells. The initial attachment of Src-/- cells to FN 
(at 5 min on FN) was equal to that of wild type cells, but the process was obviously 
delayed after 10 min on FN, exhibiting an average 2.2 fold decrease in cell adhesion 
onto FN. The α/s DKO cells adhered less well than Src-/- cells, and this difference was 
readily apparent after 30 min on FN. Some of the Src-/- and α/s DKO cells could not 
adhere to the matrix even after 2 h on FN (Fig. 4.3A). To rule out non-specific binding 
of cells in this assay, the cells were plated on BSA-coated plates as a negative control 
for the cell adhesion assay. Cell adhesion on BSA-coated plates was negligible for all 
four cell lines (Fig. 4.3B). To further confirm that the different rates of cell adhesion 
on FN among the four cell lines were PTPα and Src related, cells were plated onto 
poly-L-lysine (PLL)-coated plates as a positive control for the assay. No detectable 
difference among the four cell lines was observed in the rate of adhesion to PLL. To 
determine whether the FN adhesion differences among the four cell lines resulted from 
a different expression of integrins in cells, the expression level of the integrin 
 β1 subunit, that binds to FN, was determined. Integrin β1 expression was similar 
among the four cell lines (data not shown). Taken together, these data indicate that the 
inefficiency of cell adhesion on FN in α/s DKO cells is mainly attributable to the lack 
of Src, but that the combined absence of PTPα exacerbated this process. 
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Figure 4.3. α/s DKO cells exhibit defective integrin-induced cell adhesion. 
Fibroblasts of the indicated genotypes were plated on (A) FN-coated, (B) BSA-coated, 
or (C) poly-L-lysine (PLL)-coated plates at different times as indicated and incubated 
at 37ºC. Adherent cells were fixed and stained with crystal violet. The cells were de-
stained with 10% acetic acid 10 min after staining. The absorbance of the destaining 
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solution was measured at 600 nm, and the higher absorbance reflects a higher number 
of adherent cells. Each assay was conducted in duplicate, and the results shown are an 
average. 
 
After cells adhere to FN through integrins, the cells begin to spread. The spreading of 
cells is characterized by a decrease in cell refractility and an appearance of projections 
around the cell periphery. Wild type fibroblasts initiated spreading 10-20 min after 
plating on FN, and were well spread in 30 min. The cells exhibited typical fibroblast 
morphology when they were well spread (Fig. 4.4, WT). In agreement with the 
observation of Su et al. (1999), PTPα-/- cells displayed a clear but transient delay in 
spreading on FN, which was most obvious 20 min after plating on FN. PTPα-/- cells 
initiated spreading on FN later than did wild type cells, but could finally achieve a 
typical fibroblastic morphology (Fig. 4.4, PTPα-/-). There was a dramatic delay in the 
ability of Src-/- cells to spread on FN (Fig. 4.4, Src-/-). A majority of Src-/- cells 
remained rounded 20 min after plating on FN, but eventually the cells were well spread 
after 60 min on FN. This observation is consistent with an earlier report from another 
group (Kaplan et al., 1995). Compared with wild type, PTPα-/- or Src-/- cells, the α/s 
DKO cells were clearly impaired in their ability to spread on FN (Fig. 4.4, α/s DKO). 
Most of the α/s DKO cells remained rounded even 60 min after plating on FN, and did 
not achieve a normal fibroblastic morphology even 2 h after plating on FN (data not 
shown). The severely impaired cell spreading of the α/s DKO cells probably resulted 
from their inefficient adhesion to the FN substrate, such that subsequent events 
required for spreading could not be fully activated. The more severe impairment of cell 
spreading in α/s DKO cells, compared to cells lacking only PTPα or Src, indicate that 
both PTPα and Src play roles in spreading on FN. PTPα-mediated SFK activation is 
likely required for spreading on FN, especially at later stages. 
 
 



























 Figure 4.4. α/s DKO cells exhibit an integrin-mediated cell spreading defect that 
is more severe than that of PTPα -/- or Src-/- cells. Cells of the indicated genotypes 
were placed in suspension for 1 h, and replated onto FN-coated dishes for the indicated 
time periods (10, 20, 30 and 60 min). The cells were then fixed and stained with crystal 




4.2.3 Integrin-induced cytoskeletal organization is altered in α/s DKO cells 
Integrin-induced cell spreading involves cytoskeletal rearrangement, leading to actin 
stress fiber assembly and focal adhesion formation. To determine whether the impaired 
cell spreading on FN observed in α/s DKO cells resulted from a disorganization of the 
cytoskeleton, cells were investigated for the organization of actin stress fibers and the 
distribution of focal adhesion proteins such as paxillin by immunofluorescent staining 
after cells were plated on FN for 15, 30 and 60 min. Plating of wild type fibroblasts on 
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FN for 15 min led to cell spreading; membrane ruffles and lamellipodia were detected 
around the cell periphery (Fig. 4.5A, left panels). The cells were well spread and 
polarized, with the formation of long actin stress fiber oriented in bundles at the 
leading edge of the polarized cells after 30 min on FN (Fig. 4.5A, middle panels). At 
60 min on FN, wild type cells displayed thick longitudinally oriented actin stress fibers 
and paxillin presented at the ends of the actin stress fibers in focal adhesion-like 
structures (Fig. 4.5A, right panels). As reported, PTPα-/- cells were much less well 
spread at 15 min on FN (Su et al., 1999; Zeng et al., 2003), and lacked the membrane 
ruffles and lamellipodia around the cell periphery (Fig. 4.5B, left panels). After 30 min 
on FN, PTPα-/- cells were still unpolarized and had less apparent actin stress fibers 
than wild type cells, accompanied by a lack of F-actin-rich membrane ruffles around 
the cell periphery. Furthermore, PTPα-/- cells had more compacted cytoplasmic 
paxillin staining, consistent with less focal adhesion formation (Fig. 4.5B, middle 
panels). The PTPα-/- cells were well spread after 60 min on FN. Focal adhesions began 
to appear at the periphery of the cells, and actin stress fibers formed and were oriented 
in bundles, but the appearance of these structures was still different from those in wild 
type cells (Fig. 4.5B, right panels). Corresponding to the delayed cell spreading 
observed in Src-/- cells, no obvious membrane ruffles and lamellipodia were detected 
around the cell periphery at 15 min on FN (Fig. 4.5C, left panels). Src-/- cells appeared 
very similar to PTPα-/- cells when the cells were plated on FN for 30 min, with reduced 
F-actin in membrane ruffles and no actin stress fibers detected, together with more 
compacted cytoplasmic paxillin staining (Fig. 4.5C, middle panels). After 60 min on 
FN, focal adhesions and actin stress fibers were detected in numerous Src-/- cells, 
although with less density than in wild type cells (Fig. 4.5C, right panels). Thus the 
absence of PTPα or Src in fibroblasts leads to a delay in integrin-induced cell 
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spreading, accompanied by delayed actin stress fiber assembly and focal adhesion 
formation. The α/s DKO cells appeared more spread than PTPα-/- or Src-/- cells at 15 
min on FN, but these cells exhibited more flattened pattern compared to the wild type 
cells. After 15 min on FN, the α/s DKO cells had more microspikes around the cell 
periphery than they did lamellipodia or membrane ruffles (Fig. 4.5D, left panels). 
Microspikes are structures typically apparent at the early stage of non-polarized cell 
spreading (Gumbiner 1996). This non-polarized cell spreading could be due to a failure 
to form focal adhesions, however, paxillin staining in α/s DKO cells indicated that 
prominent focal adhesions were detected around the cell periphery after 30 min on FN 
that were comparable to those in wild type cells. The assembly of actin stress fibers 
was disorganized in α/s DKO cells, as no F-actin-rich membrane ruffles and 
lamellipodia were detectable (Fig. 4.5D, right panels). Similar defects in integrin-
mediated cytoskeletal organization were detected in another α/s DKO cell line (data 
not shown). 
 
A summary of integrin-induced cell adhesion, spreading, and cytoskeletal organization 
of wild type, PTPα-/-, Src-/- and α/s DKO cells is presented in Table 4.1. These 
observations indicate that there is an early delay or impairment in integrin-induced 
actin stress fiber assembly and focal adhesion formation in both PTPα-/- and Src-/- cells. 
After 60 min on FN, these processes eventually reached an equivalent point to those in 
the wild type cells. However, integrin-stimulated actin stress fiber assembly and focal 
adhesion formation are completely altered in α/s DKO cells. An increased amount of 
microspikes and an enhanced focal adhesion are detected in the α/s DKO cells upon 
integrin stimulation. These observations indicate that PTPα and Src may be not only 
important for the assembly of focal adhesions, but also involved in their disassembly. 
 











































Figure 4.5(1). FN-induced actin stress fiber assembly and focal adhesion 
formation in wild type, PTPα-/-, Src-/-, and α/s DKO fibroblasts. The indicated cells 
(A, wild type; B, PTPα-/-; C, Src-/-; D, α/s DKO) were placed in suspension for 1 h, 
and then plated on FN-coated converslips for 15 (FN15), 30 (FN30), and 60 (FN60) 
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(green) and labelled with phalloidin to detect actin (red). Representative images of the 
stained cells were taken using a fluorescence microscope. The bottom panels show 














































Figure 4.5(2). FN-induced actin stress fiber assembly and focal adhesion 
formation in wild type, PTPα-/-, Src-/-, and α/s DKO fibroblasts. The indicated cells 
(A, wild type; B, PTPα-/-; C, Src-/-; D, α/s DKO) were placed in suspension for 1 h, 
and then plated on FN-coated converslips for 15 (FN15), 30 (FN30), and 60 (FN60) 
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(green) and labelled with phalloidin to detect actin (red). Representative images of the 
stained cells were taken using a fluorescence microscope. The bottom panels show 
merged images of paxillin and actin staining (Scale bars, 100 μm). 
 
 
Table 4.1. Integrin-induced structural and morphological properties of wild type, 
PTPα-/-, Src-/- and α/s DKO fibroblasts. 
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4.2.4 Integrin-induced FAK Tyr397 phosphorylation is not affected in α/s DKO 
fibroblasts 
The tyrosine kinase FAK plays a central role in integrin-stimulated events (Ilic et al., 
1997; Parsons 2003), and several tyrosine residues on FAK are important for its 
functions in these events. FAK Tyr397 is the first site on FAK that becomes 
phosphorylated upon integrin stimulation, and this is critical for ensuing FAK 
activation and function (Schaller et al., 1994; Calalb et al., 1995). Initial low level 
autophosphorylation of Tyr397 creates a binding site for the SH2 domain of Src or Fyn 
(Cobb et al., 1994; Xing et al., 1994; Cary et al., 1996). The recruited, activated 
Src/Fyn then phosphorylates two adjacent residues, Tyr576 and Tyr577, in the kinase 
domain of FAK, stimulating FAK kinase activity and resulting in enhanced FAK 
Tyr397 phosphorylation and full FAK activation (Calalb et al., 1995). The complexed 
Src/Fyn also phosphorylates other tyrosine residues in FAK (i.e. Tyr925) to create 
phosphotyrosine binding sites for other molecules (Schlaepfer et al., 1994). 
 
PTPα-/- cells exhibit a reduced integrin-stimulated Src/Fyn association with FAK that 
corresponds with a reduced phosphorylation of FAK Tyr397 (Zeng et al., 2003). PTPα 
is thus required for the optimal execution of these early integrin-induced events. To 
determine whether FAK autophosphorylation at Tyr397 and subsequent Src/Fyn- 
dependent phosphorylation of other sites on FAK are altered in the absence of Src or in 
cells with a dual lack of PTPα and Src, phosphosite-specific antibodies to FAK Tyr397 
and FAK Tyr576 were utilized to investigate this in lysates of FN-stimulated wild type 
(WT), PTPα-/-, Src-/-, and α/s DKO cells (Fig. 4.6). As reported (Zeng et al., 2003), the 
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phosphorylation of FAK at Tyr397 was consistently observed to be lower in PTPα-/- 
cells than in wild-type cells (Fig. 4.6A). Src-/- cells displayed reduced phosphorylation 
of FAK Tyr397 at 15 min on FN, but phosphorylation at this site appeared comparable 
to that in wild-type cells after 30 min on FN (Fig. 4.6A). The FN-stimulated 
phosphorylation of FAK Tyr576, a SFK-specific site, was also reduced in the PTPα-/- 
and the Src-/- cells at all times examined (15, 30, and 60 min on FN) (Fig. 4.6B). As 
with the three other cell lines, the α/s DKO cells did not exhibit detectable FAK 
Tyr397 phosphorylation when in suspension. Surprisingly, in view of the dramatic 
differences in cell morphology, cytoskeletal arrangement, and focal adhesion 
formation observed in the α/s DKO cells (Fig. 4.5), integrin-induced phosphorylation 
of FAK Tyr397 was equivalent in extent and timing to that observed in wild-type cells 
(Fig. 4.6A). However, reduced phosphorylation of FAK Tyr576 was persistently 
detected in the α/s DKO cells, compared to that in wild type cells, but at the same level 
as in PTPα-/- and Src-/- cells (Fig. 4.6B). This suggests that the requirements for 
integrin-stimulated tyrosine phosphorylation of different sites on FAK are not identical, 
as effective Tyr397 phosphorylation can be achieved despite a lack of optimal Tyr576 
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Figure 4.6. Integrin-induced phosphorylation of FAK at Tyr397 and Tyr576 in 
single and double knockout fibroblasts lacking Src and/or PTPα. Cells were 
maintained in suspension (0) or plated on FN for the indicated times (15, 30, 60 min) 
before harvesting. Cell lysates were probed with (A) anti-phospho-FAK Tyr397 or 
anti-FAK antibodies, and (B) anti-phospho-FAK Tyr576 or anti-FAK antibodies. 
Autoradiographs from three independent experiments as described in (A) and (B) were 
quantified for FAK phospho-Tyr397 or phospho-Tyr576 content relative to the amount 
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of FAK protein. The graphs show the mean ± S.D. The FAK Tyr397 phosphorylation 
in wild-type cells on FN for 15 min was taken as 100%. FAK Tyr576 phosphorylation 
in wild-type cells in suspension was taken as 100%. 
 
4.2.5 Constitutive activation of Erk is a consequence of the combined absence of 
PTPα and Src 
Integrin engagement leads to activation of the mitogen-activated protein (MAP) kinase 
cascade. This is mediated by a recruitment of Grb2 to the FAK-Src complex or through 
Fyn-mediated Shc (another adaptor protein) phosphorylation (Clark et al., 1995; 
Schlaepfer et al., 1997; Schlaepfer et al., 1998). Integrin-induced Erk activation is 
dependent on an intact cytoskeleton, suggesting that integrin-dependent cytoskeletal 
re-organization is instrumental in the activation of the MAP kinase pathway. In 
accordance with this, FN stimulation of wild type cells resulted in Erk1 and Erk2 
activation, as assessed by immunoblotting cell lysates with anti-phospho-Erk1/2 
antibody (Fig. 4.7). In contrast, Erk activation was significantly reduced as a 
consequence of PTPα or Src ablation (Fig. 4.7), which is consistent with other reports 
(Klinghoffer et al., 1999; Su et al., 1999). Erk activation in α/s DKO cells plated on 
FN for 30 min was comparable to that in wild type cells (Fig. 4.7). However, Erk was 
highly activated prior to FN stimulation in suspended α/s DKO cells, unlike any of the 
other three cell types. Thus, in contrast to the typical inhibition or down-regulation of 
Erk observed when wild-type (or PTPα-/- and Src-/-) cells are serum starved and placed 
in suspension, this event is defective in cells lacking both PTPα and Src and results in 
constitutive Erk activation. It is possible that the negative feedback loop in α/s DKO 













Figure 4.7. Erk 1/2 activation status in single and double knockout fibroblasts 
lacking Src and/or PTPα. Suspended cells (0) were plated on FN-coated dishes for 
30 min (30). Lysates were probed with anti-phospho-Erk1/2 antibody to assess Erk 




Fibroblasts with a dual deficiency in both PTPα and Src were utilized to investigate 
their responses to integrin stimulation, including cell adhesion and spreading, integrin-
mediated cytoskeleton organization, and selected signaling events. 
 
Cells lacking PTPα (PTPα-/-) exhibit a transient delay in cell spreading (Su et al., 1999; 
Zeng et al., 2003), while the ablation of Src results in delayed cell adhesion and 
spreading (Kaplan et al., 1995). The α/s DKO cells lacking both PTPα and Src exhibit 
defects in adhesion and spreading that are more severe than those of cells lacking 
either PTPα or Src alone. Compared to wild type and PTPα-null fibroblasts, or to Src-
null fibroblasts, α/s DKO cells display about 70% and 50% reduced adhesion to FN (2 
h after plating), respectively (Fig. 4.3A). Likewise, the α/s DKO cells exhibit an 
obvious impairment of spreading on FN, even after 2 h, that is more profound than the 
delays observed with either the PTPα-null or Src-null fibroblasts. These findings 
0 30 0 30 0 30 0 30 
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reveal a previously unsuspected role of PTPα in cell adhesion, and highlight the likely 
involvement of the PTPα-regulated activities of other SFKs in both these processes. 
While Src is required for fibroblast adherence to FN, PTPα itself is not (Su et al., 
1999). Nevertheless, the more pronounced defect in adhesion to FN of α/s DKO cells 
indicates that in the absence of Src, the loss of PTPα activity is indeed detrimental to 
adhesion. These results can be interpreted to mean that PTPα-activated SFKs other 
than Src participate in, but are not normally essential for, cell adhesion. In the presence 
of Src, PTPα-stimulated SFK activity (of Src or of other SFKs) is not required for 
adhesion (thus PTPα-null cells adhere normally), but in the absence of Src, this PTPα-
stimulated SFK activity becomes important for adhesion and thus its absence is 
manifested by adhesion defects that are more severe than those of Src-null cells. The 
implications of this are, firstly, that PTPα may not function as a Src activator to 
mediate adhesion, and that other PTPs may fulfill this role or that the combined basal 
activity of fibroblast SFKs (Src, Fyn, Yes) is sufficient. Secondly, it implies that PTPα 
can function as an activator of non-Src SFKs to mediate adhesion, that this activity is 
manifested or becomes important in the absence of Src, and that other PTPs cannot 
compensate in this respect for the lack of PTPα. Fyn is certainly a candidate SFK that 
could function as a PTPα effector in this context, as Fyn has been implicated in 
adhesion. Previous report identified that Fyn was involved in Rho-mediated cell-cell 
adhesion events (Calautti et al., 2002). Further investigations have shown that only re-
expression Fyn, but not Src or Yes, can rescue the partial defects in PTPα-/- and SYF 
cells, suggesting the unique role of Fyn in integrin signaling (von Wichert et al., 2003; 
Kostic et al., 2006) 
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PTPα is required for cell spreading (Su et al., 1999; Zeng et al., 2003). Thus in 
contrast to the process of cell adhesion, PTPα functions as an upstream activator of 
SFKs to mediate cell spreading, regardless of the presence or absence of Src. This 
action of PTPα cannot be fully, although it may be partially, compensated for by the 
actions of other PTPs. The observation that α/s DKO cells have more severe spreading 
defects than do either the single mutant PTPα or Src cells indicates that basal Src 
activity or Src activation mediated in a PTPα-independent manner may play a role in 
the spreading process distinct from or in addition to that of PTPα-activated Src. One 
possibility is that a non-catalytic or scaffolding function of Src is required for cell 
spreading (Kaplan et al., 1995). If so, the ablation of Src would deplete both its 
catalytic and non-catalytic actions, but the PTPα-mediated activation of other SFKs 
would permit Src-/- cell spreading, albeit delayed. On the other hand, the ablation of 
PTPα would deplete the PTPα-mediated kinase activity of SFKs, but the residual SFK 
activity (basal or mediated by other PTPs) combined with the scaffolding function of 
Src would be sufficient to permit delayed PTPα-/- cell spreading. However, the 
combined ablation of Src and PTPα would abolish both the PTPα-independent SFK 
catalytic activity as well as the non-catalytic action of Src, resulting in not merely 
delayed, but severely impaired, cell spreading. 
 
Integrin-induced cell spreading involves cytoskeletal re-arrangement, leading to actin 
stress fiber assembly and focal adhesion formation. Corresponding to delayed cell 
spreading on FN, PTPα-/- and Src-/- cells are defective in the assembly of actin stress 
fibers and in the formation of focal adhesions. As shown in Fig.4.5, both PTPα-/- and 
Src-/- cells displayed a lower density of actin stress fibers and less focal adhesions on 
FN, compared with wild type cells, The similar defects in cytoskeletal organization of 
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these two cell types indicate that PTPα and Src are implicated in regulating the 
assembly of actin stress fibers and formation of focal adhesions upon integrin 
stimulation. Further experiments demonstrate that PTPα-mediated SFK activation is 
essential for integrin-mediated cytoskeletal rearrangement, as inhibition of SFKs by a 
selective inhibitor PP2 in wild type cells delays the process of cell spreading and 
assembly of actin stress fibers on FN, and is similar to the delay observed in PTPα-/- 
cells (Zeng et al., 2003). As α/s DKO cells exhibit a more delayed rate of spreading on 
FN, similar or more severe defects in cytoskeletal organization would be expected to 
occur in these cells, and are indeed evident. Membrane ruffles and lamellipodia did not 
form in α/s and unusual microspikes were obvious around the cell periphery after 15 
min on FN. After 30 min on FN, prominent focal adhesions formed in the α/s DKO 
cells that were different from these structures in cells lacking either PTPα or Src. The 
assembly of actin stress fibers was also impaired in the α/s DKO cells upon integrin 
stimulation, and the lack of actin stress fibers after 60 min on FN implies that PTPα 
and Src are both required for the assembly of actin stress fibers, and PTPα-mediated 
SFK activation is essential. The enhanced focal adhesion formation observed in the α/s 
DKO cells indicates that the combined ablation of PTPα and Src affects the 
disassembly of focal adhesions. Although delayed actin stress fiber assembly and focal 
adhesion formation are observed in Src-/- cells, there is an absence of defective 
cytoskeletal organization in SYF cells when they are plated on FN (Klinghoffer et al., 
1999). SYF cells display reduced cell migration towards FN, indicating that SFKs are 
important for the dynamics of cytoskeleton organization. PTPα ablation in fibroblasts 
decreases the activity of Src, Fyn, and probably Yes (Le et al., 2006) by 50%, and the 
cells share the same phenotypes as those of Src-/- cells. In the combined absence of 
PTPα and Src, the residual activity of Fyn and Yes or other SFKs may be insufficient 
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to maintain a balance of focal adhesion assembly and disassembly upon integrin 
stimulation, leading to prominent focal adhesion formation in α/s DKO cells that is 
quite similar to those observed in SYF cells. 
Tyrosine phosphorylation of FAK is an early event in integrin signaling, and 
phosphorylation at FAK Tyr397 is a critical first step upon integrin engagement (Guan 
et al., 1991; Owen et al., 1999). A consistently reduced FAK Tyr397 phosphorylation 
was observed in the absence of PTPα, leading to defects in downstream events in 
integrin signaling (Zeng et al., 2003). In Src-/- cells, reduced phosphorylation at FAK 
Tyr397 was detected at early times on FN (15 min), but it eventually reached the same 
level as that of wild type cells (Fig. 4. 6A). These results indicate that Src is essential 
for the initiation of FAK Tyr397 phosphorylation during the early stage on FN, but that 
FAK Tyr397 can be fully phosphorylated by Fyn, Yes, or other SFKs in Src-/- cells. 
However, the residual Src/Fyn and/or Yes activity in PTPα-/- cells is insufficient for 
full integrin-stimulated FAK Tyr397 phosphorylation. Based on FN-stimulated FAK 
Tyr397 phosphorylation in PTPα-/- or Src-/- cells, a similar reduction was expected to 
occur in α/s DKO cells. However, FN-induced phosphorylation of FAK Tyr397 was 
normal (comparable to wild-type cells) in α/s DKO cells, although it was completely 
dephosphorylated when suspended (Fig. 4.6A). Previous investigations have proposed 
that FAK Tyr397 is autophosphorylated upon integrin engagement, and that FAK 
localization and its intermolecular associations within the cytoplasm are important for 
regulating FAK tyrosine phosphorylation (Owen et al., 1999; Katz et al., 2002). The 
normal FAK Tyr397 phosphorylation upon integrin stimulation in α/s DKO cells may 
result from the upregulation of other kinases involved in integrin signaling or the 
downregulation of phosphatases responsible for its dephosphorylation. In contrast, the 
FN-stimulated phosphorylation of FAK Tyr576 within the FAK kinase domain, a 
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SFK-specific site, was consistently reduced in the PTPα-/-, Src-/- and α/s DKO cells, 
and these cell lines displayed a comparable level of FAK Tyr576 phosphorylation (Fig. 
4.6B). The different phosphorylation responses of FAK Tyr397 and Tyr576 to integrin 
stimulation indicate that differential requirements of PTPα and Src in these events, and 
that PTPα-mediated SFKs activation is important for FAK Tyr576 phosphorylation 
and full FAK activation. 
 
Integrin-induced Erk activation is another important downstream event, and previous 
studies have demonstrated that PTPα-mediated Src activation is required for this (Su et 
al., 1999). FN-stimulated Erk activation is reduced in both PTPα-/- and Src-/- cells, but 
Erk activation in α/s DKO cells is comparable to that in wild type cells (Fig. 4.7). 
However, the Erk activity in α/s DKO cells appears to be due to a defect in Erk down-
regulation. Erk remained highly activated when α/s DKO cells were placed in 
suspension, unlike any of the other cell types, indicating that certain signaling events in 
α/s DKO cells cannot be turned off. The sustained high activity of Erk in suspended 
α/s DKO indicates that PTPα-mediated SFK activation plays a negative feedback role 
in orchestrating integrin signaling. 
 
Overall, α/s DKO cells displayed reduced cell adhesion and spreading on FN, 
accompanied by a cytoskeletal organization distinct from that in Src-/- and PTPα-/- cells. 
PTPα is an early upstream mediator of integrin signaling cascades, acting as an 
effector of Src and Fyn kinases to stimulate the initial tyrosine phosphorylation of the 
central signaling molecule FAK (Zeng et al., 2003). The present findings further 
demonstrate that PTPα-mediated Src/Fyn activation is necessary for most integrin 
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signaling events. The different phenotypes observed between α/s DKO cells and 
PTPα-/- or Src-/- cells indicate that PTPα-mediated SFK activation may play not only 
positive but also negative roles in integrin signaling, including involvement in the 
assembly and disassembly of focal adhesions, and downregulation of Erk activity upon 
cell detachment from the substratum. Several PTPs have been shown to be important 
for the process of focal adhesion disassembly, such as PTP1B, SHP2 and PTEN (Yu et 
al., 1998; Tamura et al., 1999; Zhang et al., 2006). The precise roles of PTPα-mediated 





































Integrin-induced PTPα Tyrosine Phosphorylation is Required for 






Activation of integrins by binding to extracellular matrix ligands generates 
intracellular tyrosine phosphorylation-based signals that regulate many cellular 
activities, including cell attachment, spreading, proliferation and survival. Many of the 
signals resulting from integrin ligation are centered around FAK and its interaction 
with SFKs (Schlaepfer et al., 1997; Schaller 2001). Cell adhesion and migration are 
dynamic processes, which require rapid and precise regulation. An increasing body of 
evidence shows that phosphatases play crucial roles in integrin-induced signaling 
events (Angers-Loustau et al., 1999). Protein dephosphorylation could result in 
changes in polypeptide folding, enzymatic activity and protein-protein interaction. 
 
PTPα-null fibroblasts exhibit reduced cell spreading and migration (Su et al., 1999; 
Zeng et al., 2003). The initial delay in integrin-stimulated cell spreading involves 
altered actin cytoskeletal organization and retarded focal adhesion formation in PTPα-/- 
cells, and this is associated with reduced FAK Tyr397 phosphorylation and formation 
of an SFK-FAK complex (Zeng et al., 2003). Many integrin-stimulated responses are 
mediated through phosphorylation of FAK and participation of SFKs. Phosphorylation 
of FAK at Tyr397 occurs by autophosphorylation, but maximal Tyr397 
phosphorylation requires SFKs that participate in an autocatalytic loop by 
phosphorylating FAK at Tyr576/577 to enhance activity and thus promote full FAK 
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Tyr397 phosphorylation (Cary et al., 2002). Reduced FN-stimulated phosphorylation 
of FAK Tyr397 and reduced SFK kinase activity of PTPα-null cells are consistent with 
the demonstrated action of PTPα as a positive regulator of SFKs (Ponniah et al., 1999), 
which suggests that PTPα dephosphorylates and then activates SFKs (Zeng et al., 
2003). The molecular mechanism linking integrin engagement to PTPα activity and 
regulation is unclear. 
 
PTPα catalytic activity and specificity is regulated in a combinatorial manner, and 
phosphorylation of PTPα is one mode of regulation that can affect PTPα function 
(Zheng et al., 2001). To date, there has been no report of the consequences of tyrosine 
phosphorylation of PTPα on integrin signaling pathways. In this chapter, the molecular 
mechanisms of regulation of PTPα and the role of PTPα tyrosine phosphorylation in 
integrin stimulated events are described. 
 
5.2 Results 
5.2.1 Integrin-induced tyrosine phosphorylation of PTPα 
PTPα is tyrosine phosphorylated in adherent fibroblast cell cultures (Fig. 5.1A, lanes 1 
and 5; and 1B). To determine if PTPα phosphorylation status is regulated by cell 
adhesion and integrin stimulation, wild type fibroblasts were placed in suspension for 1 
h and then plated on dishes coated with the integrin ligand fibronectin (FN). 
Detachment of cells from the substratum induced the partial dephosphorylation of 
PTPα (to 57±4% of that of PTPα in fully adherent and spread cells) (Fig. 5.1A, lanes 2 
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Figure 5.1. Integrin-induced tyrosine phosphorylation of PTPα. (A) PTPα was 
immunoprecipitated from lysates of mouse  embryonic fibroblasts grown on plastic 
dishes (lanes 1 and 5), placed in suspension (lanes 2 and 6), and then replated on FN-
coated dishes for 5 and 30 min (lanes 3 and 4) or on PLL-coated dishes for 30 min 
(lane 7). The immunoprecipitates were probed for phosphotyrosine (PY-20) (top 
panels). The membrane was stripped and reprobed for PTPα (second panels). Total 
cell lysates were probed for phosphotyrosine (4G10), and also probed for FAK and 
actin as a loading control. (B) Autoradiographs from three independent experiments 
described in (A) were quantified for phosphotyrosine content of PTPα relative to the 
amount of PTPα protein. The graph shows the mean ± S.D. Phosphotyrosyl PTPα in 
adherent cells was taken as 100%. 
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Plating the suspended cells on FN induced phosphorylation of PTPα, with PTPα 
phosphorylated to 71±4% of the level in growing adherent cells after 5 min on FN, and 
increasing to 93±7% of the original level after 30 min on FN (Fig. 5.1A, lanes 3 and 4; 
and 1B). In contrast, plating the suspended cells on poly-L-lysine (PLL)-coated dishes 
for 30 min did not induce significant rephosphorylation of PTPα (68±7%) (Fig. 5.1A, 
lane 7; and 1B). Under the above conditions, the tyrosine phosphorylation of PTPα 
correlated with that of other cellular proteins that were phosphorylated upon integrin 
stimulation (Fig. 5.1A, third panels). 
 
5.2.2 SFKs are essential for FN-induced PTPα tyrosine phosphorylation 
It has been reported that PTPα tyrosine phosphorylation can be increased by transient 
overexpression of Src, suggesting that Src might be the kinase responsible for PTPα 
tyrosine phosphorylation in vivo (den Hertog et al., 1994). To determine whether SFKs 
were required for integrin-induced phosphorylation of PTPα, PTPα phosphorylation 
was examined in mouse embryonic fibroblasts lacking Src (Src-/-), lacking Src, Fyn 
and Yes (SYF), or lacking Fyn and Yes (Src+/+). As observed in wild type fibroblasts, 
PTPα was dephosphorylated when Src-/- or Src+/+ cells were placed in suspension, and 
rephosphorylated when cells were plated on FN (Fig. 5.2A and C), suggesting that 
either Src or Fyn and Yes themselves were not essential for integrin-regulated PTPα 
phosphorylation. However, phosphorylation of PTPα was reduced in adherent SYF 
cells, and did not increase when cells were detached from substratum or replated on 
FN (Fig. 5.2B). These results indicated that one or more SFKs, either Yes and Fyn or 
Src, were essential for integrin-induced PTPα phosphorylation. The genotypes of the 
cells were confirmed by immunoblotting as shown in Figure 5.2D. 
 
 















































Figure 5.2. SFKs are essential for integrin-induced PTPα phosphorylation. Mouse 
embryonic fibroblasts deficient in Src (Src-/-) (A), in Src, Yes and Fyn (SYF) (B), or in 
Fyn and Yes (Src+/+) (C) were grown on plastic dishes (Ad), or placed in suspension (0) 
and then replated on FN-coated dishes for 5 or 30 min (5, 30). PTPα was 
immunoprecipitated from the prepared lysates. The immunoprecipitates were probed 
for phosphotyrosine (PY-20) and PTPα. (D) Cell lysates were prepared from cell lines 
of the five genotypes and probed for PTPα, Src, Fyn and Yes. They were probed for 




5.2.3 Catalytically inactive mutant PTPαDM or Tyr789 mutant PTPαY789F is 
not phosphorylated upon integrin stimulation 
Since PTPα dephosphorylates and activates Src (Ponniah et al., 1999), PTPα catalytic 
activity might be required for SFK-mediated PTPα phosphorylation. To test this 
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hypothesis, PTPα-/- fibroblasts were transiently transfected with plasmids expressing 
wild type PTPα (PTPαWT), and different mutant forms of PTPα including a 
catalytically inactive mutant (PTPαDM) and a Tyr789 to Phe mutant of PTPα 
(PTPαY789F). In adherent cells, only PTPαWT was phosphorylated (as observed in 
wild type fibroblasts), while PTPαDM and PTPαY789F were not detectably 
phosphorylated (Fig. 5.3A). The lack of phosphorylation of PTPαDM suggested that 
PTPα catalytic activity might be required to activate SFKs in order to induce 
subsequent PTPα phosphorylation, and that the residual Src/Fyn kinase activity of 
PTPα-/- cells was not sufficient for PTPα phosphorylation. This was confirmed by the 
co-expression of PTPαDM and constitutively active Src (SrcY527F) in PTPα-/- 
fibroblasts, as this resulted in pronounced PTPα phosphorylation both in adherent cells 
and cells plated on FN (Fig. 5.3B). These results indicate that PTPα catalytic activity 
is required for SFK-mediated PTPα phosphorylation. 
 
The absence of phosphorylation of PTPαY789F, both in adherent cells or cells on FN, 
suggests that Tyr789 is the major tyrosine residue of PTPα that is phosphorylated upon 
integrin stimulation (Fig. 5.3A and C). To exclude the possibility that the lack of its 
phosphorylation resulted from the inability of this mutant to activate Src, PTPαY789F 
was co-expressed with constitutively active Src. However, no PTPα phosphorylation 
was detected, whereas PTPα phosphorylation did occur when cells were co-transfected 
with wild type PTPα and active Src (Fig. 5.3C). Together, these findings indicate that 
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Figure 5.3. Catalytic activity of PTPα is required for integrin-stimulated and 
SFK-mediated PTPα phosphorylation at Tyr789. (A) Adherent PTPα-/- fibroblasts 
on plastic dishes were transiently transfected with different plasmids expressing wild 
type or the indicated mutant forms of PTPα. Precipitates of PTPα from cell lysates 
were probed for phosphotyrosine (PY-20) and PTPα. (B) PTPα-/- fibroblasts were 
transiently transfected with PTPαDM alone or co-transfected with constitutively active 
Src (SrcY527F). Transfected cells were grown on dishes (Ad), or placed in suspension 
(0) and replated on FN coated dishes for 30 min (30). Precipitates of PTPα were 
probed for phosphotyrosine (PY-20) and PTPα. (C) PTPα-/- cells were transfected with 
mutant Y789F or wild type PTPα alone or co-transfected with active Src (SrcY527F). 
The transfected cells were treated as in (A). 
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5.2.4 Integrin-induced PTPα phosphorylation is dependent on an intact actin 
cytoskeleton and FAK 
The above experiments indicated that PTPα-mediated SFK activation was required for 
integrin-induced PTPα phosphorylation. Many of the signals resulting from integrin 
ligation are centered around FAK and its interaction with SFKs (Schaller 2001). 
Multiple phosphorylation events upon integrin stimulation are mediated by the 
activated SFK-FAK complex, so the reduced PTPα phosphorylation in SYF cells 
could also be due to reduced FAK activity. Therefore, cells were treated with 
cytochalasin D, an agent that disrupts actin polymerization and prevents integrin-
induced FAK phosphorylation but does not affect Src activation (Lipfert et al., 1992). 
Accordingly, this treatment was observed to reduce phosphorylation of FAK Tyr397 
(Fig. 5.4B). PTPα was phosphorylated in adherent cells, and this was not affected by 
cytochalasin D (Fig. 5.4A). Dephosphorylation of PTPα induced by cell detachment 
was also unaltered (Fig. 5.4A). However, the FN-induced tyrosine phosphorylation of 
PTPα was blocked by the presence of cytochalasin D (Fig. 5.4A). 
 
The ability of FN stimulation to induce PTPα phosphorylation was also investigated in 
FAK-null fibroblasts. Greatly reduced phosphorylation of PTPα was detected in 
adherent FAK-/- fibroblasts compared to that of wild type fibroblasts, and PTPα 
phosphorylation remained low when cells were suspended and replated on FN (Fig. 
5.4C). These results, together with the reduced PTPα phosphorylation observed in 
SYF cells (Fig 5.2B), indicate that the FAK-SFK complex is necessary for integrin-
induced PTPα phosphorylation. Since cytochalasin D disrupts FN-induced actin 
polymerization, reduced phosphorylation of PTPα in the presence of cytochalasin D 
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Figure 5.4. Integrin-induced PTPα phosphorylation is dependent on an intact 
cytoskeletal organization and FAK is required for integrin-stimulated PTPα 
phosphorylation. (A) Wild type fibroblasts were left untreated (-) or treated with 
cytochalasin D 3 μM (+). Cells were grown on plastic dishes (Ad), detached (0), and 
replated on FN for 30 min (FN30) in the presence or absence of cytochalasin D. Cell 
lysates were subjected to immunoprecipitation with anti-PTPα antibody and probed for 
phosphotyrosine (PY-20) or PTPα, or (B) immunoprecipitated with anti-FAK antibody 
and probed for P-FAK Tyr397 or FAK. (C) Wild type or FAK-deficient fibroblasts 
were grown on plastic dishes (Ad), or placed in suspension (0) and then replated on 
FN-coated dishes for 5 or 30 min (FN 5 or 30). PTPα was immunoprecipitated and 





5.2.5 A PTPα adenoviral expression system efficiently reintroduces wild type 
and mutant forms of PTPα into PTPα-/- fibroblasts 
To reintroduce PTPα into PTPα-/- fibroblasts, adenoviral expression systems carrying 
wild type PTPα (PTPαWT), catalytically inactive PTPα (PTPαDM), or PTPαY789F 
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were created. Adenovirus infection could efficiently introduce PTPα into PTPα-/- cells. 
Expression and tyrosine phosphorylation of the virally reintroduced forms of PTPα 
were comparable to that of endogenous PTPα in wild type cells (Fig. 5.5). PTPα 
tyrosine phosphorylation was only detectable upon expression of wild type PTPα, 




















Figure 5.5. Re-introduction of wild type and mutant forms of PTPα into PTPα-/- 
fibroblasts by adenoviral infection. Wild type (+/+) and PTPα-null (-/-) fibroblasts, 
and PTPα-null fibroblasts infected with adenovirus expressing wild type PTPα (WT), 
catalytically inactive PTPα (DM), or unphosphorylatable PTPα (Y789F) were grown 




5.2.6  PTPα phosphorylation at Tyr789 is not required for integrin-induced 
Src/Fyn activation and FAK or paxillin phosphorylation 
There is reduced Src/Fyn kinase activity in PTPα-null fibroblasts (Ponniah et al., 
1999). It has been reported that phosphorylated Tyr789 of PTPα is essential for the 
activation of Src/Fyn during mitosis (Zheng et al., 2000). It is also well established that 
Src catalytic activity is required for integrin-regulated tyrosine phosphorylation of 
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multiple proteins involved in downstream signaling events, and PTPα-mediated SFK 
activation is important for efficient integrin signaling transduction (Cary et al., 2002; 
Zeng et al., 2003). Reduced Src activity, as determined by analysis of Src tyrosine 
phosphorylation status, was detected in PTPα-/- cells compared to that of wild type 
fibroblasts when they were plated on FN for 30 min (Fig.5.6A and B). To determine 
whether PTPα Tyr789 phosphorylation was required for Src/Fyn activation upon 
integrin stimulation, PTPα wild type (WT), catalytically inactive PTPα (DM), or 
PTPαY789F (Y789F) were reintroduced into PTPα-/- cells by adenoviral infection. 
These cells, together with wild type and parental PTPα-/- cells, were suspended and 
replated on FN for 30 min. Src/Fyn phosphorylation status was determined using three 
site-specific antibodies. SrcTyr527 phosphorylation status was determined using the 
Src2 antibody, which recognizes only the dephospho-Tyr527 form of Src. Cell lysates 
prepared as described (Materials and Methods 2.8.1d) were immunoprecipitated with 
either Src2 or anti-Src antibody (v-Src), with the latter antibody recognizing Src 
independent of its phosphorylation status, and the relative amounts of Src were 
compared. Similar amounts of Src were precipitated by the v-Src antibody from the 
cell lysates, while less Src was precipitated by the Src2 antibody from PTPα-/- cells 
than from wild type cells, indicating enhanced Tyr527 phosphorylation of Src in the 
absence of PTPα (Fig. 5.6A). SrcTyr416 is the autophosphorylation site within the 
activation loop of Src. This site is highly phosphorylated in fully activated Src, and 
thus its phosphorylation status is another indicator of Src kinase activity. Upon integrin 
stimulation, Src immunoprecipitates from PTPα-/- cells exhibited reduced Tyr416 
phosphorylation compared to those from wild type cells (Fig. 5.6B). Enhanced Fyn 
Tyr528 phosphorylation was detected in PTPα-/- cells upon probing cell lysates with 
anti-Src phospho-Tyr527 antibody that recognizes the homologous C-terminal 
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phosphorylated Tyr528 site of Fyn (Fig. 5.6C). Expression of wild type PTPα 
increased the dephosphorylation of Src Tyr527 and phosphorylation of Src Tyr416, 
and reduced the phosphorylation of Fyn Tyr528, to levels comparable to those detected 
in wild type fibroblasts on FN (Fig. 5.6). These features are all consistent with the 
PTPα-mediated activation of Src and Fyn. However, reintroduction of PTPαDM into 
PTPα-/- cells had no effect on Src or Fyn phosphorylation status (Fig. 5.6). On the 
other hand, the expression of PTPαY789F in PTPα-/- cells resulted in altered Src and 
Fyn phosphorylation, to levels observed in wild type fibroblasts and equivalent to 
those detected in cells re-expressing wild type PTPα (Fig. 5.6). These results indicate 
that PTPα catalytic activity but not Tyr789 phosphorylation is required for PTPα-
mediated SFK activation upon integrin stimulation. 
 
SFK activity is required for integrin-induced FAKTyr397 and Tyr576 phosphorylation, 
and both these phosphorylation events are required for full FAK activation (Calalb et 
al., 1995; Klinghoffer et al., 1999). Integrin-mediated phosphorylation of FAKTyr397 
and Tyr576 were reduced in PTPα-/- cells (Fig. 5.7), as has been reported (Zeng et al., 
2003). These defects were rescued by the reintroduction of wild type PTPα into PTPα-
null cells (Fig. 5.7). Expression of PTPαY789F in PTPα-/- cells also restored integrin-
induced phosphorylation of FAKTyr397 and Tyr576, while expression of PTPαDM 
did not significantly affect FAKTyr397 and Tyr576 phosphorylation (Fig. 5.7). Similar 
rescues of paxillin phosphorylation, an event mediated by the active SFK-FAK 
complex, were observed upon expression of PTPαWT and PTPαY789F, but not by 
PTPαDM (Fig. 5.7). Taken together, these results demonstrate that integrin-induced 
PTPα phosphorylation is not required for Src/Fyn activation and FAK or paxillin 
phosphorylation, while the catalytic activity of PTPα is required to restore these events. 
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Figure 5.6. PTPα Tyr789 phosphorylation is not required for Src/Fyn activation 
upon integrin stimulation. Wild type fibroblasts (+/+), PTPα-/- (-/-) cells and PTPα-/- 
cells infected with adenovirus expressing wild type PTPα (WT), catalytically inactive 
PTPα (DM) and PTPαY789F (Y789F) were plated on FN for 30 min. (A) Dephospho-
Src or total Src were immunoprecipitated from cell lysates of these cells and probed 
for v-Src. (B) Total Src immunoprecipitates were prepared from cell lysates and 
probed with anti-phospho-Tyr416-specific antibody or anti-Src. (C) Fyn was 
immunoprecipitated from the cell lysates and probed with anti-phospho-Tyr527 
specific antibody or anti-Fyn. The phosphorylation status of Src/Fyn was quantified 
from at least three independent experiments. The Src/Fyn phosphorylation level in 
wild type fibroblasts (+/+) on FN 30 min was taken as 100%, and other data were 



























































































Figure 5.7. PTPα Tyr789 phosphorylation is not required for integrin-stimulated 
FAK or paxillin phosphorylation. Wild type fibroblasts (+/+), PTPα-/- (-/-) cells and 
PTPα-/- cells infected with adenovirus expressing wild type PTPα (WT), catalytically 
inactive PTPα (DM) and PTPαY789F (Y789F) were plated on FN for 30 min. (A) 
Cell lysates were probed with anti-phospho-Tyr397 or Tyr576 specific antibodies or 
anti-FAK antibody. (B) Paxillin immunoprecipitates were probed with anti-
phosphotyrosine (PY-20) or anti-paxillin antibody. FAK Tyr397 and Tyr576 
phosphorylation were quantified from at least three independent experiments, and are 
shown as the mean ± S.D. FAK phosphorylation in wild type fibroblasts (+/+) was 
taken as 100%, and the other values were calculated relative to this. 
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5.2.7 PTPα Tyr789 phosphorylation is required for integrin-induced cell 
spreading and cytoskeletal organization 
Integrin-stimulated cell spreading is delayed in PTPα-deficient cells, and is associated 
with impaired assembly of actin stress fibers and focal adhesion formation (Zeng et al., 
2003). Reintroduction of wild type PTPα into PTPα-/- cells restores these defects (Fig. 
5.8). After 15 min on FN, it was apparent that PTPα-/- cells with re-introduced wild 
type PTPα had spread and possessed a clearly visible ring-like actin ruffles and 
vinculin around the cell periphery (Fig. 5.8A), very similar to that observed in wild 
type fibroblasts. After 30 min on FN, the PTPα-/- cells re-expressing wild type PTPα 
were well spread with a thick peripheral actin ring and clearly defined actin stress 
fibers across the cells. Well developed focal adhesions at the end of the stress fibers 
around the cell periphery were visualized by vinculin staining, comparable to those in 
wild type fibroblasts (Fig. 5.8B). These results confirmed that PTPα was important for 
the integrin-induced cytoskeletal rearrangement processes. To determine whether 
PTPα catalytic activity and its phosphorylation at Tyr789 were required for these 
integrin-mediated processes, PTPαDM or PTPαY789F was reintroduced into PTPα-/- 
cells by adenoviral infection. The infected cells were replated on FN for 15 or 30 min, 
and immunostained to visualize both actin and vinculin. PTPα-/- cells expressing 
PTPαDM exhibited compacted F-actin and vinculin staining after 15 min on FN, and 
displayed fewer actin stress fibers, a lack of a thick peripheral actin ring, and few focal 
adhesions around the cell periphery after 30 min on FN, similar to the uninfected 
parental PTPα-/- cells (Fig. 5.8A and B). After 15 min on FN, PTPα-null cells 
expressing PTPαY789F could spread to some extent, and the cells showed some 
peripheral localization of actin and vinculin although these were reduced compared to 
wild type fibroblasts or PTPα-/- cells expressing PTPαWT. The defects were more 
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obvious after 30 min on FN, and although PTPαY789F re-expressing cells had spread 
more than was observed at 15 min, they still exhibited retarded development of actin 
stress fibers and focal adhesion formation (Fig. 5.8). The inability of PTPαDM or 
PTPαY789F to rescue the impaired assembly of actin stress fibers and focal adhesion 
formation indicate that both PTPα catalytic activity and its phosphorylation at Tyr789 
are necessary for optimal integrin-induced cell spreading, cytoskeletal rearrangement 





















































Figure 5.8. PTPα catalytic activity and phosphorylation at Y789 are required for 
integrin-induced cell spreading, assembly of actin stress fibers and focal adhesion 
formation. Wild type fibroblasts (+/+), PTPα-null cells (-/-) and PTPα-/- cells infected 
with adenovirus expressing wild type PTPα (WT), catalytically inactive PTPα (DM) 
and PTPαY789F (Y789F) were suspended and replated on FN coated glass coverslips 
for 15 min (A) or 30 min (B). The cells were fixed and immunostained for F-actin 
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5.2.8 PTPα Tyr789 phosphorylation is required for integrin-stimulated cell 
migration 
PTPα-/- cells showed significantly impaired migration to FN in a haptotactic assay 
(67± 4% of wild type cells migrated), and this was associated with altered cytoskeletal 
rearrangement and retarded focal adhesion formation (Fig. 5.9). The migration defect 
could be rescued by re-expression of wild type PTPα (WT) into PTPα-/- cells (90± 9% 
of wild type cells migrated) but not catalytically inactive PTPα (DM) (67± 3% of wild 
type cells migrated) (Fig. 5.9). In accordance with the inability of introduced 
PTPαY789F to restore actin stress fiber assembly and focal adhesion formation in 
PTPα-/- cells, the unphosphorylatable mutant form of PTPα (Y789F) was not able to 
rescue the reduced migration of PTPα-/- cells towards FN (67± 1% of wild type cells 
migrated) (Fig. 5.9). 
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Figure 5.9. Haptotactic migration assay towards FN. Wild type fibroblasts (+/+), 
PTPα-null cells (-/-) and PTPα-/- cells infected with adenovirus expressing wild type 
PTPα (WT), inactive PTPα (DM) or unphosphorylatable mutant PTPαY789F (Y789F) 
were analyzed for migration towards FN as described in Materials and Methods 
(2.6.5.3). Each bar represents the average ± S.D. of three independent experiments, 
with each experiment comprising three wells per cell type. The number of migrating 
wild type cells was taken as 100% and other values were calculated relative to this. 
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5.2.9 The cell detachment-induced dephosphorylation of PTPα is not due to 
auto-dephosphorylation 
When cells were detached from plastic cell culture dishes, partial dephosphorylation of 
PTPα was detected (to ~57% of the PTPα phosphorylation in fully adherent and 
spread cells) (Fig. 5.1). Protein dephosphorylation is an important step in focal 
adhesion disassembly and turnover, and virtually all protein tyrosine phosphorylation 
observed in adherent cells is lost when cells are placed in suspension (compare lanes 1 
and 2 of the phosphotyrosine immunoblot shown in Fig. 5.1). Several phosphatases 
have been reported to be involved in integrin-stimulated signaling events such as 
PTP1B, SHP2, PTEN, and PTP-PEST, and one or more of these could be responsible 
for detachment-induced PTPα dephosphorylation. It is also possible that PTPα could 
dephosphorylate itself. To investigate the latter possibility, PTPα-/- cells were 
transiently co-transfected with catalytically inactive PTPαDM and constitutively active 
Src (SrcY527F) to effect PTPαDM tyrosine phosphorylation. No dephosphorylation of 
PTPα was detected when the transfected cells were detached from the culture dishes 
(Fig. 5.10A; lane 4). While this lack of dephosphorylation could be due to the inability 
of catalytically inactive PTPα to autodephosphorylate itself, it might alternatively be a 
consequence of the constitutively elevated Src kinase activity. To distinguish between 
these two possibilities, the experiment was repeated with cells treated with and without 
PP2 or PP3 (Fig. 5.10B). PP2 is a compound that inhibits Src kinase activity, and its 
addition to the culture medium of adherent cells 15 min prior to placing the cells in 
suspension should inhibit the Src-mediated phosphorylation of PTPαDM. PP3 is a an 
inactive analogue of PP2 that was included as a control. An obvious detachment-
induced dephosphorylation of PTPαDM was observed when cells were treated with 
PP2 but not with PP3 (Fig. 5.10B), demonstrating that inactive PTPα could be 
 
    131 
dephosphorylated (Fig. 5.10B). These results indicate that PTPα itself is not the 
phosphatase responsible for PTPα dephosphorylation when cells are detached, and that 
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Figure 5.10. Catalytically inactive PTPα (PTPαDM) is dephosphorylated upon 
cell detachment. (A) PTPα-/- cells were transfected with PTPαDM alone or with 
constitutively active Src (SrcY527F). PTPα was immunoprecipitated from lysates 
prepared from adherent cells (Ad), suspended cells (0), or from cells replated on FN 
for 30 min. (B) The co-transfected cells were untreated (0), or treated with PP2 (10 
μg/ml) or PP3 (10 μg/ml) for 15 min before trypsinization. The cells were then held in 
suspension with or without PP2 or PP3 for 45 min at 37°C. PTPα was 
immunoprecipitated from the lysates. All precipitates were probed for phosphotyrosine 




5.2.10 SHP2 is not the phosphatase responsible for detachment-induced 
dephosphorylation of PTPα 
SHP2 is an intracellular PTP that is also reported to be involved in early integrin-
stimulated events. Increased FAK phosphorylation is detected in SHP2-/- cells when 
cells are placed in suspension (Yu et al., 1998; Oh et al., 1999), suggesting that SHP2 
is the phosphatase responsible for the dephosphorylation of FAK that is observed when 
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cells are detached from the substratum. To determine whether SHP2 similarly 
catalyzes PTPα dephosphorylation when cells are suspended, the phosphorylation 
status of PTPα was investigated in SHP2-/- mouse embryonic fibroblasts. However, as 
observed when wild type fibroblasts were placed in suspension, PTPα was 
dephosphorylated when SHP2-/- cells were detached from dishes (Fig. 5.11). 
Furthermore, PTPα could not be rephosphorylated when SHP2-/- cells were replated on 
FN (Fig. 5.11). This result indicates that SHP2 is not the major phosphatase 
responsible for PTPα dephosphorylation upon cell detachment. More experiments 
need to be done to determine why PTPα is not rephosphorylated after integrin 
stimulation in cells lacking SHP2, but this observation implicates SHP2 in the process 






















Figure 5.11. PTPα is dephosphorylated upon detachment of SHP2-/- cells. Lysates 
were prepared from wild type (SHP2+/+) and SHP2-deficient (SHP2-/-) fibroblasts 
cultured on plastic dishes (Ad), placed in suspension for 1 h (0), and replated on FN 
coated dishes for 30 min (FN30). PTPα was immunoprecipitated from the cell lysates 
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5.3 Discussion 
 
These studies reveal that regulated PTPα tyrosine phosphorylation occurs in response 
to integrin stimulation or cell detachment from the substratum. PTPα is constitutively 
phosphorylated in adherent cells, partially dephosphorylated when cells are placed in 
suspension and rephosphorylated when cells are plated on FN. Detachment-induced 
dephosphorylation of PTPα is catalyzed by an as yet unidentified PTP, however, this 
PTP is neither PTPα itself nor SHP2. Tyrosine residue 789 near the C-terminus of 
PTPα is the major site that is phosphorylated upon integrin-stimulation, and this is 
mediated by either Src or Fyn/Yes. PTPα catalytic activity is required for SFK-
mediated integrin-induced PTPα phosphorylation because PTPαDM introduced into 
PTPα-/- cells is not phosphorylated at Tyr789. Furthermore, not only SFKs but also 
FAK are required for integrin-induced PTPα phosphorylation, suggesting that PTPα 
phosphorylation likely occurs following the formation of the SFK-FAK complex and is 
indeed effected by this kinase complex. Interestingly, SHP2 appears to also be required 
for efficient integrin-induced phosphorylation of PTPα, likely reflecting a role of this 
PTP as an additional upstream regulator of Src/FAK. 
 
It has been reported that PTPαTyr789 phosphorylation is required for Src activation in 
mitosis and a displacement model was proposed as a mechanism of PTPα-mediated 
Src activation (Zheng et al., 2001). In this model, the Src SH2 domain binds to the 
phosphorylated Tyr789 site of PTPα and disrupts the intramolecular interaction of Src 
SH2 domain with its own phosphorylated tail residue Tyr527. This exposes Src 
phospho-Tyr527 and brings it closer to the PTPα catalytic domain to be 
dephosphorylated. However, this mechanism of PTPα-mediated Src activation clearly 
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does not operate in integrin-stimulated signaling events. Reintroduction of 
PTPαY789F into PTPα-/- cells restores the defective Src/Fyn activation observed upon 
integrin stimulation of the PTPα-null cells, to a level comparable to that in wild type 
fibroblasts or achieved upon wild type PTPα re-expression in PTPα-/- cells. However 
catalytically inactive PTPα (PTPαDM) cannot rescue these defects. Consistent with 
the restoration of SFK activation, PTPαY789F could also rescue the phosphorylation 
of FAK Tyr397 and Tyr576 and paxillin phosphorylation. Clearly, PTPα catalytic 
activity but not Tyr789 phosphorylation is necessary for integrin-stimulated SFK 
activation, leading to subsequent FAK activation and paxillin phosphorylation. Thus a 
mechanism of PTPα-catalyzed SFK activation that is distinct from the PTPα-phospho-
Tyr789 displacement model proposed to operate in mitotic Src activation (Zheng et al., 
2001) must be involved in integrin signaling. 
 
Although PTPα Tyr789 phosphorylation is not required for SFK activation and FAK 
Tyr397 phosphorylation and activation, it is required for other downstream events in 
integrin signaling. Expression of PTPαY789F in PTPα-/- cells could not rescue the 
impaired assembly of actin stress fibers and focal adhesion formation in PTPα-/- cells, 
while expression of wild type PTPα restores these events. As would be expected as a 
consequence of such defects, the PTPαY789F expressing cells have a reduced ability 
to migrate towards a FN stimulus, similar to the parental PTPα-null cells. These 
observations demonstrate that tyrosine phosphorylation of PTPα is required for a 
distinct second function of PTPα that is operative at a later point in integrin signaling 
to regulate cytoskeletal rearrangement and focal adhesion formation. The mutation of 
tyrosine 789 in PTPα results in its altered intracellular localization in NIH3T3 
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fibroblasts (Lammers et al., 2000). In neuronal cell growth cones, PTPα is recruited  to 
focal adhesion sites when neurons are plated on laminin (Helmke et al., 1998). These 
observations indicate that phospho-PTPα is localized in focal adhesion structures that 
mediate the interaction of cells with the substratum. These findings, together with 
those of the present study, suggest not only that integrin-stimulated phosphorylation of 
PTPα Tyr789 is required for localization to focal adhesion complexes, but that it is 
required for a previously unidentified action of PTPα in regulating the formation of 
these complexes, and events leading to cytoskeletal rearrangement that are critical for 
cell migration. How phosphorylated PTPα functions in integrin signaling pathways 
will require further investigation, and will focus on the identification of the putative 
focal adhesion protein that interacts with PTPα-phospho-Tyr789 to mediate 























6.1  Roles of PTPα and Src in embryonic development 
 
Embryonic development is a multi-step process, which starts with the fertilization of 
an ovum to form a zygote. The zygote undergoes rapid mitotic divisions without 
obvious growth and cellular differentiation, and then the embryo is formed. The 
formation and development of the embryo include implantation in the uterus, 
gastrulation (an important process during which cells migrate to the interior of the 
blastula, forming three germ layers), organogenesis, as well as fetal growth. Many 
cellular processes such as proliferation, adhesion, and migration are involved in 
embryonic formation, while other processes like growth, proliferation and death are 
important for specific organogenesis. Molecules involved in these biological processes 
are essential for normal embryonic development. The ablation of these molecules leads 
to embryonic lethality or abnormal embryonic development. FAK- and FN-deficient 
mice share some similar developmental defects, including death by embryonic days 
E8.5 to 10.5, failure to turn during gastrulation, and neural tube deformation (George 
et al., 1993). Inefficient cell migration during embryonic development may be 
responsible for the similar phenotypes observed in these two animals. FAK is a central 
molecule in integrin signaling, and FAK-/- cells display reduced cell migration (Ilic et 
al., 1995). PTPα and Src are two molecules involved in the regulation of integrin-
induced cytoskeleton rearrangement and cell migration (Klinghoffer et al., 1999; Zeng 
et al., 2003). Their roles and interactions in embryonic development have been 
clarified through studies of genetically modified mice. 
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6.1.1  PTPα is not essential for embryonic development, but is required for 
normal hippocampal development and proper function 
The role of PTPα in embryonic development was investigated using a genetically 
targeted mouse model system. PTPα-null mice are viable and fertile, and there is an 
absence of detectable gross physical abnormalities. The lack of phenotypes of PTPα-/- 
mice indicates that PTPα is not essential for embryonic development (Ponniah et al., 
1999; Su et al., 1999), although subsequent, more detailed investigations have shown 
the role of PTPα in tissue differentiation and neuronal development. The function of 
PTPα in neuronal differentiation was first studied in P19 embryonal carcinoma (P19 
EC) cells. Increased PTPα mRNA expression was observed during in vitro neuronal 
differentiation of P19 EC cells, and overexpression of PTPα in the cells promoted 
differentiation (den Hertog et al., 1993). The expression pattern of PTPα during 
embryonic development in zebrafish or mice reveals that PTPα is differentially 
expressed in a spatio-temporal manner, and in mice PTPα is highly expressed in neural 
crest derivatives such as dorsal root ganglia and cranial ganglia at ten days after 
fertilization (den Hertog et al., 1996; van der Sar et al., 2001). Knockdown of PTPα in 
zebrafish by anti-sense morpholinos results in smaller eyes and fewer cells are detected 
in the retina, suggesting the importance of PTPα in normal retina development at least 
in zebrafish (van der Sar et al., 2002). PTPα has also been implicated in skeletal 
muscle differentiation, as diminished PTPα expression in cultured myoblasts inhibits 
differentiation and the cells cannot form myotubes (Lu et al., 2002). 
 
Histological analysis shows that hippocampi obtained from PTPα-null mice possess 
less compacted cell bodies in the pyramidal cell layer in the CA1 region, compared 
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with that in wild type animals. The abnormal hippocampal morphology observed in 
PTPα-/- mice results from an defective radial neuronal migration during hippocampal 
development (Petrone et al., 2003). The hippocampus is important for learning and 
memory processes, and mice deficient in PTPα have defects in Morris Maze learning, 
a test used to measure hippocampus-dependent working memory (Skelton et al., 2003). 
Taken together, these findings suggest an essential role of PTPα in hippocampal 
development and function. NMDA receptors (NMDARs) are essential molecules 
involved in the processes related to learning and memory. Phosphorylation of 
NMDARs can increase NMDARs activity, thus modulating their channel conductivity 
and facilitating their movement to the neural plasma membrane to maintain synaptic 
plasticity (Salter et al., 2004). NMDARs associate with Src and Fyn through the 
adaptor protein PSD95, and the NR2 subunits of NMDARs are phosphorylated by the 
SFKs Src and Fyn (Tezuka et al., 1999; Cheung et al., 2001). PTPα, Src and the 
NMDAR form a complex in rat brain via the PDZ2 domain of PSD95, suggesting a 
role of PTPα in regulating synaptic strength in the central nervous system (Lei et al., 
2002). The activity of Src/Fyn is significantly reduced in PTPα-/- mouse brain, 
concomitant with the reduced phosphorylation of the NMDAR in PTPα-null mice (Le 
et al., 2006). These findings support the notion that PTPα-mediated Src/Fyn activation 
is essential for hippocampal development and function. However, PTPα-deficient mice 
display hippocampal abnormalities that are distinct from those of Fyn-/- mice, although 
Fyn-/- mice also display aberrant hippocampal development and impaired spatial 
learning (Grant et al., 1992). The hippocampal abnormality in Fyn-/- mice affects 
granule cells in the dentate gyrus, and pyramidal cells in the CA3 region, but not cell 
bodies in the pyramidal layer of the CA1 region as in PTPα-null mice. There are two 
possibilities that may explain this difference between PTPα-/- and Fyn-/- mice regarding 
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the defects of hippocampal development; firstly, that SFKs have redundant functions, 
and/or secondly that PTPα acts on substrates other than Fyn in hippocampal 
development. Enhanced phosphorylation of the C-terminal regulatory tyrosine residue 
of Yes or Lck is detected in PTPα-null mice brain (Le et al., 2006), suggesting that 
PTPα is a positive regulator of Yes and/or Lck at least in brain. However, the 
physiological actions of these SFKs in process relating to hippocampal development 
and function need to be investigated. 
 
6.1.2  SFKs play essential but redundant roles in embryonic development 
 
SFKs play important roles in a variety of cellular processes, including proliferation, 
differentiation and growth factor-induced signaling events (Brown et al., 1996). Src is 
greatly up-regulated during development of the nervous system, suggesting that it is 
the product of a developmentally regulated gene that may be important for the initial 
differentiation and normal function of neurons (Cartwright et al., 1988). Src, Fyn, Yes 
and Lyn are widely expressed during early embryonic development with especially 
high levels in neural cells. Four other SFK members; Hck, Fgr, Blk and Lck, are 
predominantly present in hematopoietic cells, and T cells mainly express Lck and Fyn 
whereas B cells express Lyn, Blk, Fyn and Fgr (Lowell et al., 1996). 
 
Single ablation of Src, Fyn or Yes did not reveal the requirement of any single kinase 
for embryogenesis, but mice deficient in Src (Src-/-Fyn+/+Yes+/+) or Fyn (Src+/+Fyn-/-
Yes+/+) display unique phenotypes (Soriano et al., 1991; Stein et al., 1992). The major 
phenotype associated with the single Src mutant is osteopetrosis (Soriano et al., 1991). 
Fyn-/- mice display defects in the development of the hippocampus (Grant et al., 1992), 
and thymocyte proliferation in response to T cell receptor stimulation is impaired 
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although Fyn is not essential for mouse thymus development (Stein et al., 1992). 
Double mutant Src/Fyn (Src-/-Fyn-/-Yes+/+) or Src/Yes (Src-/-Fyn+/+Yes-/-) mice do not 
exhibit embryonic lethality, however, they display increased postnatal mortality 
compared with their single mutant counterparts (Stein et al., 1994). This is not evident 
in double mutant Fyn/Yes (Src+/+Fyn-/-Yes-/-) mice (Stein et al., 1994). The reduced 
survival of Src/Fyn or Src/Yes mice suggests that the residual Yes activity in Src/Fyn 
or Fyn activity in Src/Yes mice is insufficient for maturation and survival to adulthood. 
Triple ablation of Src, Fyn and Yes (Src-/-Fyn-/-Yes-/-) results in embryonic lethality at 
E9.5 (Klinghoffer et al., 1999). These investigations of mice with single or combined 
ablation of Src, Fyn and/or Yes indicate the essential but redundant roles of these 
kinases in embryonic development. 
 
The deficiency in SFKs with restricted expression, such as Hck, Blk, Fgr or Lck, does 
not lead to embryonic lethality, and the absence of any of these kinases in mice mainly 
affects the development or function of hematopoietic cells (Lowell et al., 1994; Lowell 
et al., 1996). A deficiency in Lyn results in a 50-60% reduction in the number of 
peripheral B cells, but the mice have normal antibody responses to antigenic challenge. 
By 3-4 months of age, Lyn-/- mice have circulating autoreactive antibodies, leading to 
severe glomerulonephritis (Hibbs et al., 1995). The ablation of Blk or Fgr has little 
effect on mouse B-cell development, and Hck, Fgr and Lyn triple deficient mice are 






6.1.3. A combined deficiency in PTPα and Src does not affect mouse embryonic 
development, but does increase postnatal mortality 
Many Src/Fyn or Src/Yes mice die shortly after birth, suggesting that residual Yes or 
Fyn activity in these mice is insufficient for maturation to adulthood (Stein et al., 
1994). As activity of Src and Fyn is reduced in PTPα-/- mice (Ponniah et al., 1999), a 
similarly reduced ~50% Fyn and/or Yes activity is predicted to remain upon the 
combined ablation of both PTPα and Src that may result in embryonic lethality or in 
more severe defects. To test this hypothesis, mice with a combined deficiency in PTPα 
and Src (PTPα-/-Src-/-) were generated. The combined ablation of PTPα and Src does 
not result in embryonic lethality. Double mutant PTPα/Src (PTPα-/-Src-/-) mice are 
viable, and organs obtained from these mice at three weeks of age appear normal and 
well developed (Table 3.1, Fig. 3.2). PTPα/Src double mutant pups are toothless and 
exhibit growth retardation, similar to single Src mutant mice (Soriano et al., 1991). The 
lack of more severe phenotypes associated with double mutant PTPα-/-Src-/- mice 
indicates that the observed phenotypes likely result from the absence of Src itself, and 
are not due to the additional or combined effects of PTPα ablation. The residual Fyn, 
Yes, and/or other SFK activity in the absence of PTPα and Src is sufficient for 
embryonic development. However, there is a 45% mortality observed between birth to 
four weeks of age in double mutant PTPα-/-Src-/-mice, slightly higher than that of 
single Src-/- mice (around 30% at five weeks of age) (Soriano et al., 1991). A 
comparative summary of the phenotypes of PTPα-/-, Src-/-, and PTPα-/-Src-/- mice is 
shown in Table. 6.1. Overall, these results suggest that the residual Fyn/Yes activity in 
PTPα-/-Src-/- is not sufficient for their survival to adulthood, similar to the situation in 
Src/Fyn- or Src/Yes- deficient mice. 
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    Table 6.1. Summary of phenotypes of PTPα-/-, Src-/-, and PTPα-/-Src-/- mice.  
         Phenotype PTPα-/- Src-/- PTPα-/-Src-/- 
Embryonic Lethality Noa No No 
Failure of tooth eruption  No Yes Yes 
Growth retardation No Yes Yes 
Abnormal hippocampal development Yesb No NAC 
Postnatal mortality                        
(birth to four weeks of age) 
No ~30% ~45% 
 
a: Ablation of the gene does not result in the indicated phenotype  




The absence of more severe defects in PTPα/Src double mutant mice than in mice with 
single ablation of Src or PTPα is likely attributable to a functional compensation 
among genes, as ablation of PTPα does not completely abolish SFK activity. The 
presence of other phosphatases or kinases may effectively substitute for PTPα and Src, 
and have dominant functions in the absence of PTPα and Src during embryonic 
development. Some phosphatases, such as CD45, SHPs, and PTP1B, are reported to be 
responsible for the activation of SFKs, in different signaling pathways (Thomas et al., 
1999; Cheng et al., 2001; Neel et al., 2003). This could occur at several levels. Firstly, 
SFKs share specific and redundant functions in embryonic development, and only the 
triple ablation of Src/Fyn/Yes leads to embryonic lethality (Stein et al., 1994; 
Klinghoffer et al., 1999). The residual Fyn, Yes, or other SFK activity in PTPα/Src 
double mutant mice is sufficient for embryonic development. Secondly, selective 
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increases in expression of other proteins may substitute for the loss of PTPα and Src 
during embryogenesis in PTPα-/-Src-/- mice, although the expression of Fyn or Yes did 
not increase in fibroblasts lacking both PTPα and Src (data not shown). Thirdly, the 
catalytic activity of other related enzymes might change. For example, a highly 
phosphorylated p90 kDa protein is uniquely detected in PTPα/Src double mutant brain 
and fibroblasts (data not shown), although the protein has not been identified. More 
investigations are required to differentiate between these possibilities. 
 
6.2  The roles of PTPα and Src in integrin signaling 
Integrins are the major cell surface receptors mediating adhesive interactions with the 
extracellular matrix (ECM), an essential process during embryonic development. 
Integrins play a central role in organizing the actin cytoskeleton, and the dynamics of 
actin cytoskeleton in integrin-mediated responses are important for many cellular 
activities. A series of tyrosine phosphorylation events centered around FAK are 
initiated upon integrin stimulation, and these mediate numerous downstream signaling 
events (Schaller et al., 1994; Schlaepfer et al., 1997). In integrin signaling, the 
dephosphorylation of proteins is as important as their phosphorylation in controlling 
actin cytoskeleton dynamics. Many PTKs and PTPs, including PTPα and Src, have 
been implicated in integrin-mediated signaling events. 
 
6.2.1  SFKs are required for integrin signaling 
The role of Src in integrin signaling is apparent from defects observed in Src-/- 
fibroblasts. The Src-/- cells display delayed cell adhesion and spreading on FN, and the 
defects can be rescued by re-expression of Src. In addition, there is a transient increase 
in the activity of Src during cell attachment to FN, followed by a redistribution of Src 
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to the newly formed focal adhesions (Kaplan et al., 1995). In the resting condition, Src 
associates with endosomal membranes in fibroblasts, and upon integrin stimulation, 
activated Src translocates to focal adhesion sites and associates with proteins found in 
focal adhesion complexes (Kaplan et al., 1992; Kaplan et al., 1994). The translocation 
of activated Src to focal adhesions upon integrin stimulation is dependent on integrin-
induced conformational changes of Src that allow its SH2 and SH3 domains to be 
accessible to other cellular proteins (Kaplan et al., 1995). In addition, Src activity is 
also required for integrin-regulated tyrosine phosphorylation and cell spreading (Cary 
et al., 2002). These findings indicate that both Src activity and its scaffolding function 
are required for the optimal integrin-induced signaling transduction. 
 
The activation of SFKs and their interactions with FAK are essential for downsteam 
events upon integrin stimulation. It has been proposed that FAK is autophosphorylated 
at Tyr397 and recruits Src/Fyn through their SH2 domains. The Src/Fyn-FAK 
interaction is stabilized by interactions involving the SH3 domain of Src/Fyn (Thomas 
et al., 1998). Formation of the SFK-FAK complex promotes the tyrosine 
phosphorylation of FAK on sites within its catalytic or regulatory domains and FAK 
activation. FAK is then fully activated through further Tyr397 autophosphorylation, 
and the phosphorylated tyrosine residues on FAK provide additional docking sites for 
multiple SH2 domain-containing proteins (Cobb et al., 1994; Schaller et al., 1994; 
Schlaepfer et al., 1994). However, no tyrosine phosphorylation of FAK is detected in 
integrin-stimulated cells lacking Src, Fyn and Yes (SYF cells), suggesting that 
phosphorylation of FAK occurs downstream of SFK activation in response to integrin 
engagement (Klinghoffer et al., 1999). 
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These findings suggest that SFKs share redundant and specific functions in integrin 
signaling, and are a critical link between integrins and the multiple signaling events 
which emanate from tyrosine phosphorylated FAK. How SFKs are activated and how 
they then regulate the phosphorylation of FAK are largely unknown. Upon integrin 
stimulation, FAK initiates some autophosphorylation at Tyr397 independently of Src , 
but Src is required for full FAK Tyr397 phosphorylation (Salazar et al., 2001). 
Consistent with this, delayed phosphorylation at FAK Tyr397 is detected in Src-/- cells 
15 minutes after plating on FN (Fig. 4.6A). Src activity is required for full 
phosphorylation of FAK at other sites, such as FAK Tyr576 or Tyr925. Reduced 
phosphorylation at FAK Tyr576 is consistently detected in Src-/- cells upon integrin 
stimulation (Fig. 4.6B). 
 
6.2.2 Role of PTPα as an activator of SFKs in integrin signaling 
A role of PTPα in modulating the interaction of cells with the substratum was 
established from studies of A431 cells. Overexpression of PTPα in A431 cells 
increases cell-substratum attachment and the cells are resistant to EGF-induced cell 
rounding (Harder et al., 1998). Src activity increased in A431 cells overexpressing 
PTPα, accompanied by an increased association of Src with FAK and increased 
phosphorylation of paxillin. Furthermore, PTPα-/- cells, with reduced Src/Fyn activity, 
displayed delayed cell spreading on FN, and reduced phosphorylation of FAK and 
p130Cas , and reduced Erk activation, when plated on FN (Su et al., 1999), similar to 
Src-/- fibroblasts (Figure 4.4, and (Kaplan et al., 1995; Su et al., 1999; Zeng et al., 
2003). The importance of PTPα-mediated Src/Fyn activation in integrin signaling has 
been further demonstrated using the selective SFK inhibitor PP2, as inhibition of Src 
activity in wild type cells by PP2 can mimic the defects observed in PTPα-/- cells 
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(Zeng et al., 2003). Unlike Src-/- cells, FAK Tyr397 phosphorylation is consistently 
reduced in PTPα-/- cells after integrin engagement, suggesting that PTPα is required 
for early integrin-proximal events, acting upstream of FAK to affect timely and 
efficient FAK Tyr397 phosphorylation (Fig. 4.6A). Correlating with reduced FAK 
Tyr397 phosphorylation, a reduced association of Src/Fyn with FAK is detected in 
PTPα-/- cells (Zeng et al., 2003). Formation of the SFK-FAK complex is essential for 
full phosphorylation and activation of FAK, and for subsequent downstream signaling 
events (Schlaepfer et al., 1997; Owen et al., 1999). FAK Tyr576 phosphorylation is 
reduced in PTPα-/- cells, probably resulting from the reduced SFK-FAK association 
upon integrin stimulation. It is possible that PTPα also affects Yes, but so far this has 
not been investigated in PTPα-null fibroblasts. The similar defects in PTPα-/- and Src-/- 
cells in integrin signaling suggest that PTPα and Src are linked in a common signaling 
cascade, and that PTPα is required for early integrin-stimulated signaling events as an 
activator of Src, Fyn and/or Yes. 
 
6.2.3 Additional roles of PTPα-mediated SFK activation in integrin signaling 
Previous studies showed that Src is required for both cell adhesion and spreading, but 
PTPα is only required for cell spreading not for cell adhesion (Kaplan et al., 1995; Su 
et al., 1999). Further investigations identified that PTPα functions as an activator of 
SFKs in integrin signaling. However, the cells lacking both PTPα and Src (termed α/s 
DKO) displayed more severe defects in cell adhesion to and spreading on FN than 
cells lacking PTPα or Src alone. These findings implied that the presence of PTPα is 
required for cell adhesion and spreading in the absence of Src and that PTPα-regulated 
activity of other SFKs may be involved in these processes upon integrin stimulation. 
Another possibility for the more severe defect in α/s DKO cells may result from the 
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abolishment of both PTPα-independent Src activation and its scaffolding function in 
integrin signaling in the cells dually deficient in Src and PTPα, as both catalytic and 
non-catalytic activity of Src are necessary for cell spreading (Kaplan et al., 1995; Cary 
et al., 2002). 
 
In line with the impaired cell spreading on FN, α/s DKO cells displayed obvious 
defective cytoskeletal organization on FN. α/s DKO cells had more microspikes than 
they did lamellipodia or membrane ruffles at early period on FN, and prominent focal 
adhesions at later time point on FN (Fig. 4.5). The lamellipodia and filopodia formed 
at the leading edge of cells on FN are major sites of actin filament attaching with ECM, 
an early event and important structure for cell polarization and migration (Gumbiner 
1996). Integrin-mediated cytoskeletal organization and focal adhesion formation are a 
dynamic process, balanced by the effect of kinases and phosphatases that are involved 
in regulation of integrin signaling (Martin et al., 2002). Phenotypes of FAK-/- and SYF 
cells (cells lacking Src, Fyn and Yes) have revealed that SFKs and FAK play important 
roles in the regulation of dynamics of focal adhesions, as FAK-/- cells displayed 
enhanced focal adhesion formation on FN and SYF cells migrated slowly towards FN 
(Ilic et al., 1995; Klinghoffer et al., 1999). The importance of phosphatases in 
regulating dynamics of cytoskeletal organization is the same as those of kinases. SHP2 
and PTEN are the phosphatases responsible for dephosphorylating FAK, and then 
inactivating it upon cell detachment. Recent finding has demonstrated that PTP1B is 
involved in the disassembly of FAK-Src complex during cell migration (Yu et al., 
1998; Tamura et al., 1999; Zhang et al., 2006). PTPα-mediated SFK activation is 
required for actin stress fibers assembly and focal adhesion formation, and enhanced 
 148
focal adhesion in α/s DKO cells on FN indicates that PTPα-mediated SFK activation 
is likely required for the disassembly of focal adhesions as well. 
 
Like wild type, and PTPα-/- or Src-/- cells, FAK Tyr397 was fully dephosphorylated in 
α/s DKO cells upon cell detachment from the substratum, but integrin-induced 
phosphorylation of FAK Tyr397 in α/s DKO cells was equivalent in degree and timing 
to that observed in wild type cells, unlike that in PTPα-/- cells (Fig. 4.6A). However, 
phosphorylation of FAK Tyr576 was reduced in the α/s DKO cells upon integrin 
stimulation, same as that in PTPα-/- and Src-/- cells (Fig. 4.6B). The difference of 
integrin-induced phosphorylation at FAK Tyr397 and Tyr576 suggests the different 
requirement of PTPα and Src for phosphorylation of these tyrosine residues within 
FAK, and phosphorylation of FAK Tyr576 is Src dependent and more factors can 
affect the status of FAK Tyr397 phosphorylation. Furthermore, α/s DKO cells 
displayed an unexpected normal Erk activation, another important downstream event 
in integrin signaling. Integrin-mediated Erk activation is dependent on an intact 
cytoskeletal organization and on phosphorylation of FAK Tyr925, phosphorylated by 
the SFK-FAK complex. Erk activation upon integrin stimulation in PTPα-/- and Src-/- 
cells was lower than that in wild type cells (Fig. 4.7). Accordingly, reduced Erk 
activation would be expected to occur in the α/s DKO cells upon plating on FN, but 
Erk activation in α/s DKO cells 30 min on FN was comparable to that in wild type 
cells (Fig. 4.7). Normal Erk activation in α/s DKO cells seems integrin-independent, as 
Erk cannot be inactivated in α/s DKO cells upon detachment from the substratum. 
Normally, Erk activity is down-regulated when cells are placed in suspension, as 
observed in wild type and PTPα-/- or Src-/- cells. The persistent activation of Erk both 
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in suspended cells and cells plated on FN indicates that the activating signal cannot be 
turned off in α/s DKO cells. The defective Erk inactivation upon detachment from the 
substratum in α/s DKO cells suggest that PTPα-mediated SFK activation may be in a 
negative feedback loop in modulating integrin signaling transduction, or other related 
enzymes that are involved in integrin signaling are upregulated in the absence of both 
PTPα and Src. 
 
The phenotypes of α/s DKO, as well as Src-/- and PTPα-/- cells are shown in Table 6.2. 
The defects of α/s DKO cells upon integrin stimulation, together with the defects 
observed in PTPα-/- or Src-/- cells, suggest that PTPα-mediated Src/Fyn activation is 
necessary for most integrin-mediated signaling events, and these events may have 
different requirements for Src and Fyn. These findings also indicate additional roles of 
PTPα-mediated SFK activation in integrin signaling, such as a potential involvement 
in controlling the dynamics of cytoskeleton organization. 
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Table 6.2. Summary of phenotypes of PTPα-/-, Src-/-, and α/s DKO (PTPα-/-Src-/-) cells in response to FN stimulation. 
 
     Integrin-induced 
      signaling event                   PTPα-/-                      Src
-/- α/s DKO (PTPα-/-Src-/-) 
Cell adhesion                   Normal                     Delayed Delayed 
Cell spreading                   Delayed                     Delayed Delayed 
Cytoskeletal 
rearrangement 
Delayed assembly of actin stress 
fibers with lower density. Reduced 
formation of focal adhesions. 
Delayed assembly of actin stress 
fibers with lower density. Reduced 
formation of focal adhesions.  
Lack of organized actin stress 
fibers. Prominent focal adhesions. 
FAK Tyr397 
phosphorylation 
Reduced compared to the level in 
wild type cells. 
Reduced at 15 min on FN, but it can 
reached the level compared to that in 
wild type cells after 30 min on FN. 
Reached the level equivalent in 
extent and timing to that in wild 
type cells. 
FAK Tyr576 
phosphorylation                   Reduced                     Reduced  Reduced 
Erk activation                   Reduced                     Reduced Normal 
Erk inactivation upon 
cell detachment                   Inactivated                     Inactivated Activated 
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6.3  Regulation of PTPα by integrin stimulation 
 
Previous studies have demonstrated that PTPα is required for early integrin-proximal 
events and acts as a transducer of mechanical forces in integrin cytoskeleton linkages 
(von Wichert et al., 2003; Zeng et al., 2003), but how a signal resulting from integrin 
stimulation is transduced to PTPα is unclear. PTPα-mediated SFK activation is 
involved in most integrin-mediated events. One defined mechanism by which PTPα-
mediated Src activation can be regulated is through phosphorylation of PTPα at its C-
terminal Tyr789 (Zheng et al., 2001). In mitosis, this is essential for the activation of 
Src by PTPα, enabling phospho-PTPα to bind to and dephosphorylate Src through a 
displacement mechanism. To address how PTPα is regulated upon integrin stimulation 
and functions in integrin signaling, the phosphorylation status of PTPα in response to 
integrin engagement and the importance of PTPα tyrosine phosphorylation in integrin-
mediated signaling events were investigated. 
 
6.3.1 PTPα is tyrosine phosphorylated upon integrin stimulation, but this is not 
required for SFK activation 
About 20% of cellular PTPα is constitutively tyrosine phosphorylated at Tyr789 near 
its C-terminus, and tyrosine phosphorylated PTPα interacts with Grb2 via the Grb2 
SH2 domain (den Hertog et al., 1994; Su et al., 1994). The phospho-Tyr789 and Grb2 
association appears to protect phospho-Tyr789 from dephosphorylation and block 
other SH2 domain-containing proteins from interacting with PTPα. Conformational 
changes in PTPα that occur just prior to or early in mitosis, reduce the binding affinity 
of Grb2-SH2 for PTPα phospho-Tyr789 while enhancing the binding affinity of Src-
SH2 for this phosphotyrosine site. In this manner, phosphorylated Tyr789 acts to pry 
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open the closed conformation of Src by displacing the Src tail phospho-Tyr527 residue 
from the Src-SH2 domain, thus disrupting this intramolecular interaction and thereby 
exposing the phospho-Tyr527 residue in Src for dephosphorylation by the nearby 
PTPα catalytic domain (Zheng et al., 2000). Whether this displacement mechanism of 
PTPα-mediated Src activation is involved in SFK activation in integrin-mediated 
events was investigated. 
 
The Tyr789 residue at the C-terminus of PTPα is phosphorylated in adherent 
fibroblasts (Fig. 5.1A). PTPα tyrosine phosphorylation is enhanced in response to 
integrin stimulation, and either Src or Fyn/Yes (SFKs) is responsible for integrin-
induced PTPα phosphorylation (Fig. 5.2), in accord with the report that co-expression 
of PTPα with Src enhances phosphorylation of PTPα (den Hertog et al., 1994). This 
finding that PTPα tyrosine phosphorylation is enhanced upon integrin stimulation is 
the first report of the regulated phosphorylation of this receptor PTP. Furthermore, 
PTPα catalytic activity is required for this event, as a catalytically inactive mutant 
form of PTPα (C433S/C723S) is not tyrosine phosphorylated when expressed in 
PTPα-/- cells (Fig. 5.3). Together, these findings suggest that PTPα activation of SFKs 
is required to in turn effect SFK-mediated PTPα tyrosine phosphorylation, and that the 
residual Src/Fyn or other SFKs activity in PTPα-/- fibroblasts is not sufficient for PTPα 
phosphorylation. FAK is also required for PTPα phosphorylation, as evidenced by the 
reduced PTPα tyrosine phosphorylation detected in FAK-/- cells in adherent and 
integrin-stimulated conditions (Fig. 5.4A). Disruption of actin polymerization by 
cytochalasin D affects PTPα tyrosine phosphorylation upon integrin stimulation (Fig 
5.4B), suggesting that PTPα tyrosine phosphorylation is dependent on an intact actin 
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organization. As shown in Fig. 6.1, these results indicate that PTPα tyrosine 
phosphorylation occurs following the formation of the SFK-FAK complex and is 
indeed effected by this complex. In addition, integrin-induced PTPα phosphorylation 
is impaired in cells lacking SHP2, suggesting that SHP2 is implicated in the process of 
integrin-mediated PTPα phosphorylation. SHP2 is likely an additional PTP involved in 
the regulation of the formation of the SFK-FAK complex upon integrin stimulation. 

























Figure 6.1 A diagram of integrin-induced PTPα phosphorylation. PTPα-mediated 
SFK activation is required for integrin-induced PTPα phosphorylation. Integrin-
stimulated PTPα phosphorylation is dependent on integrin-induced cytoskeleton 
organization. SHP2 is implicated in the process of integrin-stimulated PTPα 







Consistent with the observation that PTPα Tyr789 phosphorylation occurs subsequent 
to PTPα-mediated SFK activation, this phosphorylation of PTPα is not required for 
SFK activation upon integrin stimulation. The reintroduction of PTPαY789F into 
PTPα-/- cells is fully able to rescue the defective integrin-induced Src/Fyn activation, 
to a level comparable to that in wild type fibroblasts or PTPα-/- cells re-expressing wild 
type PTPα. However, catalytically inactive PTPα (PTPαDM) cannot rescue the 
defective SFK activation in PTPα-null cells (Fig 5.6). The findings are in accord with 
a report that mutant PTPαY789F is capable of generating Src dependent foci in 
NIH3T3 cells, while catalytically inactive mutant PTPα does not possess this ability 
(Lammers et al., 2000). In line with its ability to rescue integrin-induced activation of 
SFKs, PTPαY789F can also rescue impaired FAK Tyr397 or Tyr576 and paxillin 
phosphorylation (Fig. 5.7). This is in contrast to the report that phosphorylation of 
PTPα Tyr789 is essential for PTPα-mediated Src activation during mitosis (Zheng et 
al., 2001). However, the present findings clearly demonstrate that PTPα catalytic 
activity, but not Tyr789 phosphorylation, is necessary for integrin-stimulated Src/Fyn 
activation and subsequent FAK activation and phosphorylation. Thus a mechanism 
other than that operating in the PTPα phospho-Tyr789 displacement model is 
responsible for PTPα-mediated Src activation upon integrin stimulation. Src can bind 
to the β3 integrin subunit (or to other integrins) through an interaction with its SH3 
domain (Obergfell et al., 2002; Arias-Salgado et al., 2003). This interaction can perturb 
Src intramolecular interactions or induce conformational changes that result in the 
exposure of the C-terminal phospho-Tyr527 of Src, thereby promoting its accessibility 
for dephosphorylation by phosphatases (Arias-Salgado et al., 2003). Furthermore, 
PTPα has been shown to associate with αv integrins following their binding to ligands 
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(von Wichert et al., 2003). The FN-stimulated interaction of integrin with PTPα thus 
may enhance the physical proximity of PTPα to integrin-bound SFKs. In this model 
(Fig. 6.2), integrins act as a scaffold to bring PTPα and Src into close proximity. In 
addition, the integrin-Src SH3 interaction and the integrin-PTPα interaction result in 
conformational alterations that promote PTPα-catalyzed Src dephosphorylation. 
Through these means, activated integrins provide an environment analogous to that 
occurring through direct PTPα-SFK binding in the displacement model, but 
circumvent the requirement for PTPα Tyr789 phosphorylation for integrin-induced 
SFK activation. 
 
6.3.2 PTPα Tyr789 phosphorylation is required for integrin-stimulated cell 
spreading and migration 
PTPα-/- and Src-/- cells exhibit delayed FN-induced cell spreading, accompanied by 
impaired actin stress fiber assembly and focal adhesion formation (Kaplan et al., 1995; 
Zeng et al., 2003). Tyrosine phosphorylation of PTPα is dependent on an intact actin 
cytoskeleton, as there is a reduced PTPα phosphorylation when cells are treated with 
cytochalasin D, an agent that disrupts integrin-induced actin polymerization (Fig. 
5.3A). Although PTPα Tyr789 phosphorylation is not required for integrin-induced 
SFK activation and full FAK phosphorylation and activation, it is required for other 
downstream events in integrin-mediating signaling. Expression of PTPαY789F in 
PTPα-/- fibroblasts cannot rescue the delayed cell spreading and retarded cytoskeletal 
reorganization upon integrin stimulation, whereas these defects are rescued in PTPα-/- 
cells expressing wild type PTPα (Fig. 5.8). Therefore, tyrosine phosphorylation of 
PTPα is required for a second function of PTPα that regulates integrin-induced 
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cytoskeletal rearrangement and focal adhesion formation. These findings are consistent 
with the report that the C-terminal Tyr789 residue of PTPα is important for its 
localization to focal adhesion, as PTPαY789F overexpressed in NIH3T3 cells cannot 
be detected in focal adhesion sites where wild type or catalytically inactive PTPα is 
typically localized (Lammers et al., 2000). Grb2 can interact with phosphorylated 
PTPα via its SH2 domain and associate with other proteins such as Sos, an Ras 
activator, but Sos is not present in the Grb2-PTPα complex. Therefore, PTPα is 
unlikely to be coupled to the Ras pathway through this interaction (Su et al., 1996). It 
remains to be determined whether Grb2 mediates novel protein interactions that 
transduce signals from integrins to the cytoskeleton upon integrin stimulation, or if 
integrin-induced phosphorylated PTPα can interact with other unidentified focal 
adhesion proteins to mediate downstream signals. 
 
6.3.3  Two roles of PTPα in integrin signaling 
PTPα plays an important role in integrin-induced SFK activation, and this is dependent 
on the catalytic activity of PTPα to dephosphorylate the C-terminal regulatory tyrosine 
residue of Src and Fyn. PTPα Tyr789 phosphorylation is important for Src activation 
during mitosis (Zheng et al., 2002), but is not required for integrin-mediated SFK 
activation. PTPα phosphorylation at Tyr789 is a downstream event resulting from Src 
and Fyn activation, and is in turn required for other downstream events in integrin 
signaling including cell spreading, the assembly of actin stress fibers, and focal 
adhesion formation. The results here demonstrate two roles of PTPα in integrin 
signaling: an early role as an activator of SFKs and FAK which does not require 
PTPαTyr789 phosphorylation, and a later role in mediating integrin-induced 
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cytoskeletal organization that is PTPα Tyr789 phosphorylation dependent (Fig. 6.2). 










































































Figure 6.2. A proposed model of the two roles of PTPα in integrin signaling. (1) 
An early role of PTPα as an activator of SFK in integrin signaling which does not 
require PTPα Y789 phosphorylation. (2) A later role of PTPα in integrin-mediated 






6.3.4 The reciprocal link between integrin-induced PTPα phosphorylation and 
cytoskeleton organization may underlie the defects observed in α/s DKO cells 
Many proteins are reported to be temporally and spatially involved in integrin 
signaling, and these molecules are interconnected and affected reciprocally in the 
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complex network of integrin signaling (Martin et al., 2002) (Fig. 6.3, black line). This 
type of regulation occurs between PTPα and Src. PTPα-mediated SFK activation is 
essential for efficient integrin-induced signaling (Su et al., 1999; Zeng et al., 2003), 
and a novel effect of PTPα-mediated SFK activation is the ensuing integrin-induced 
phosphorylation of PTPα (Fig. 6.2). PTPα phosphorylation is not required for integrin-
mediated SFK activation, but it is required for integrin-induced events that are 
dependent on cytoskeletal rearrangement such as cell spreading and migration. On the 
other hand, integrin-induced phosphorylation of PTPα requires an intact actin 
cytoskeleton. Taken together, these data demonstrate a reciprocal link between PTPα 
phosphorylation and cytoskeleton organization in integrin signaling, although the 
signaling mechanism(s) underlying this linkage are unclear. 
 
The absence of either PTPα or Src in mouse embryonic fibroblasts results in a reduced 
cell spreading and delayed actin cytoskeletal organization, suggesting that the residual 
activities of Fyn, Yes and/or other SFKs in PTPα-/- or Src-/- cells are insufficient to 
accomplish these processes at the same rate as in wild type cells. Due to reduced 
Src/Fyn activity in PTPα-/- cells or the absence of Src in Src-/- cells, the defects 
observed in these single knockout cells may result from reduced signal efficiency upon 
integrin stimulation rather than from an altered signal transduction pathway. The 
combined absence of PTPα and Src not only greatly reduces SFK activity, to an 
overall level that is much lower than that in cells lacking only PTPα-/- or Src-/-, but also 
abolishes the second role played by PTPα in cytoskeleton-linked integrin signaling. 
The consequences of this dual ablation lead to the unique phenotypes observed in α/s 
DKO cells when plated on FN, including the early formation of microspikes and 
enhanced late stage focal adhesion formation. A functional link between PTPα 
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phosphorylation and cytoskeletal organization indicates that the combined ablation of 
Src and PTPα may severely interfere with their balanced regulation of focal adhesion 
dynamics, or that PTPα-mediated SFK activation may be involved in focal adhesion 
disassembly. If the latter is the case, PTPα-mediated SFK activation may operate as a 
negative feedback loop in integrin signaling to orchestrate integrin-induced responses 
(Fig. 6.3). The inability of α/s DKO cells to inactivate Erk when cells are detached 
from the substratum further supports this possibility. 
 
6.4 Overall summary 
PTPα is a positively regulator of SFKs, and PTPα-mediated Src/Fyn activation has 
been demonstrated to be essential for many biological processes including 
differentiation, transformation, and specific tissue development (Ponniah et al., 1999; 
Petrone et al., 2003). The requirement for the dual expression of PTPα and Src in 
embryonic development and FN-induced tyrosine phosphorylation and cytoskeleton 
organization were investigated in this study. This revealed that the combined ablation 
of PTPα and Src does not result in embryonic lethality. Mice deficient in Src exhibit 
growth retardation and a failure in tooth eruption that is not dependent on the presence 
or absence of PTPα. The residual Fyn, Yes and other SFK activities in PTPα-/-Src-/- 
mice are not sufficient for mouse maturation to adulthood, as postnatal mortality 
increased in PTPα-/-Src-/- mice at a rate higher than in Src-/- mice. The lack of more 
severe phenotypes in PTPα-/-Src-/- mice is likely due to redundant functions of SFKs 
and/or compensatory actions of PTPs during embryonic development.  
 
Unlike PTPα-/- or Src-/- cells, α/s DKO cells display normal FAK Tyr397 
phosphorylation and enhanced focal adhesion formation upon FN stimulation. This 
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observation suggests that PTPα-mediated SFK activation is important not only for 
focal adhesion formation but also for focal adhesion disassembly. Both processes are 
equally important for integrin-regulated cell migration. Furthermore, Erk activation 
cannot be turned off in α/s DKO cells upon detachment from the substratum, 
suggesting that a negative feedback loop operates through PTPα and Src to modulate 
integrin signaling. Another possibility for these unique phenotypes observed in FN-
stimulated α/s DKO cells may be the upregulation of other integrin signaling 
transduction pathways (Fig. 6.3, red lines), thereby bypassing a requirement for the 
normal functions of PTPα and Src. For example, a highly phosphorylated, unidentified 
p90 kDa protein is detected in PTPα/Src double mutant mouse brain and fibroblasts, 
although its function is unknown. Numerous PTKs and PTPs are proposed to be 
involved in integrin signaling, but precisely how their actions are connected and 
orchestrated is still unclear. 
 
To further understand the functional link between integrin stimulation and PTPα 
function in transducing a signal to SFKs, the regulation of PTPα upon integrin 
stimulation was investigated. My data distinguish two roles of PTPα in integrin 
signaling, an early role as an SFK activator, and a later role in cytoskeletal 
organization and focal adhesion formation. PTPα-catalyzed SFK activation is essential 
for integrin signaling, and also important for integrin-induced PTPα phosphorylation 
(Fig 6.3, dark lines). This study has revealed that not only FAK and SFKs, but also 
SHP2, is implicated in integrin-induced PTPα phosphorylation, as this is impaired in 
the absence of SHP2. As PTPα and SHP2 are not the PTPs responsible for 
dephosphorylating PTPα upon detachment from the substratum, other PTPs must 
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catalyze this dephosphorylation. Further studies are required to delineate how other 
PTPs are functionally integrated in this and in the myriad and complex biological 






























Figure 6.3. Integrin signaling transduction pathways. (1) The black lines depict the 
classical integrin signaling pathway. Integrin engagement leads to SFK and FAK 
activation, thus leading to formation of a SFK-FAK complex that transduces 
downstream signaling events. (2) The blue lines indicate the pathway that may 
dominantly operate in the absence of PTPα. Integrin-induced signaling processes are 
delayed as a result of reduced Src/Fyn activity. (3) The pathway indicated by the red 
lines may be upregulated in the absence of both PTPα and Src, leading to distinct 














6.5 Future directions 
My findings have demonstrated a novel relationship between PTPα and SFK in 
integrin signaling. PTPα-mediated SFK activation is necessary for most integrin-
stimulated signaling events, and PTPα-mediated activation of SFKs is required for 
integrin-induced tyrosine phosphorylation of PTPα, thus leading to efficient 
downstream signaling events. The mechanism by which PTPα phosphorylation is 
linked to these downstream events is still unknown. The small GTPases RhoA, Rac1, 
and Cdc42, are important molecules controlling cytoskeleton organization upon 
integrin stimulation, and SFKs as well as FAK have been shown to be implicated in 
regulating GTPase activities (Arthur et al., 2000; Ren et al., 2000). As tyrosine 
phosphorylation of PTPα is required for cytoskeletal rearrangement and focal adhesion 
formation upon integrin stimulation, it will be important to determine if PTPα 
phosphorylation regulates the activity of small GTPases, perhaps through SFKs or by 
interacting with other focal adhesion proteins. 
 
Multiple studies have demonstrated that PTPs are as important as PTKs in integrin 
signaling (Angers-Loustau et al., 1999; Oh et al., 1999; Tamura et al., 1999; Cheng et 
al., 2001). Furthermore, the present study has shown that PTPα is dephosphorylated 
upon cell detachment from the substratum and is rephosphorylated when cells are 
plated on FN, demonstrating a regulated tyrosine phosphorylation of PTPα. PTPα 
itself and SHP2 are not responsible for the detachment-induced dephosphorylation of 
PTPα. Cell lines derived from genetically modified mice lacking particular PTPs 
would be excellent tools to use in investigating the identity of the PTPα PTP. 
Although it is clear that integrin-induced PTPα phosphorylation occurs following the 
formation of the SFK-FAK complex, it is still unclear which kinase directly 
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phosphorylates PTPα upon integrin stimulation. FAK- and SFK- deficient cell lines 
(FAK-/- and SYF cells) manipulated to re-express different mutants of FAK or Src 
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